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Abstract
There are difficulties in the standardization of traditional Chinese medicines
(TCM) because of the complexity of TCM preparations. This leads to regu-
latory problems. In the present work, several Chinese medicinal plants were
investigated including Danshen(Salvia miltiorrhiza Bunge), Sanqi(Panax no-
toginseng Burk.), compound Danshen dripping pill, and several species of the
genus Panax.
Plant materials and commercial products containing these taxa were anal-
ysed by a range of techniques, including chemical- and activity-based stan-
dardization methods: the chemical techniques used include high performance
liquid chromatographic (HPLC), nuclear magnetic resonance (NMR) spec-
troscopic and infrared (IR) spectroscopic methods, followed by chemometric
analysis.
Different brands of Danshen finished products, Danshen plant root ma-
terials of different origin, and Sanqi plant root materials with different pro-
duction dates were successfully discriminated from each other. Asian and
American ginseng were successfully discriminated, and arginine was found
for the first time as a main difference, together with other primary and sec-
ondary metabolites, using 1H-NMR-PCA. For wild and cultivated American
ginseng which had reputed activity in diabetes, an activity-based standard-
ization method based on a cell viability test and proteomic analysis (using
two-dimensional difference gel electrophoresis (2D-DIGE) analysis) of mouse
insulinoma (MIN6) cells was performed. 83 proteins were found to be signif-
icantly up or down-regulated.
This work shows that HPLC, and NMR and IR spectroscopy coupled
with PCA methods are applicable to standardization methodologies. The
3
4advantages and disadvantages of HPLC, and NMR and IR spectroscopic
technology are discussed and compared. The 2D-DIGE protein profile can
be correlated with TCM treatments.
This work contributes to the current problem of regulatory control of
TCM preparation as traditional medicines and may suggest a practical way
forward.
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Chapter 1
General introduction
1.1 Traditional Chinese medicine
Traditional Chinese medicine (TCM) is mainly based on the Yin-yang and
five element theory (metal, wood, water, fire and earth) in traditional Chi-
nese philosophy. TCM include herbal medicines, animal products, minerals,
and metals. A TCM preparation is often a mixture consisting of up to a
dozen TCM acting as the “emperor”, “minister”, “assistant” and “guide” re-
spectively. The “emperor” is the main medicine targeting as the disease. The
“minister” medicine assists the “emperor” or to target at the accompanying
symptom. The “assistant” may inhibit the toxic effect of the “emperor” and
the “minister” and the “guide” leads all the TCM to the diseased region. In
a TCM preparation, the “emperor” is always present, while the others are
not always necessary. TCM practitioners prescribe an individualised mix-
ture according to each patient’s symptoms and physical condition. However,
there are also famous combinations of TCM that have been repeatedly pre-
scribed. Traditionally, the prescribed TCM is boiled by the patients and the
soap is consumed. Currently, preprepared TCM are made into tablets, pills,
granulations, and liquids for the convenience.
The use of TCM was first recorded from the years 2,698 - 2,596 BC by
the supposed yellow emperor. The book Neijing Suwen or Inner Canon:
Basic Questions, also known as the Huangdi Neijing (Yellow Emperor’s Inner
17
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Canon) was written in that period. In the Han Dynasty (202 BC - 220 AD),
TCM flourished. The representative character is Zhang Zhongjing who wrote
Shang Han Za Bing Lun which was composed of two parts “Treatise on Cold
Damage” - focusing on febrile conditions attributed to “Cold”, and the Jingui
yaolue (“Essentials of the Golden Cabinet”) - focusing on “miscellaneous
illnesses”. Shang Han Za Bing Lun is the first literature of TCM including
theories, methods, treatments and medicines which has great significance in
the history of TCM.
In the Ming Dynasty (1,368-1,644 AD), Li Shizhen wrote Ben Cao Gang
Mu (Compendium of Materia Medica) which is regarded as the most com-
plete and comprehensive medical book ever written on TCM. It lists all the
plants, animals, minerals, and other objects which were believed then to have
medicinal functions.
TCM has been widely used in China, Korea, Japan, etc. Coming to the
present day, natural products have been a productive source of drug discov-
ery. Over a 100 natural product derived medicine are undergoing clinical
development, especially anti-cancer and anti-infective medicines[1]. Nowa-
days, TCM have been found to have effects on anaemia[2], dysmenorrhea[3],
cardiovascular disease[4] etc.
TCM has drawn the world’s attention. Around 40% Americans with
chronic diseases have used complementary and alternative medicines[5], while
TCM is the most commonly used. In the past five years, the Chinese gov-
ernment has invested 130 million US dollars for TCM research and develop-
ment[6].
TCM has been extensively reviewed on the treatment of diabetes [7],
hepatitis B virus infection [8]. TCM has been used to treat cancer widely in
China [9].
Being widely used in the world, the quality, safety and efficacy of TCM
became the biggest concern. In this chapter, current situation, various meth-
ods used in quality control of TCM are briefly reviewed. Chapters 2, 3 and
4 consist of more information in their introduction sections.
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1.1.1 Current quality control methods for TCM and
the problems
Currently there are some 3,000 Chinese practitioners in the UK. Although
some parts of TCM have been found to be effective, it has had difficulties
in being accepted by western countries. Standardization is a prerequisite
for western clinical evaluation of the materials if they are to be successfully
registered as medicinal products. There are several difficulties for the defini-
tion of Chinese Medicines. Firstly, an individual plant species contains many
(active and inactive) substances and the medicinal remedies often contain
many different plants used together. Purification of the various compounds
turns out to be difficult and time consuming. The identification of all con-
stituents in one single plant would be prohibitively expensive. Secondly, the
same species of plant grown in different places[10] or harvested in different
years [11] may have different constituents. Thirdly, the health care policy
needs to be modified in order to bring TCM into western countries because
herbals cannot be simply treated the same as chemical compounds. Conven-
tional chemical drugs only consist one or a few chemicals, therefore quality
control is straightforward. For botanical drugs, with more than hundreds
of chemicals present, precise control of each chemical is impossible. Till
now, the underlying ethnopharmacology mechanisms of none of the herbal
medicine are fully explained. Therefore, it is not sufficient to say that any
a few biomarkers could represent the true quality of any TCM. Finally, an
effective method is required in order to analyse the numerous constituents.
Due to all these difficulties, herbal materials are sometimes unidentified and
almost always unstandardised[12].
Recently, modern technologies have been introduced in the quality control
of TCM. In the 2005 Chinese Pharmacopoeia[13], 1,523 items are tested
by TLC, 518 items are tested by high performance liquid chromatography
(HPLC) and 47 items are tested by gas chromatography (GC). Most of the
products have only one compound as quality control marker while in recent
years some of them have two or more. However, the chemical markers are
usually not the only active compounds in the product[14] .
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NMR spectroscopy is not included in the standard tests in the Chinese
Pharmacopoeia. However, it becomes increasingly interesting as a non-
reductive method for quality control of TCM, and is often used together
with statistical analysis[15][16].
Despite all the difficulties, some herbal products have been registered
as drug. In 2006, Veregen R© Ointment (http://www.veregen.com/) gained
FDA approval (http://www.accessdata.fda.gov/drugsatfda_docs/nda/
2006/021902s000TOC.cfm), as the first botanical drug. It is used to treat ex-
ternal genital warts. The active ingredient in Veregen R© Ointment is Sinecat-
echins, a partially defined purified water extract from green tea leaves.
1.2 Chemical-based standardization of TCM
Chemical-based standardization, as is named by the author, means using var-
ious analytical approaches such as chromatography or spectroscopy to quan-
tify, identify, and analyse the chemical composition of TCM, and therefore
control the quality of TCM. Researchers try to understand the differences in
compositions of TCM from different species, different regions[10], different
parts of the plants[17], different years of harvesting[11], etc. Chemical-based
standardization is the most common method used to control the quality of
TCM. The interest in quality control of TCM has been growing quickly over
the last few years.
Figure 1.1 was generated using the following search conditions on PubMed:
(authentication[Title/Abstract] OR quality control[Title/Abstract] OR
metabolomics[Title/Abstract] OR fingerprinting[Title/Abstract]) AND (herbal
medicine[Text word] OR Chinese medicine[Text word]) AND HPLC [Ti-
tle/Abstract] AND (”20xx/01/01”[PDAT] : ”20xx/12/31”[PDAT])
For the papers related to NMR or IR, “HPLC” was substituted by into
“NMR” or “IR” in the searching terms. The years indicated in “20xx” need
to be replaced accordingly. For IR, only 17 papers ever published and many
of them came from a low quality journal. Therefore it was not presented in
this figure.
The results shown were manually checked and most of them are related
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Figure 1.1: Yearly publications on quality assessment of herbal medicines
using HPLC and NMR spectroscopic techniques.
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to quality control of TCM. There are also other papers are related to quality
control of TCM but not found using this term, because the key word they
used may be“discrimination”, “separation”, or only used the Latin or Chinese
name of a specific herb, without mentioning “herbal medicine” or “Chinese
medicine”. Therefore figure 1.1 is only a brief indication of the trend.
HPLC was used the most in quality control of TCM, because it is easy
to use, and the separated known chemical compounds can be identified and
quantified easily. Fewer papers used NMR, because chemical compounds are
not separated in the spectrum, resulting the identification and quantification
more difficult than HPLC. However, since 2006, the publications using HPLC
did not increase much, but those using NMR showed an increasing trend. The
number of publications using NMR on quality control of TCM increased 2-
fold in 2012 compared to 2011. The reason may be that researchers realised
that NMR, as a non-reductive method, can detect all the compounds with
protons, therefore coincide with the “holistic” concept of the TCM.
1.2.1 Chromatographic methods used in quality con-
trol of TCM
The most popular chromatographic methods used in quality control of TCM
include thin-layer chromatography, high performance liquid chromatography
and gas chromatography. Chromatographic methods have different mech-
anisms (adsorption, partition, ion exchange etc.) to separate compounds
from a mixture using different detection systems. Most common detectors
include ultraviolet (UV), photodiode array detection (DAD), and evaporative
light scattering detectors (ELSD) detectors. DAD detector can be used to
measure several UV wavelengths at the same time, but can not detect non-
UV-absorbing components. ELSD is good at detecting non-chromophoric
compounds[14], but has a slightly low sensitivity to low molecular weight
components due to their small size. However, none of the detectors could de-
tect all the compounds. Therefore, chromatographic method is also referred
to as a reductive method[15]. Despite of this, chromatographic methods are
still the most widely used since it is easy to quantify and identify separated
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compounds.
Thin-layer chromatography (TLC)
TLC is widely applied because it is easy, fast and cheap. Compounds without
UV absorption can be detected by TLC by spraying with a visualization
reagent. In a single TCL plate, more than 30 compounds can be detected. It
is easy to identify the existence of the compounds in botanical extracts simply
by comparing the retentions times of the spots with all the chromatographic
conditions fixed. However, this method is not as powerful because sometimes
some spots may overlap therefore could not be distinguished sufficiently[14].
TLC is a simple and rapid way to perform qualitative analysis and could
provide a general idea of the compound contents although the basic TCL has
lower accuracy and repeatability than other chromatographic methods such
as HPLC and GC. Enhanced forms of basic TLC such as high performance
thin layer chromatography (HPTLC) is used to gain higher resolution and
accuracy. [18] TLC is a convenient method to perform a quick check to
distinguish certain adulterants or fake TCM.
HPLC
HPLC is widely used in standardization of TCM for its powerful separation
and quantitative capabilities. HPLC is easily attached to different detectors,
such as UV, DAD and ELSD, and spectroscopy such as MS and NMR[19].
Mass spectrometry helps to analyse the structure of the compound as well
as gaining information about the molecular weights.
In recent years, Jacob et al. have applied ultra-performance liquid chro-
matography (UPLC) combined with mass spectrometry (MS) on research
of the chromatographic fingerprints of herbal medicines[20]. UPLC has a
smaller particle size in the stationary phase than a normal HPLC, therefore
band-broadening was decreased but resolution and sensitivity were increased.
Zhou et al. have developed an improved quality control method for fin-
ished Chinese medicine products using HPLC-DAD hyphenated technology
[21]. Six hydrophilic and lipophilic components were compared between fin-
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ished medicinal products produced by 8 different companies. The result
indicated that the content of the six components vary considerably between
different brands and tablets.
Gas chromatography(GC)
Many active compounds existing in the Chinese medicines are volatile. GC
has high sensitivity on separating most of the volatile compounds. However,
it has some disadvantages such as the inability of separating non-volatile or
polar compounds.
Coupled with MS, both qualitative and quantitative information can be
obtained. Two dimensional GC/MS has been applied on the research on
Pogostemon cablin Benth.[22]. Volatile oils were successfully separated into
more than 800 chromatographic peaks and 394 of these were identified.
1.2.2 Spectroscopic methods used in quality control of
TCM
Nuclear magnetic resonance (NMR) spectroscopy
1H-NMR is the most commonly used NMR spectroscopy in TCM, because
hydrogen is widely present in most of organic compounds. 1H-NMR needs
less sample and less time to run than 13C-NMR.
Contrary to HPLC, in 1H-NMR spectra, one compound can result in
multiple peaks, depending on the different magnetic properties of its pro-
tons. TCM extractions contain many compounds, which resulting overlap-
ping peaks in NMR spectrum, making the quantitative analysis difficult.
However, quantification of compounds is possible by using an internal stan-
dard in NMR spectroscopic analysis of multi-ingredient TCM extracts[23].
Due to its advantage of whole structure analysis, NMR spectroscopy can
give details of the molecular composition. However, the extract of TCM is
usually a mixture of compounds and it is difficult to obtain pure compound.
This mixture can show thousands of peaks in the NMR spectrum. Therefore
statistical methods become necessary to extract useful information from this
CHAPTER 1. GENERAL INTRODUCTION 25
mixture of data. Combining NMR spectra with statistical methods such
as PCA or PLS is becoming a trend [11][16]. Several batches of authentic
TCM were analysed by PCA to construct a model, in order to predict the
authenticity of an unknown samples.
Infrared spectroscopy
Infrared spectroscopy exploits the specific frequencies that a molecule absorbs
according to the characteristic of its structure. A beam of infrared light is
used to pass through the sample and the spectrum is recorded. Absorption
occurs when the frequency of light matches to the vibrational frequency of
covalently bonded atoms and groups. All organic compounds absorb infrared
radiation, and their absorption spectra are characteristic to the wide variety
of vibration motions of molecules. Reciprocal centimetre (cm−1) is used as
the frequency scale to show the number of wave cycles in one centimetre.
As a fast, cheap, non-destructive method, Fourier transform near infrared
spectroscopy (FT-NIRS) coupled with PCA has been used to successfully
distinguish Danshen roots grown in four different regions [24].
Two dimensional near infrared correlation spectroscopy (2D-NIR) was
used to discriminate Chinese herbal medicine of different geographic regions.
This method was found to be reliable and reproducible[25].
1.2.3 Statistical methods used in the quality control of
TCM
Statistical analysis is crucial in studies of TCM since large amounts of data
from the complex composition of TCM need to be analysed. Common sta-
tistical methods in the quality control of TCM include hierarchical cluster
analysis, principal component analysis, and partial least squares analysis.
Hierarchical cluster analysis (HCA) is a method to find out the natural
groupings of samples. In HCA, each sample is regarded as a group initially,
then the two most similar samples are linked, then the next two, until all the
samples are clustered in one group.
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HCA was use to find out some natural groupings of TCM species. Aconi-
tum kusnezoffii Rchb. was differentiated from other species using HPLC fin-
gerprints with HCA[26]. In this case, the differences between species is large,
some difference can even be visualised on the chromatogram. However, in
the current study HCA was found difficult to distinguish very similar TCM
samples, such as different species of ginseng, and the difference is not easy
correlated to the plant metabolites. Therefore HCA is not used in this thesis.
PCA is an unsupervised method that reduces the dimensions of datasets
by reducing many variables to a few components (factors) according to the
relationships between those variables, summarizes the main differences be-
tween datasets, and explains the differences. Unsupervised means no class or
difference of the data has been predetermined. PCA can reveal inter-sample
and inter-variable relationships visually. Principal component analysis is be-
coming increasingly popular for the quality control of plants and TCM. It
has been used, for example, on grape[27], beer[28] and TCM including Dan-
shen injections[29] and ginseng[30][16]. PCA was coupled with HPLC, NMR
and ATR-IR to study five species of TCM, and some industrial compound
products in Chapter 2 and Chapter 3 of this thesis. Details of principal
component analysis are introduced in chapter 2.
Partial least squares analysis is a supervised method which means that
the groups are defined beforehand. The algorithm of PLS-DA is based on
PCA. Partial least squares analysis is often used to link the complex chemical
composition to a specific activity value, therefore predict the activity of a new
sample. For example, PLS has beem used to correlate the NMR and HPLC
fingerprints of Scutellaria baicalensis under different extraction methods to
the results of MTT assay[31], which is a colorimetric assay for assessing cell
viability.
1.2.4 Metabolomic
Metabonomics was derived from the application of NMR spectroscopy on
biofluids from the mid - 1980s. Metabonomics was applied together with
the use of pattern recognition and multivariate statistical analysis on com-
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plex datasets. The term of metabolomics grew out of metabonomics around
2001 and was defined as a comprehensive and quantitative analysis of all
metabolites. The two words metabonomics and metabolomics are often used
interchangeably[32]. Currently metabolomic methods are applied in many
fields such as human health care, plant science, animal health and model
organisms for research[32]. Nicholson’s group from Imperial College London
has been trying to apply metabolomic method on developing personalized
health care. Urinary metabolites from 4,630 individuals from the U.K., the
U.S. and Asia were analysed. Blood pressure data are correlated with the
urine NMR spectroscopic data to determine if any consistent metabolic dif-
ferences exist between individuals with and without hypertension[33].
HPLC and NMR coupled with PCA were used on differentiating prazi-
quantel tablet from different manufacturers using metabolomic method. Preser-
vative was found in the products from one manufacturer and counterfeit
products are successfully distinguished from the authentic ones[34].
Metabolomics analysis has been carried out on herbal products Artemisia
afra Jacq. using LC-MS and NMR spectroscopic methods[35]. This work
found that those claimed anti-malaria products under study contain Artemisia
afra Jacq. instead of Artemisia annua L. However, the anti-malaria com-
pound artemisinin only exist in Artemisia annua L. which means that those
claimed anti-malaria products could be far too low to be effective.
These works indicated that metabolomics analysis using NMR spectro-
scopic method is a rapid and valuable tool in study of metabolite and quality
control of medicines.
1.2.5 Metabolomics quality control of TCM
Conventional pharmaceutically acceptable methods for standardization and
quality control have until recently relied on inappropriate reductive analyses
- for example, of (often inactive) marker substances. Increasingly, metabo-
nomic applications are finding a place in non-reductive analyses[29][30][16].
Multivariate data analysis (MDA) including principal component analysis,
partial least squares discriminant analysis (PLS-DA), and partial least squares
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are the tools used in metabolomics studies.
A number of analytical techniques are available for metabolite profiling,
including the reductive (involving methods separating constituents such as
gas/liquid chromatography and HPLC) and the non-reductive (eg, mass spec-
trometry and high field NMR). A number of publications [30][16][36][37][38]
showed the feasibility of the use of high field NMR spectroscopic profiling
coupled with multivariate analysis a viable approach for the standardization
and quality control of complex herbal mixtures. This approach is particu-
larly well suited to the problem because, contrary to the chromatographic
methods, the use of high field NMR spectroscopy does not rely on separation
of individual compounds. Such a method is useful because of the increasingly
validated concept of synergy[39] implying that the control of one compound
(active or not) is not sufficient when the clinically observed activity is likely
to be due to the biological effects of more than one compound.
This thesis involves the application of these approaches to the difficult
issue of the standardization and quality control of widely used mixtures of
several different plant species in proprietary and prescription TCM prepara-
tions. This would be an important advance, allowing the possibility of their
precise definition prior to clinical evaluation and eventual registration as a
drug. This outcome, if successful, would be a major advance in the much
needed control of the quality of TCM.
1.3 Activity-based standardization
Activity-based standardization on TCM means linking the activity of the
TCM on a biological system (such as cells, animal, human) to its quality.
If the standard of known activities of good quality TCM is established, the
tested TCM which can not achieve the same activities can be regarded a
“worse” quality sample. Ideally, the selected method to test the activity of
TCM should be “holistic”. Because a TCM contains many chemical com-
pounds, the activities caused by those compounds are complex. Some poten-
tial “holistic” methods may be feasible for the activity-based quality control
of TCM, including metabonomics, genomics and proteomics. The meanings
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of these terms are explained and their usage discussed in the introduction of
Chapter 4 of this thesis.
Not much research has been done on the activity based standardization
of TCM. Although some links have been made between plant to its effect
on a biological system, the purposes of these research are often not quality
control of TCM, but focus on the activities of the plant or the difference
of the biological samples used. For example, human urine was tested after
ingestion of chamomile tea using 1H-NMR metabonomics, and the changes
of metabolites were discovered[40].
In chapter 4 of this thesis, proteomics was used to study the holistic
effects of American ginseng extract on a pancreatic β cell line. Proteins
perform many basic activities in human. As a holistic method, proteomics
quantitatively monitor the changes of thousands of proteins at the same
time. This holistic approach fits the “wholism” concept of TCM, and can
potentially be the future trend to standardize herbal medicines.
1.4 Structure of this thesis
This thesis consists of three experimental chapters. Each chapter is self
contained, including its own introduction, materials and methods, results
and discussion, and conclusion.
The study of the second chapter was done in the beginning of this PhD
project, as an initial study of metabolomic quality control of TCM, using
various analytical methods including HPLC-DAD, 1H-NMR and ATR-IR.
A brief comparison of those methods was carried out, and the feasibility of
those methods on different material types was discussed.
In the third chapter, the metabolomic quality control methods were ex-
plored in a deeper level based on a large sample size (37 batches of ginseng).
1H-NMR with PCA was used to assess the quality of 4 types of ginseng,
including cultivated American ginseng (15 batches), wild American ginseng
(11 batches), Asian ginseng (5 batches), Sanqi ginseng (5 batches). The
difference between them were compared and discussed. Chemical shifts in
1H-NMR spectra which are responsible for the main differences were assigned
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to the primary and secondary metabolites. A two-step exclusion analysis was
used to separate different types of ginseng. Firstly the whole spectra were
analysed, and the main differences between ginseng types were due to sugars,
which are highly abundant in ginseng extract. Secondly the sugar regions
were excluded, then the differences between ginseng types were mainly due
to some less abundant primary and secondary metabolites.
In the fourth chapter, a proteomic approach was used to study the changes
of the protein composition of MIN6 pancreatic β cells, before and after treat-
ment with wild or cultivated American ginseng, during a period of 24, 48 and
66 hours. The proteins that showed a significant up or down regulation were
presented, and the trend of changes over time was plotted. Comparison has
also been made between the protein changes of MIN6 cells treated by wild
and cultivated American ginseng. This work allows the effect of ginseng
extracts on MIN6 cells whole proteome to be characterised, and significant
differences before and after treatment may be used to assess the quality of
ginseng. For example, some products might not cause the same changes in
proteins levels as good quality ginseng.
1.5 Aim of study
The aim of the project is to study the chemical- and activity-based standard-
ization methods of Traditional Chinese Medicine. The feasibility of chemical-
based methods such as HPLC-DAD, 1H-NMR and ATR-IR coupled with
principal component analysis were used to distinguish the chemical differ-
ences of TCM between growing regions, harvesting dates, species, wild and
cultivated, and between batches of the same brands using Danshen, Sanqi
and ginseng products. Also, raw material (original herb) is used, as well as
intermediate preparations, and final product (TCM) samples of a well char-
acterized TCM (compound Danshen dripping pill, CDDP) to demonstrate
the effectiveness of the process analytical technology (PAT)’s in a whole
TCM production process. The data from well characterized TCM samples
(CDDP) from a reputable company (Tasly) should provide meaningful re-
sults to show if the technology is truly a suitable PAT for TCM production
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process quality control/quality assurance (QA/QC). The plan is to test the
feasibility of using a metabolomics approach as a PAT for TCM QA/QC to
provide production/product data from TCM preparations with most of its
content intact, which may be more convincing to the regulation for satisfying
the desire of knowing everything about medication before granting a licence
for use as a drug. These tests investigate the suitability of the metabolomic
method for following, constituent changes during a TCM production process
and for monitoring the constituents consistency in different batches of the
TCM production.
This study also aims to assess the feasibility of proteomics for activity-
based standardization of TCM. Difference in gel electrophoresis(DIGE) was
used to investigate its suitability to distinguish the differences of protein
regulation changes in a pancreatic β cell line (MIN6) before and after Amer-
ican ginseng treatment. Also, the protein changes in MIN6 cells caused by
cultivated and wild American ginseng treatments were compared, therefore
finding the similarity and differences of the the activities (in this case, protein
changes) of similar TCM.
Chapter 2
Evaluation of quality control
methods including multivariate
analysis of HPLC, IR and
NMR spectroscopic data using
various Danshen products
2.1 Introduction
There are difficulties in the standardization of traditional Chinese medicine
(TCM) because of the complexity of TCM preparations. Traditionally, TCM
preparations are combinations of several ingredients designed individually for
patients. In recent years, however, popular TCM combinations are sold as
pre-prepared products. Compound Danshen product is one of the most well
known pre-prepared TCM products. Compound Danshen products usually
refer to a combination of Danshen(Salvia miltiorrhiza Bunge) , Sanqi(Panax
notoginseng Burk.) and borneol. Danshen is used as the main effective
ingredient which is called the emperor, and Sanqi is used as the minister.
Compound Danshen products have been shown to improve cardiovascular
function and consist mainly of extract of Danshen and Sanqi [41]. Compound
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Danshen products are produced in various formulations including tablets,
pills, granules, injections, oral liquids, etc. Among these, compound Danshen
dripping pill (CDDP) is the most popular formulation, with worldwide annual
sales exceeding $148 million in 2009[42]. CDDP will soon begin Phase III
clinical investigation[42].
The U.S. Food and Drug Administration (FDA) new drug registration
process consists of three steps: phase I, II, and III. Phase I is a small scale
investigation that principally includes safety, and dose finding. Phase II is
a clinical trial that studies safety and efficacy on hundreds volunteers and
usually takes up to 5 years. In Phase III investigation, the drug is studied
on a large group of people of thousands, in order to confirm efficacy, monitor
adverse effects, collect safety information and compare to other commonly
used drugs[43]. The Phase III investigation may take another 5 years. De-
spite the efforts and money spent on Phase I and II, 10% to 30% drugs fail
during Phase III [43].
If the Phase III clinical trial is successfully completed, a “New drug ap-
plication” can be submitted to the FDA. At this stage, various factors will
be evaluated, especially if the company has the capability of manufacturing
the drug with a consistent quality. Finally, the drug can be marketed and
prescribed.
Control of drug quality is thus crucial in the process of passing FDA-
regulated clinical trials. For conventional chemical drugs which only consist
of one or a few chemicals, quality control is straightforward. For botanical
drugs, with more than hundreds of chemicals present, precise control of each
chemical is impossible. In 2004, the FDA published guidelines that includes
botanical drugs into “food supplement” category.
In June 2004, the FDA released “Guidance for Industry: Botanical Drug
Products” that also emphasized the importance of an effective quality control
method for herbal medicines[44].
However, quality control of CDDP is still largely based on evaluating
the quantity of a few active compounds[45]. The existing quality control
method is inadequate since the synergy effects of the multi-ingredient CDDP
is ignored[46].
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In the present study, Danshen, Sanqi, intermediate product and finished
products including commercial CDDP and compound Danshen tablets have
been studied using HPLC, NMR and IR spectroscopic methods with PCA
and PLS-DA data analysis methods in an attempt to improve the process.
2.1.1 Danshen and Sanqi plant
Danshen, Salvia miltiorrhiza Bunge, also known as red sage, Chinese sage or
Tanshen, is from the Lamiaceae family. Danshen was recorded in Shennong’s
Chinese Materia Medica, which is considered the earliest Chinese Pharma-
copoeia, and a significant reference work for Chinese medicine[47]. Danshen
root (Figure 2.1(a)) is the most common part of the plant to be used for
medication. Danshen inhibits platelet aggregation[48][49], dilates coronary
arteries[50] and relieves angina pectoris[51].
Sanqi(Figure 2.1(b)), Panax notoginseng Burk., also named as Tianqi, or
Jinbuhuan, is grown widely in Yunnan province in China. The root of Sanqi is
the most commonly used part in TCM. Sanqi has been used to treat coronary
atherosclerotic heart disease[52], and improve blood circulation[53]. Interest-
ingly, Sanqi has been shown to have both antiplatelet, anticoagulant[54][55],
and anti-bleeding effects[56]. The mechanisms of this dual-direction effects
of Sanqi is unclear. Sanqi has also been shown to have antihyperglycemic
effects[57].
2.1.2 Compound Danshen dripping pill
A group of compound Danshen products are shown in figure 2.2. Among
them, CDDP and industry imitated intermediate material were studied in
this thesis. Compound Danshen tablets were studied in the author’s MSc.
thesis, therefore the data was not presented here.
Compound Danshen dripping pill, also referred to as Cardiotonic Pill, is
composed of aqueous extracts of Danshen, Sanqi and synthesized borneol.
Borneol is a terpene and bicyclic organic compound. Borneol is an adju-
vant and guiding component in Chinese medicine, which does not count as
the main effective medicine in a compound prescription. Synthetic borneol
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(a) Danshen roots
(b) Sanqi roots
Figure 2.1: Commercially available Danshen and Sanqi roots. (a):
Danshen roots, adapted from http: // www. tcm100. com/ Images£_
£ZhongYaoXue/ Danshen-YaoCai. jpg. (b): Sanqi roots, adapted from
http: // files. mainone. com/ company/ companyNews/ 2010£_ £01/
18131555543. gif.
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Figure 2.2: Commercially available compound Danshen products includ-
ing compound Danshen tablets (CDT) and compound Danshen dripping pill.
CDT are produced by various companies including: GKH Natural Herbs
(CDT-G), Hefei Shenlu Double-Crane pharmaceutical company (CDT-G),
and Herbal Inn (CDT-H). IM: intermediate product of CDDP. Photo was
taken by Huiying Zhao on 31 Oct. 2011.
is much cheaper to produce than the natural ones. Sythetical borneol was
shown to have the same pharmacodynamics effect as the natural borneol[58].
It was not known if synthesized or natural borneol was used in CDDP in the
current market.
However, research shows that borneol has the effect of anti-inflammation,
and protecting against cerebral ischemia[59]. Borneol has been shown to
enhance intestinal absorption of salvianolic acids, including a few biological
effective compounds in Danshen such as salvianolic acid B, rosmarinic acid
and salvianolic acid A[60]. Borneol is usually analysed by gas chromatogra-
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phy and is not studied in this chapter.
More than 707 companies produce compound Danshen products. Among
them, 687 companies produce compound Danshen tablets but only one com-
pany produces compound Danshen dripping pill. This is a leading TCM
pharmaceutical manufacturer in China, called Tianjin Tasly pharmaceutical
company (Tasly). CDDP has been produced for 15 years since 1994 and has
become the leading product of Tasly. The sales of CDDP exceeded 1 billion
Chinese Yuan in 2007 which makes it one of the leading Chinese Medicine
products.[42] In January 2010, CDDP became the first compound Chinese
medicine product (produced from more than one plant) that has completed
phase II investigation (FDA, NCT00797953). Till 2010, CDDP has already
been marketed as a drug in Russia, South Korea, Mongolia, Singapore, Viet-
nam, and South Africa[61][62][63].
CDDP has been found to be more effective than isosorbide dinitrate,
which is routinely used medicine, in treating angina pectoris[51]. 60 eligi-
ble randomized controlled trials (with 6931 participants involved) published
between 1994 and 2009 were used, and CDDP was shown more effective.
2.1.3 The general manufacturing process of dripping
pills
The production method of dripping pills was first established in Denmark
and was developed rapidly in China for production of TCM. Water and
organic solvents are commonly used as extraction methods in herbal medicine
manufacture. The herbal extracts are mixed with polyethylene glycol (PEG)
4000 or 6000 or sometimes a mixture of these two as a matrix[64] . The
volumetric ratio of the liquid extract to the matrix is usually around 1:1.5
to 1:2.5[65] . The mixture of plant extracts and matrix is heated to 70◦C to
80◦C and then dripped from a height of about 1 metre into a coolant, often
liquid paraffin, thereby forming the dripping pills in the form of spherical
solid masses of about 3 mm diameter. The size and the temperature of the
dripping nozzle, the rate of dripping, and the distance from the dripping
nozzle to the coolant are all controlled in order to achieve the optimal size
CHAPTER 2. EVALUATION OF QC METHODS 38
and shape of the dripping pills. Common coolants include liquid paraffin,
dimethyl silicone oil and vegetable oil. Dimethyl silicone oil is commonly
used among water soluble dripping pills since it has a smaller surface tension
therefore shapes the pills well[64]. A mixture of coolants is often used[65].
The manufacturing process for compound Danshen dripping pill
Danshen and Sanqi are refluxed with water. The water extract is decantated
and concentrated by evaporation. Ethanol is added to the concentrated
sample to cause sedimentation. The sediment is removed by decantation
and the upper liquid is concentrated to give a sticky mass. Borneol is ground
and mixed with the paste in molten PEG. The final mixture is dripped into
paraffin to produce compound Danshen dripping pill, the dripping pills are
then washed with water and packaged[45].
2.1.4 Primary and secondary metabolites
Primary and secondary metabolites are organic chemicals synthesised in
plants. Primary metabolites serve the purpose for the plants’ fundamen-
tal metabolic pathways involved in their growth and development. Primary
metabolites include mainly carbohydrates, lipids, proteins and nucleic acids.
It was not until the late 20th century that secondary metabolites were
clearly recognised to have important functions in plants. Secondary metabo-
lites serve the purpose of signalling and defence systems in plants, such as
pesticides, scent, colouring and flavouring. Secondary metabolites include
alkaloids, phenolics and terpenoids. They usually present as unique combi-
nations of specific chemicals in different plants, and serve specific purposes
for that plant. Secondary metabolites have no nutritional value to humans,
but may have proved biopharmacological effects, although most of the mech-
anisms remain unknown[66].
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Figure 2.3: Structure of representative diterpenoid quinones in Dan-
shen including: tanshinone IIA, cryptotanshinone, tanshinone I and 15,16-
dihydrotanshinone, representative phenolic compounds including: salvianolic
acid A, protocatechuic aldehyde, salvianolic acid and rosmarinic acid.
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Figure 2.4: Representative saponins from Sanqi
2.1.5 Major compounds and their functions in com-
pound Danshen dripping pill
There are 4 major saponins, 4 major phenolic acids and 4 major diter-
penoid quinones in CDDP. The 4 major phenolic acids from Danshen include
salvianolic acid A (Danshensu, 3-(3,4-dihydroxyphenyl)-2-hydroxylpropionic
acid), rosmarinic acid, protocatechuic aldehyde and salvianolic acid B (Fig-
ure 2.3). The 4 major diterpenoid quinones that come from Danshen include
15,16-dihydrotanshinone, cryptotanshinone, tanshinone I and tanshinone IIA
(Figure 2.3). All of them are bioactive compounds[67][21]. The 4 major
saponins come from Sanqi include notoginsenoside R1, ginsenoside Rg1, gin-
senoside Rb1 and ginsenoside Rd(Figure 2.4).
Salvianolic acid A has vasodilatation ability[68]. It was shown that sal-
vianolic acid A inhibits platelet aggregation, improves micro circulation, pro-
tects the myocardium from reperfusion injury of the ischemic heart, and
has antitumer activity[69]. The mechanisms maybe related to inhibition of
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Ca2+aggregation in cardiac muscle cells[70], inhibiting angiogenesis and tu-
mor cell invasion[69], etc.
Salvianolic acid B has been shown to have free radical-scavening activity
[70]. It has been shown that salvianolic acid B has a higher antioxidant
activity than salvianolic acid A and vitamin C. The mechanisms of salvianolic
B and salvianolic acid A’s antioxidant activities were not fully understood
but are believed to be related to the phenol group[70].
The cardioprotective effects[71] of tanshinone IIA include platelet aggre-
gation, anti-oxidant and anti-inflammatory actions[72]. It has been shown to
significantly reduce mycardial infarct size[72].
Notoginsenoside R1 is the main compound in Sanqi that has cardiovascu-
lar effect [73] .Notoginsenoside R1 may protect the progression of atheroscle-
rosis[74].
The biomarkers mentioned above were the most studied ones in Danshen
and Sanqi products but the precise mechanisms of the biomarkers are not
fully understood. It is even more complex when many compounds work
together to achieve a reinforced effect than when single compounds are used
separately[75].
2.1.6 Current quality standards and the limitations
Quality control of traditional Chinese medicine is important because the
same plant species produced in different places can have different chemical
constituents, therefore leading to different effects[10]. Adulterants are usually
cheaper and less effective than the authentic plant, or not effective at all. For
example, Arctium lappa L., Ipomoea batatas Lam. (sweet potato) and Salvia
przewalskii Maxim. are common adulterants of Danshen[76][10]. Ipomoea
batatas Lam. can be coloured to look very similar to Danshen.
In the past, organoleptic tests such as appearance, taste, smell and feel
were the main quality control methods for TCM. These tests still play an
important part of quality evaluation in China[45]. However, organoleptic
tests are not sufficient since it is impossible for them to be standardised.
In the Chinese Pharmacopoeia 2010 (CP 2010), the following factors are
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mentioned for TCM products: description (appearance), microscopic and
chemical identification, quantitative chemical assay, heavy metals and harm-
ful elements, microbial limits, and animal safety test. HPLC is used for
quantitative analysis for Danshen and Sanqi biomarkers.
The standards for Danshen, Sanqi and CDDP in Chinese Pharmacopeia
are used by the Tianjin Tasly Parmaceutical Company as its quality con-
trol method. In Chinese Pharmacopoeia 2005, three compounds had been
selected to be quantitative biomarkers for Danshen. Tanshinone IIA should
not be less than 0.20%, salvianolic acid B should not be less than 3.0 % and
salvianolic acid A should not be less than 1.2%; for Sanqi, ginsenoside Rg1,
ginsenoside Re, ginsenoside Rb1 and notogingsenoside R1 should not be less
than 6.0% in total[13].
In the CP 2010, salvianolic acid A in Danshen and ginsenoside Re in Sanqi
were not listed in their quantitative analysis( CP2010, volume 1. Sanqi, page
11; Danshen, page 70). Only two compounds were selected to be quantitative
biomarkers for Danshen. Tanshinone IIA should not be less than 0.20% and
salvianolic acid B should not be less than 3.0%. For Sanqi, ginsenoside Rg1,
ginsenoside Rb1 and notogingsenoside R1 should not be less than 5.0% in
total[45].
A limitation of Chinese Pharmacopoeia is that only the lowest value of
chemical markers was defined, not the highest. However, an overdose of effec-
tive chemicals might cause side effects[77]. The lowest threshold of chemical
markers defined by the CP 2010 might only work using exactly the same ex-
perimental parameters. For example, according to the CP 2010, salvianolic
acid B should not be less than 3.0% and tanshinone IIA should not be less
than 0.20% in Danshen. In recent studies by Zhong et al., 74 Danshen sam-
ples were collected from different cultivation locations and provincial hospi-
tals in China, and were simultaneously quantified using a UPLC method[10].
Comparing to the CP, only 11 out of 74 samples contained level of tanshinone
IIA higher than 0.20%, and 17 out of 74 samples contained level of salvianolic
acid B higher than 3.0%. It appears that only 3 out of 74 samples meet both
requirement by CP 2010. This might have been caused by the difference of
extraction methods and experimental conditions. In Chinese Pharmacopoeia
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2010, 75% methanol was used to extract salvianolic acid B. Zhong et al. used
methanol instead. Salvianolic acid B dissolves better in 75% methanol than
in methanol. This might be the reason that a lower content of salvianolic
acid B is obtained in the majority of samples by Zhong et al. than in CP
2010. For tanshinone IIA, methanol was used in both Zhong et al.’s research
and the CP 2010, but the extraction methods are different. Dried Danshen
powder was sonicated for 45 min in Zhong et al.’s study, but was refluxed for
1 hour in the CP 2010. This might means that the mentioned reflux method
is more efficient in extracting tanshinone IIA than sonication method.
Research on simultaneous quantification analysis of Danshen marker com-
pounds by Li et al. [78] showed similar results to Zhong et al.[10]. The con-
centration of tanshinone IIA is 1.58% on average (with a standard deviation
of 0.15, samples with highest and lowest value were not included since they
were far off the average) of Danshen from 7 geographical locations. Ethanol
was used as the extraction solvent. Therefore, the concentration of chemical
markers were not comparable to those obtained using methanol. There are
also many other studies on quantification of chemical markers of Danshen
using various extraction solvents and processes[79], in order to determine the
quantities of biomarkers simultaneously. None of the results obtained can be
compared to the requirements of the CP 2010, or to the research of other
groups, unless the same extraction method was used.
For the quantitative analysis of tanshinone IIA, UPLC (detected at 280 nm)
was used by Zhong and Li[10], and HPLC (detected at 270 nm) was used in
CP 2010. However, this should not be a problem causing the concentra-
tion of tanshinone IIA different, since pure reference compound was used for
calibration in both cases.
Adulterants are not always without bioavailability. The Danshen adul-
terant Salvia przewalskii Maxim. has a unique diterpene quinone called
przewaquinone, which has been shown to be effective against vascular dis-
orders[80] . Salvia przewalskii Maxim has a higher content of rosmarinic
acid and a lower content of salvianolic acid B than Danshen. This makes
it easy to be identified from Danshen, using HPLC. Quantitative control of
reference chemicals helps to distinguish some adulterants and poor quality
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herbs, which have a different content of marker chemicals from the desired
herb. Many studies have suggested quantifying chemical markers as a quality
control method for Danshen. For compound Danshen preparations, Zhou et
al.[21] have selected 6 markers and Wei et al. [67] have selected 12 compounds
as quality control markers. The content of each compound was measured by
HPLC and the overall stability variations and the overall recoveries were de-
termined. By comparing an unknown batch of product with the known ones,
the quality of the unknown product could be evaluated. If the product has
a higher content of the selected biomarkers than the required amount, it is
usually considered a qualified product. However, this herb might have very
distinct concentrations of other chemicals other than the selected biomarkers,
therefore it might also have a very different biological effect. For example, CP
2010 only requires content of salvianolic acid B (SAB) 3.0% and tashinone
IIA 0.2% in Danshen. However, other compounds such as rosmarinic acid
also have reported effects on human[81] .
Therefore, a chemical-based non-selective method has the advantage in
quality control of TCM. As many chemicals as possible can be considered in
a non-selective method, which combines the whole chromatography or spec-
troscopic fingerprints with statistical evaluation methods. All the chemicals
contributed to the signals in the fingerprints were considered in this qual-
ity control method. Non-selective quality control method fits the “synergy”
concept of TCM, and is considered the future of modernization of TCM[82].
Various chromatographic techniques were used to access the quality of
TCM[83]. Ultra-performance liquid chromatography (UPLC) was used with
rPCA (robust principal component analysis) to distinguish commercially
available extract granules of Danshen[84]. rPCA is very similar to PCA,
but use the median instead of the mean of data for the calculation, therefore
minimising the impact of outliers[85].
Fourier transform near infrared spectroscopy was used with PCA and
PLS to distinguish geographical regions of Danshen and its antioxidant ac-
tivity was correlated to different regions[24]. Direct analysis in real time
mass spectrometry (DART-MS) was used with multivariate data analysis to
distinguish Danshen injections and analytical markers were found[29].
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In this chapter, HPLC-DAD (photodiode array detection), 1H-NMR and
ATR(attenuated total reflectance)-IR coupled with PCA were used to study
the quality of Danshen, sanqi, intermediate product and finished commercial
product (CDDP). Two ATR-IR methods including extraction evaporation
and solid sample method were evaluated using CDDP. Danshen grown from
different regions and Sanqi supplied in different dates were analysed. CDDP
produced from different years were compared.
2.2 Materials and methods
2.2.1 Materials
5 batches of Danshen (numbered 1-5) produced in different regions, Sanqi
plant root material supplied in different dates (numbered 1-5) were supplied
by Tianjin Tasly company.
5 batches of Danshen (numbered A-E, provided by Tasly to Zhejiang
University, China), Sanqi (numbered A-E, produced by Hangzhou Chinese
medicine factory) and correlated intermediate products alphabetised from A
to E were provided by Professor Yongping Yu in Zhejiang University. The
intermediate product was prepared by Yu’s group using the same process
as Tasly (Details described in section 2.2.2). The origins of plant materials
are listed in table 2.1. A map of China is shown in figure 2.5 for better
understanding of the origins of Danshen and Sanqi.
9 batches of CDDP produced by Tasly in 2007 and 2009 were listed in
table 2.2.
Voucher specimens of tested samples were deposited in the pharmacog-
nosy library in Institute of Pharmaceutical Science, King’s College London.
Methanol, acetonitrile, water were all of HPLC grade and purchased from
Fisher Scientific (Fisher Scientific Ltd., Pittsburgh, PA), salvianolic acid B,
tanshinone IIA, salvianolic acid A, ginsenoside Rg1, Rb1 were purchased from
Carbosynth (Carbosynth Ltd, Berkshire, UK). Notoginsenoside R1 was pur-
chased from The National Institutes for Food and Drug Control, Beijing.
Protocatechuic aldehyde (D108405, 97%), deuterium oxide (D2O, 661643,
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Table 2.1: Details of herbal materials studied in this chapter. Each batch
has a unique warehouse number (not provided for reasons of confidentiality )
and batch number. Danshen 1–5 were provided by Tasly and used for region-
to-region study. Sanqi 1–5 were provided by Tasly and used for date-to-
date study. Danshen A–E, Sanqi A–E and intermediate products A–E were
used for products in industrial process study. Abbreviations: NOM: nature of
material. P: ground root powder, R: dried and trimmed root, S: sticky syrup.
Studies: which studies have been performed in this chapter. R: region-to-
region study, D: date-to-date study. I: products in industrial process study.
IM: intermediate product. pt.: planting base. HZ: Hangzhou pharmaceutical
factory. ZU: Zhejiang University.
Name NOM Grown in Supply date Supplied by Studies
Danshen 1 P Shaanxi pt. 20/01/2009 Tasly R
Danshen 2 P Shaanxi pt. 09/03/2009 Tasly R
Danshen 3 P Shandong pt. 04/03/2009 Tasly R
Danshen 4 P Shandong pt. 04/03/2009 Tasly R
Danshen 5 P Shandong pt. 04/03/2009 Tasly R
Sanqi 1 P Yunnan pt. 28/10/2008 Tasly D
Sanqi 2 P Yunnan pt. 20/10/2008 Tasly D
Sanqi 3 P Yunnan pt. 25/10/2008 Tasly D
Sanqi 4 P Yunnan pt. 15/11/2008 Tasly D
Sanqi 5 P Yunnan pt. 03/03/2009 Tasly D
Danshen A R Tasly pt. 08/2009 Tasly I
Danshen B R Tasly pt. 08/2009 Tasly I
Danshen C R Tasly pt. 08/2009 Tasly I
Danshen D R Tasly pt. 08/2009 Tasly I
Danshen E R Tasly pt. 08/2009 Tasly I
Sanqi A R Yunnan Prov. 08/2009 HZ I
Sanqi B R Yunnan Prov. 08/2009 HZ I
Sanqi C R Yunnan Prov. 08/2009 HZ I
Sanqi D R Yunnan Prov. 08/2009 HZ I
Sanqi E R Yunnan Prov. 08/2009 HZ I
IM A S N/A 08/2009 ZU I
IM B S N/A 08/2009 ZU I
IM C S N/A 08/2009 ZU I
IM D S N/A 08/2009 ZU I
IM E S N/A 08/2009 ZU I
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Figure 2.5: A map of Chinese provinces. Underlined provinces are related
to the origin of plant used in this chapter. Shandong and Shaanxi provinces
produces Danshen. Yunnan province produce Sanqi. Adapted from http:
// www. sacu. org/ .
%99.99 atom % D, contains 1% DSS-d6) was from Sigma (Sigma Co., St
Louis, MO, USA). 5 mm NMR tubes (Wilmad 507-PP) and methanol-d4
(CD3OD; 99.8% purity) were purchased from Goss Scientific (Goss Scientific
Instruments, Great Baddow, Essex, UK).
2.2.2 Sample preparation
Danshen and Sanqi dried root material were ground using a coffee grinder
and filtered through a 350µm sieve. CDDPs were briefly ground in a mortar,
in order to break and remove the coating. The coating was formed when the
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Table 2.2: Details of CDDP studied. CDDP 1–9 are compound Danshen
dripping pills produced by Tasly in 2009 and 2007. B.B.: best before.
Product Batch no. Production date B.B. date Manufacturer
CDDP 1 090312 20/03/2009 02/2013 Tasly
CDDP 2 090310 28/03/2009 02/2013 Tasly
CDDP 3 090311 04/03/2009 02/2013 Tasly
CDDP 4 090313 04/03/2009 02/2013 Tasly
CDDP 5 090314 04/03/2009 02/2013 Tasly
CDDP 6 20070909 22/08/2007 07/2011 Tasly
CDDP 7 20070403 23/03/2007 02/2011 Tasly
CDDP 8 20070404 23/03/2007 02/2011 Tasly
CDDP 9 20070308 28/02/2007 01/2011 Tasly
liquid plant extract was dripped into the coolant, usually liquid paraffin (see
section 2.1.3).
0.5 g of the samples was extracted with 25 ml 70% methanol in a volumet-
ric flask, by sonicating for 15 minutes at 30◦C followed by shaking manually
and sonicating for a further 15 min. After cooling to room temperature,
evaporated solvent was replaced with 70% methanol and the volume of the
solvent was made up to 25 ml. The supernatant was filtered with a 0.2µm
syringe filter and stored at 4◦C for future use.
Preparation method for intermediate product
150 g Danshen and 50 g Sanqi plant material of each batch were refluxed
with 2000 ml water (pH was adjusted to 7-7.5 using NH3) for 2 hours and
then filtered. The residue was taken and refluxed by 2000 ml water (pH
was adjusted to 7-7.5 using NH3) for 2 hours. The liquid extractions were
combined and concentrated to 1:3 to 1:5 (extract: water). 95% ethanol was
added to the concentrated liquid extraction and the final solvent was made
to contain 80% ethanol by volume. The solvent was stirred and left overnight
and then filtered and concentrated until no more solvent could be evaporated.
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2.2.3 HPLC analysis
HPLC column: Zorbax SB-C18 150mmX2.1mm,5µm, flow rate 0.2ml/min,
Agilent, UK HPLC system: Hewlett-Packard, 1050 Liquid chromatography.
HPLC mobile phase solvent was filtered through a 0.2µm membrane fil-
ter. The mobile phase was composed of (A) aqueous trifluoroacetic acid
(0.1%, v/v) and (B) acetonitrile, over a gradient elution of 0-90% B at 0-40
minutes, 90% B from 40 to 45 minutes, followed by 90-0% B from 46 to 50
minutes, and 0% B from 51 to 53 minutes.
Chromatograms were produced by detection at 205, 210, 230, 254 and
281 nm. 281 nm was chosen as the detection wavelength for Danshen and
CDDP; 205 nm was chosen for detection of Sanqi plants.
Chromatographic data of each run were saved as txt. files and subjected
to data analysis.
2.2.4 NMR spectroscopy
20 ml of the supernatant obtained in section 2.2.2 was evaporated by rotary
evaporation under reduced pressure at 40◦C for 20 minutes. About 7 ml sol-
vent was left after evaporation. This solvent was removed by lyophilization.
D2O(D2O, 661643, %99.99 atom % D, contains 1% DSS(4,4-dimethyl-4-
silapentane-1-sulfonic acid)-d6), [D4]-MeOD (99.8%) with 0.05% (v/v) tetram-
ethylsilane (TMS, Cambridge Isotope Laboratories Inc., Hook, Hampshire,
UK) and DMSO were attempted to reconstitute the lyophilised samples.
Both D2O and CD3OD were found feasible to dissolve Danshen and CDDP
extract, but D2O is better at dissolving Sanqi extract.
Lyophilized samples (10 mg) were dissolved in 1 ml deuterated solvent.
One dimensional 1H NMR spectra were measured at a temperature of 300K
on a Bruker DRX 400 MHz Spectrometer (Bruker, Coventry, UK) equipped
with a 5 mm triple resonance inverse detection (TXI) probe. Spectra were
the result of the summation of 16 free induction decays (FIDs), with data
collected into 65k data points and a sweep width of 20 ppm. Acquisition
parameters were 0.126 Hz/point, pulse width was 14µs 90◦ and relaxation
delay was 1.0 s. Prior to Fourier transformation, an exponential line broad-
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ening equivalent to 0.3 Hz was applied to the FIDs. The signal intensities
for all samples were referenced to TMS at 0.00 ppm. Spectroscopic data for
each run were saved, then transformed to txt. data using MestReNova R©
(MNova) software version 5.2.3(Mestrelab research S.L. Santiago de Com-
postela, Spain).
2.2.5 IR spectroscopic analysis
IR spectroscopic analysis was performed using FT-IR Spectrometers (Perkin
Elmer, Massachusetts) with a Universal ATR Polarization Accessory. Pow-
dered and liquid extraction samples prepared in section 2.2.2 were used in
this test. Diamond was used on the sampling plate as the detection surface.
Danshen and Sanqi powder can be measured directly on top of the dia-
mond with pressure applied. This is called the solid sample method.
Liquid extraction could not be tested directly on the unheated diamond
plate, because solvents such as water and methanol gives overwhelming sig-
nals than plant metabolites. However, the sampling plate can be heated by
a temperature controller, so that solvent could be removed by evaporation.
This is called the evaporation method.
These two preparation methods were investigated on all the materials.
Each sample was prepared in triplicate before analysis.
Solid sample method
For the plant root material, 2 mg of powder was enough to cover the crystal on
the ATR sampling plate. For the dripping pills: each pill was cut through the
middle and half of the pill was placed on the crystal with the cut side down.
The biomarkers were so tested as fine powders. Pressure was applied on the
sample until the first safe lock was clicked. The spectra were then obtained
using 8 scans of each sample. The background signal of the empty sampling
plate was recorded every three sample measurements and subtracted from
the sample spectra.
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Evaporation method
0.5g of sample was extracted with 25 ml 70% methanol under sonication for
30 minutes at 30◦C[63]. The solvent was filtered though a 0.2µm syringe
filter. 10µl of the solvent was added in 5 steps on the ATR-IR sampling
plate which was maintained at 40◦C. After the signal stabilized the spectra
were obtained using 8 scans for each sample. The background signal of the




Protocatechuic aldehyde, a representative phenolic compound in CDDP was
used in this sensitivity test. The highest peak in CDDP chromatogram de-
tected at 281 nm was caused by protocatechuic aldehyde. Protocatechuic
aldehyde is also the cheapest representative chemical biomarker of CDDP.
Standard solutions contain 10, 20, 40, 80, 120 and 160µg/ml protocatechuic
aldehyde were subjected to HPLC analysis using method described in sec-
tion 2.2.3. The peak at 12.82 minutes was caused by protocatechuic aldehyde.
The concentration of protocatechuic aldehyde in CDDP extract was calcu-
lated to be 41.19µg/ml, using the standard curve. 10, 20, 50, 100, 200, 300
and 500µg protocatechuic aldehyde was added into every 25 ml CDDP 70%
methanol extraction, in order to achieve 1%, 2%, 5%, 10%, 20%, 30% and
50% protocatechuic aldehyde-spiked CDDP solutions.
NMR spectroscopy
The protocatechuic aldehyde-spiked Danshen solutions obtained in HPLC
sensitivity test in the previous section were used in this NMR spectroscopy
sensitivity test. 1 ml of each obtained solution was evaporated into dryness,
and dissolved in 0.6 ml of deuterated methanol. This solution was analysed
by NMR spectroscopy using the same parameter described in section 2.2.4.
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IR spectroscopy
Salvianolic acid B, a representative phenolic compound from Danshen, was
used in this sensitivity test. 0.5 g of Danshen powder was extracted by 25 ml
70% methanol under sonication for 30 minutes at 30 ◦C. The solvent was fil-
tered though a 0.45µm syringe filters. The dried residual is 400 mg therefore
100 mg of the Danshen was extracted into the 70% methanol solvent. To the
extract, different percentages of SAB in terms of the dry extract (100 mg)
were used to spike the Danshen: 1%, 3%, 5%, 7.5%, 10%, 15%, and 20%
(0.04, 0.12, 0.16, 0.20, 0.32, 0.4, 0.6 and 0.8 mg SAB was added to 1 ml of
DS extraction respectively). Extraction evaporation method was used in this
study.
2.2.7 Data pretreatment
The raw dataset exported from chromatograms and spectra are usually not
appropriate to perform PCA directly. For chromatographic data, alignment
is necessary because the minor shifts of peaks are inevitable due to the intrin-
sic limitations, such as minor changes in mobile phase compositions, degra-
dation of the stationary phase, and problems related to the detectors[86].
Alignment was proved to be helpful, in a study, after alignment of the
HPLC chromatograms of 79 batches of herbal medicine, the generated PCA
model can explain 35.1% of the total variance, instead of 22.4% before align-
ment[86].
For NMR spectra, bucketing is usually necessary to reduce the large
dataset into a smaller one. Usually the bucket size range from 0.002 to
0.04 ppm. Reduced dataset requires less time to calculate, and also act as a
solution to the problem of the minor shifted peaks in NMR spectra.
Normalization processes have been applied on all the data obtained by
all methods, so removing concentration effects.
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Figure 2.6: HPLC chromatograms of 5 batches of CDDP from 16 to
20 minutes. Top figure: HPLC before alignment. Bottom figure: HPLC after
alignment using Lineup Software.
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Peak alignment
Alignment is an essential part of multivariate data analysis such as PCA.
The retention times of constituents in identical material often shift slightly
because of time, temperature, gas accumulated in HPLC system, slight vari-
ance of composition of mobile phase, etc. Chromatograms without alignment
are not suitable for PCA since the retention times of the same compound may
be slightly different, which effects the correlation between PCA scores plot
and loadings plot.
When performing alignment, all the data files are aligned to one target
file. Target file is the most reliable fingerprinting signal obtained that all
the other files are aligned according to it. In this study, the target file was
selected by Pirouette R© using outlier diagnostics. The sample with the lowest
Mahalanobis distance was selected as the target file. A lower Mahalanobis
distance means closer to the average of all the signals. In this case, sam-
ple 3-1-1 was selected as the target file because it met the above criteria.
Figure 2.6 is an example of HPLC chromatogram of 5 batches of CDDP
before and after alignment. The retention times of the largest peak in the
chromatograms of 5 batches of CDDP were in a range from 18.548 to 18.598
minutes before alignment. After alignment, this range has become 18.577
to 18.580 minutes. The difference between retention times of the same com-
pound has been changed from 0.05 minute to 0.003 minute before and after
alignment which made the variability more than 30 times less. This test in-
dicates that Lineup Software (Informetrix Inc., Woodinville, WA) is suitable
for alignment of HPLC chromatograms before PCA test.
For NMR spectra, if a large bucketing size is used, such as 0.04 ppm,
alignment is usually not necessary. Because bucketing itself acts as an align-
ment function. However, if a smaller bucketing size such as 0.002 ppm is
used, alignment can help to improve the data quality.
The HPLC chromatograms and NMR spectra were aligned using Lineup
TM
software. A few parameters needed to be set before alignment. Slack param-
eters (Warp) is usually set to be 2 to 4. The segment size was best set as the
quantity of data points to form a peak. For example, if on average a peak
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contains 30 data points in a chromatogram, the segment size will be set as 30.
The sides of the fingerprints are sometimes not aligned so extended baselines
(usually called paddings) are added to both sides of the profiles. For exam-
ple, many zeros was added to the sides of chromatograms. However, this was
found not necessary in this study as the peaks in both chromatograms and
spectra are not near the edge. “Shifts” value means how many data points
are desired in order to shift the fingerprint globally. If the shift between tar-
get file and samples file is more than three peaks width, the alignment results
will not be satisfactory. Therefore “shifts” value needs to be set up. In this
study, the alignment parameters were set up as follows: for HPLC, warp, 3;
slack parameters, 100; shift, 0; for NMR spectra, warp, 3; slack parameters,
20; shift, 6.
Normalization
There are a few ways to do normalisation. The normalization algorithm of
Mnova software is simple: the selected peak (usually the highest one) is set
to 100 and each data point in the spectrum is expressed in comparison to it.
The result using Pirouette R© was better since it is based on a more powerful
algorithm known as vector length normalization (equation 2.1). Each variable
is divided by the length of the sample vector f i. The symbol m
∗ indicates
included variables, i is the number of sample, j is the variable number. In
the case of NMR, number of sample means the number of spectrum, variable






Figure 2.7 shows the difference before and after normalisation of 1H-NMR
spectra 5 batches of Danshen. Before normalisation, some concentration
difference can be seen in the intensities. After normalisation, the peaks are
more overlapping each other.
CHAPTER 2. EVALUATION OF QC METHODS 56
Figure 2.7: Effect of normalization on 1H-NMR spectra 5 batches of Dan-
shen from 3.5 to 4.5 ppm. The Y-axis is the intensity in arbitrary units, the
number was not shown.
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Scaling
The high intensity peaks in NMR spectra of TCM extracts were usually
caused by primary metabolites. Due to the low content of secondary metabo-
lites in herbal medicines, the NMR spectroscopic peak of secondary metabo-
lite is usually low. However, secondary metabolites have important pharma-
cological effect despite their low content[87][88][89]. Therefore, the difference
of content of secondary metabolites should be taken account in the analy-
sis of TCM. If the original NMR spectroscopic data (without scaling) were
put into analysis directly, the analytical results would be dominated by the
larger peaks, which came from primary metabolites. To solve this problem,
data scaling method is used to give equal or increased importance of smaller
peaks.
Different scaling methods can be used prior PCA. The most popular ones












In the above equations, xij is the value of the sample located in row i
and column j. x¯j means the average value of samples in column j, in this
case, the average value of responses with the same chemical shift in different
samples. sj means the standard deviation of samples in column j.
For autoscaling, all the data points in NMR spectra are given the same
importance. Noise is often introduced in this way, because baseline data
points are also considered to be important to the results using autoscaling.
Pareto scaling is very similar to autoscaling, however the difference between
each data point and the average data point was divided by the square root of
standard deviation instead of the standard deviation. This is a compromise
approach between non-scaling and autoscaling. Small peaks in NMR spectra
are given greater importance than the original data, yet the baseline noise
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are minimalised in the later PCA. Pareto scaling was used for NMR data
throughout studies in this thesis.
Baseline related issues
For ATR-IR spectra, first derivative was performed for baseline correction
and normalisation was performed for intensity correction. Figure 2.8 shows
the quality of data before and after derivatisation. Before derivatisation,
the baseline near 2,000 cm−1 is not aligned while after derivatisation, all the
baselines are almost overlapped, therefore only the real difference will be
analysed.
First derivatives of the HPLC chromatograms of CDDP were also tried.
Derivatisation measures the slope of the signals at each point therefore the
integrity will not be lost, but may permit great discrimination. However,
noise of the original signal might be increased by derivatisation. After the
first derivative, batch 1 and 3 were separated better but batches 1, 2, 4, and
5 were not separated as clearly as the one before derivatisation. Therefore
derivatives are also not recommended unless the baseline is particularly bad.
Baseline exclusion was tried on 1H-NMR spectra of 5 batches of Danshen.
Baseline noise was deleted and the data was subjected to PCA. The scores
plot of this PCA was compared with the previous PCA and no difference was
found in the scores plot. This indicates that the PCA of the NMR spectrum
was not affected by the noise in the baseline because it is too small.
2.2.8 Multivariate data analysis (MVA)
Principal components analysis (PCA) was performed using Pirouette R© 4.0
chemometrics modelling software (Infometrix, USA).
HPLC chromatograms comprising 2,100 discrete regions by data acqui-
sition every second from 0.00 to 45.00 min. Alignment for HPLC chro-
matograms used LineUp software 3.0 (Infometrix, USA). The resulting data
were formatted as an ASCII-text file and exported into Microsoft Excel 2007
using Totalchrom Convert 6.31(PerkinElmer, USA). The region concerning
the internal standard which had been added to all samples between 3.06 and
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Figure 2.8: IR spectra of different SAB-spiked Danshen extract 2,000 cm−1
- 650 cm−1. Upper figure: the IR spectra after normalisation without derivati-
sation. Lower image: the IR spectra after normalisation with first derivative.
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4.35 min was eliminated. The remaining 2,050 integral regions were retained
for further analysis. Normalization and mean-centering without any scaling
was applied prior to PCA and PLS analysis.
NMR spectra were reduced to 4,250 discrete chemical shift regions by
digitisation to produce a series of sequentially integrated regions, δ0.002
wide, between δ0.5 and 9, using MestReC 1.1 (Mestrenova, Spain). The
resulting data were exported into Pirouette R© 4.0 and selected regions re-
moved around the residual solvents including water (δ4.566-5.078), methanol
(δ 3.244-3.338), and also the lipid region (δ1.192-1.454, only for CDDP). The
remaining 3813 integral regions were retained for further analysis. Normal-
ization of NMR spectra was carried out using Pirouette R© 4.0 (Infometrix,
USA). Normalization and pareto scaling was applied prior to PCA.
IR spectra from 665-2000 cm−1 was analysed. 1st derivatisation, normal-
ization and pareto scaling was applied prior to PCA.
2.3 Results and discussion
All of the materials listed in table 2.1 and table 2.2 were tested using HPLC,
NMR and ATR-IR spectroscopy. Two sample preparation methods for ATR-
IR spectroscopic analysis were tested and compared. Danshen grown in Shan-
dong and Shaanxi province in China were compared. Sanqi plants supplied
on different dates from one Tasly’s planting base to Tasly company were
studied, because the production time might also affect the quality of Sanqi.
CDDP produced by Tasly with different batch numbers and production dates
were studied, because the quality of each batch of CDDP might be affected
by the plant materials, operations, and reproducibility of manufacture ma-
chines. Correlations between plant materials, intermediate materials and
finished products were studied.
2.3.1 Comparison of IR sampling methods
For the IR spectroscopy, different sampling methods have been tested in-
cluding the solid sample method and extraction evaporation method. The
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extraction evaporation method has a few disadvantages: 1. It is time con-
suming. It took 5 minutes for the liquid extraction to evaporate into dryness.
The solid sample method only needed 30 seconds. 2. It might have the risk of
compound reactions using the hot plate, although the hot plate was only set
at 40◦C. Samples could be measured at room temperature using solid sample
methods, which is lower than 40◦C, and less likely to cause any reactions. 3.
For TCM products that decrystallise at high temperature, the solid sample
method is preferred, because low resolution spectra were obtained from de-
crystallised samples. Without the effects of crystallisation, the resolution of
IR spectra obtained from extraction evaporation method is the same as solid
sample method. 4. Solid sample method is less selective than extraction
evaporation, because no extraction was performed, no compound was lost.
In extraction evaporation method, some compound may be lost using specific
solvents, because no solvents could extract all compounds from a plant.
The extraction evaporation method has some advantages over the solid
sample method on sensitivity test. In the sensitivity test, different percent-
ages of SAB were added to the Danshen plant. There are two ways of doing
this: 1. Powdered SAB standard compound could be added to the Dan-
shen powder in percentage, followed by analysing with solid sample method.
2. SAB standard was dissolved in Danshen liquid extraction at a known
percentage, followed by extraction evaporation method. For method 1 us-
ing the solid sample method, ground plant root powder was filtered through
a 320µm sieve. However the measuring crystal is only 2 mm in diameter,
and the evanescent wave only protrudes the sample for 0.5 - 5 µm (FT-IR
Spectroscopy Attenuated Total Reflectance, Technical note, Perkin Elmer,
Massachusetts). If the SAB powder was not perfectly suspended in plant
root powder, a representative spectrum could not be obtained. Therefore
extract evaporation method might give more reliable spectra compared to
the solid sample method.
The method chosen depended on experimental needs. Solid sample method
has advantages over extraction evaporation method on all the samples stud-
ied in this chapter, except in the sensitivity test.
CHAPTER 2. EVALUATION OF QC METHODS 62
2.3.2 Crystallization affects the results of ATR-IR test
It is difficult to obtain good resolution spectra of liquid extraction of CDDP
using the evaporation method described in section 2.2.5. In order to ob-
tain well resolved spectra using ATR-IR, the sample has to be crystallized.
Sometimes unsharp spectra were obtained (Figure 2.9 “State 2”) when mea-
suring CDDP solvents and this was suspected to be a problem related to
crystallisation. In order to investigate this problem, a measurement of to-
tal absorption over time of CDDP extract using different temperatures was
carried out(Figure 2.10).
The CDDP liquid extraction spectrum was found to be temperature sen-
sitive using the evaporation method. Figure 2.10 shows the total absorption
of CDDP (integration of absorption between 4000 cm−1 and 650 cm−1 over
time). The temperature of the sampling plate was maintained at 40◦C before
the sample was loaded. At the 7th second, 5µl of CDDP liquid extraction
was added to the crystal. The total absorption increased rapidly because the
liquid solvents contain methanol and water which have strong absorptions.
The absorbance between 3100-3500 cm−1 is caused by -OH absorption of wa-
ter. The absorbance between 2800-3000 cm−1 is contributed by methanol
(refer to figure 2.9). At the 34th second, methanol had evaporated so the
concentration of water in the thin layer on top of the crystal had become
higher, therefore the total absorption increased. ATR-IR spectroscopy only
measures a thin layer of samples on top of the sampling plate, no matter
how much sample was loaded on the sampling plate. After 150 seconds, all
the water had evaporated, leading to a decrease of the total absorption. The
crystallization process of the sample started from the 220th second to the
280th second increasing the total absorption from the 0.047 to 0.054 (termed
“state 2” ). This may be because the extraction of CDDP crystallized after
being dried continuously at 40◦C. This might be caused by the presence of
polyethylene glycol (PEG) 4000 or 6000 in CDDP. By raising the temper-
ature to 50◦C at the 577th second, the total absorption became lower, and
the material dropped to state 2. This might be because crystallisation of
CDDP extract was disturbed by the high temperature. The total absorption
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Figure 2.9: Top spectra: ATR-IR spectrum of extraction of CDDP using
evaporation method at 1073 second of figure 2.10. This is a representative
spectrum of which so called “State 1” by the author. In state 1, CDDP extract
was crystallised, and the IR spectrum shows sharp peaks. Bottom spectrum:
ATR-IR spectrum of extraction of CDDP using evaporation method at 972
second of figure 2.10. This is a representative spectrum of which so called
“State 2” by the author. In state 2, CDDP extract was not crystallised, and
the IR spectrum shows broader peaks. Y-axis: absorption.
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Figure 2.10: Total absorption of 70% aqueous methanol extraction of
CDDP over time. Total absorption is the integral of absorptions of a sin-
gle IR spectrum over the range 650-4000 cm−1. This curve monitored the
changes of the total absorption changes by adding samples and adjusting the
temperatures of the sampling plate. The following actions were carried out
by the author at these time points. 0 second: the temperature of the sampling
plate was maintained at 40◦C, 7th second: 5 ul of 70% aqueous methanol ex-
traction of CDDP was added to the crystal, 577th second : the temperature of
the sampling plate was raised to 50◦C, 972th second: the temperature of the
sampling plate was reduced to 40◦C.
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remained at state 2 until the temperature was dropped to the 40◦C at the
972nd second, and the spectrum switched to “state 1”. It could be that the
extract of CDDP recrystallised at 40◦C. Crystallised sample have less bond
movement freedom therefore has a lower absorption in IR spectra. In fig-
ure 2.10, from the 150 second, high resolution spectra were obtained from
the 280th seconds to the 577th seconds and from the 1073rd seconds to the
end. Low resolution spectra were obtained from the 150th seconds to the
220th seconds and from the 602nd seconds to the 972nd second(see figure 2.9).
Crystallization study of CDDP using hot stage microscopy
In order to further evaluate the crystallisation of CDDP, a polarization study
was performed using a Leitz Dialux 22EB polarized light microscope (Leitz,
Wetzlar, FRG) with a Linkam TP 92 hot stage control unit. A camera was
attached to this microscopy and software called Linksys 32 could capture
pictures and videos automatically. Natural lights vibrates in random direc-
tions. In the contrary, polarized light vibrates in only one direction. In a
polarized light microscope, the test sample is placed in between a polarizer
and an analyzer, which are perpendicular to each other. When no sample or
an uncrystallised sample is being tested, the light polarized by the polarizer
is blocked by the analyzer, therefore it appears dark. When a crystallized
sample is being tested, the light is rotated by the sample and can get through
the analyser, therefore,it appears shiny. Less than 0.5 mg CDDP was put on
the sampling plate. This is because heat transfer for big piece of sample is
slow, so long time is needed to be crystallise/decrystallise.
Figure 2.10 shows the process of decrystallisation of CDDP with increased
temperature. The temperature was increased from 30◦C to 70◦C in the speed
of 3◦C per minute. At 61.4◦C, the CDDP sample was still shiny under the mi-
croscope, which means it was still crystallised. Between 61.4◦C and 62.4◦C,
the CDDP sample appeared darker and darker, until 63.0◦C, the sample
appeared completely dark, which means that the sample decrystallised com-
pletely.
The cause of decrystallisation of CDDP in high temperature might be due
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(a) 60.5◦C (b) 60.9◦C (c) 61.4◦C
(d) 61.9◦C (e) 62.4◦C (f) 63.0◦C
Figure 2.11: 0.05 mg CDDP was measured on a hot plate under a micro-
scope with a polarization mirror, temperature raising from 30.0◦C to 70.0◦C
in the speed of 3◦C per minute. Decrystallization observed from 60.5◦C to
63.0◦C. (a) 60.5◦C, (b) 60.9◦C, (c) 61.4◦C, (d) 61.9◦C, (e) 62.4◦C and (f)
63.0◦C
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Figure 2.12: Overlapped HPLC chromatograms from 0-40 min of 5 Dan-
shen no. 1-5. Danshen 1 and 2 were produced in Shaanxi; Danshen 3, 4 and
5 were produced in Shandong.
to the presence of PEG. Decrystallisation was only found to occur in CDDP
but not in Danshen or Sanqi plant extraction. The only extra ingredient of
in CDDP than Danshen and Sanqi are borneol and PEG. Borneol is highly
volatile and evaporated easily in high temperature. PEG is easy to dissolve
in water. Therefore, the 70% aqueous methanol extraction of CDDP contains
PEG. So only PEG might be the reason for decrystallisation of CDDP. This
was also found in previous research[91].
2.3.3 Visual inspection of HPLC chromatogram, NMR
and IR spectra
70% methanol extract of 5 batches of Danshen roots grown in different re-
gions (2 batches grown in Shaanxi, 3 batches grown in Shandong supplied by
Tianjin Tasly pharmaceutical Co. Ltd.) were analysed by HPLC to evaluate
the effect of growing environment. Figure 2.12 is a collection of 5 batches
Danshen HPLC chromatograms. All the chromatograms looks almost iden-
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tical except some small differences. For example, Danshen 1 and 2 (Shaanxi)
have a higher signal at 17.5 min than Danshen 3, 4 and 5 (Shandong).
NMR spectra of 5 batches of Sanqi supplied by Tasly planting based on
different dates looks almost identical (Figure 2.18). It is also difficult using
IR spectra of to distinguish the highly similar TCM samples without PCA.
Therefore, multivariate data analysis was used to analyse the fingerprints
of HPLC, IR and NMR spectroscopy.
2.3.4 Multivariate data analysis
PCA is an unsupervised method to reduce the dimensionality of the vari-
ables in sets of data. For example, in the HPLC chromatogram dataset, each
retention time is one variable. In this study, each HPLC chromatogram was
recorded over 53 minutes and the signal was detected every 0.0016 minutes,
thus results in (53/0.0016=) 31,800 data point in each chromatogram dataset,
therefore each HPLC chromatogram dataset has 31,800 variables. Each vari-
able represents the absorbance peak height at that specific retention time.
All the chromatograms studied in this chapter used identical chromatogra-
phy condition, therefore all the chromatograms can share the same retention
times, thus all the chromatograms can form one large dataset with 31,800
variables. PCA reduces and summarise these 31,800 variables into a few
principal components.
The first PC counts for the most variance among all the PCs. Usually, the
first two or three PCs are chosen to show the scores plot. Use a 2 PCs scores
plot as a example, PC 1 and PC 2 are the axis of the plot. On this plot,
observations are plotted according to their scores. In the case of HPLC, each
chromatogram is one observation. The distance between samples is related to
how different they are. The further away two samples are from each other, the
more different they are. (0, 0) means the average of all the chromatograms.
If a sample is very far away from the centre of the coordinate, this sample is
very different from the average of all the samples.
The loadings are the coefficients multiplied by the variables. The projec-
tion of variables on the PC axis means how much this variable is contributing
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to this PC. Loadings plots can be used to detect which compound contribute
the most to the differentiation of the observations.
For NMR and IR spectroscopic analysis, the theories of PCA is the same,
but the variables means chemical shifts (ppm) and wave numbers (cm−1)
respectively in this case.
2.3.5 Sensitivity test
The sensitivity test acts as an initial evaluation of different fingerprinting
methods. A series of percentages of a standard pure chemical were use to
manually spike Danshen or CDDP extractions, thus create a series of very
similar samples, but with known differences. This allows to evaluate if PCA
coupled fingerprinting methods are sensitive enough to pick up the differ-
ences, and to tell what is the difference.
HPLC
Protocatechuic aldehyde, a representative phenolic compound in CDDP was
used in this sensitivity test as described in section 2.2.6.
The PCA scores plot (Figure 2.13) shows 6 replicates of CDDP extract
without spiking (brown) and the same CDDP extract spiked by 1% - 30% of
protocatechuic aldehyde.
The non-spiked CDDP samples are located on the left, and the most
spiked CDDP samples are located on right. In between them are the other
percentage spiked CDDP extract arranged from low to high concentration
from left to right. The non-spiked samples are located further away from
the >5% spiked samples than from the <5% spiked samples, which means
that the CDDP samples contain 5% extra protocatechuic aldehyde is very
different from CDDP solutions. The non-spiked CDDP samples overlapps
with 1% spiked samples, but not mixed with 2% spiked samples. Therefore
CDDP samples which contain 2% extra protocatechuic aldehyde could be
differentiated from non-spiked samples. This means PCA-HPLC method is
sensitive enough to distinguish 2% and above difference of protocatechuic
aldehyde among CDDP samples. Figure 2.13 also indicates that the content
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Figure 2.13: PCA scores plot of HPLC chromatogram dataset of 6 non-
spiked CDDP sample (indicated by brown squares. These samples were cir-
cled in the plot. ) and 1% (green), 2% (purple), 5% (blue), 10% (orange),
20%(grey), and 30% (dark red) protocatechuic aldehyde-spiked CDDP sam-
ples.
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difference of protocatechuic aldehyde in CDDP is less than 2% which means
that the HPLC analysis was sensitive and the batch difference of CDDP is
small.
1H-NMR spectroscopy
0%, 1%, 2%, 5%, 10%, 20%, 30% and 50% protocatechuic aldehyde-spiked
CDDP solutions were used in NMR sensitivity test. These different percent-
ages spiked samples could not be distinguished by PCA scores plot of the
NMR datasets. The 1H-NMR assignment for pure protocatechuic aldehyde
is as follows: 2.24 (1, 3H), 6.83 (5, 1H, dd, J =8.44 Hz, J =1.28 Hz), 7.59 (6,
1H, dd, J =8.44 Hz), J =1.73 Hz), 7.35 (7, 1H, dd, J =1.73 Hz, J =1.28 Hz).
These peaks could not be identified from the spiked CDDP NMR spectra.
These peaks were either too low to be detected, or only contributed to a small
percentage of a peak that overlapped by the response of other compounds.
The content difference of 0% and 50% spiked CDDP samples was only
20.5µg protocatechuic aldehyde. This small amount is difficult to be de-
tected. (http://www.chem.wisc.edu/~cic/nmr/Guides/Other/sensitivity-
NMR.pdf). No difference could be seen between 0%, 1%, 2%, 5%, 10%, 20%,
30% and 50% protocatechuic aldehyde-spiked CDDP solutions by the NMR-
PCA method in the present study.
However, this does not mean that NMR-PCA methods could not be used
to distinguish minor differences between plants. Previous studies showed
that 1H-NMR-PCA could be used to distinguish small differences between
herbs, especially primary metabolites[30][16].
IR spectroscopy
Salvianolic acid B was used to spike the Danshen liquid extraction to produce
1%, 3%, 5%, 7.5%, 10%, 15%, and 20% of dry extract of Danshen solution
(w/w). It is worth noticing that the percentage of SAB does not mean the
percentage of SAB in terms of the SAB content of Danshen, but the total
dry extract of the Danshen. This experiment was designed like it is because
ATR-IR was not expected to be as sensitive as HPLC, and a very small
CHAPTER 2. EVALUATION OF QC METHODS 72
Figure 2.14: PCA scores plot of IR spectra of Danshen extract spiked by
1% (red), 3% (green), 5%(purple), 7.5%(blue), 10% (orange), 15% (grey),
and 20% (dark red) SAB. 0% (brown) means no spiking. From the highest to
the lowest percentages SAB-spiked sample groups were separated along factor
1. Black lines that run through each sample group have been manually drawn
for easy visualization of locations.
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amount of SAB will probably not be detected.
Figure 2.14 is the PCA scores plot of Danshen extract spiked by 1% to
20% SAB. This PCA scores plot consists of 2 factors: factor 1 accounts for
65.9% of the total variance, and factor 2 accounts for 10.2%. From the highest
to the lowest percentages SAB-spiked sample groups were separated along
factor 1. This means factor 1 is the main difference among those sample
groups, and it is the common difference between any groups.
There are also some differences within groups. Samples within the same
group spread along factor 2.
By inspecting the corresponding loadings plot, factor 1 is mainly posi-
tively contributed by 1050, 1142, and 1165 cm−1, and negatively contributed
by 1537, 1615, 1300, and 1121 cm−1. These loadings should be related to
the addition of SAB. However, it is difficult to assign or interpret the data
because first derivatized spectra show the slope of each datapoint forming
the peak, instead of directly measuring the height of the peak. A spectrum
represent a mixture of chemical compound is even more difficult to interpret.
1% SAB-spiked samples are separated from 0% spiked samples indicating
that ATR-IR combined with PCA can distinguish 1% of SAB in terms of dry
extract of Danshen from the non-spiked Danshen.
2.3.6 Discrimination of Danshen samples from differ-
ent regions
In this section, three methods were used to distinguish Danshen roots pro-
duced from different planting regions. In table 2.1, Danshen 1 and Danshen
2 were produced in Tasly’s Shaanxi planting base. Danshen 3, Danshen 4,
and Danshen 5 were produced in Tasly’s Shandong planting base. CDDP
produced by Tasly mainly used Danshen from these two planting bases. It
is important that these two planting bases produce almost the same quality
of Danshen, otherwise the standard of CDDP could not be set up.
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Figure 2.15: Scores plot PC1 versus PC2 obtained from HPLC finger-
prints of Danshen from different regions. Left hand side of zero coordinate
are Danshen grown in Shaanxi province: Red triangle, Danshen 1; green dot,
Danshen 2. Right hand side of zero coordinate are Danshen grown in Shan-
dong province: blue square, Danshen 3; orange diamond, Danshen 4; purple
star, Danshen 5.
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HPLC method
Danshen plants with batch numbers 1 and 2 were grown in Shaanxi province
and batch numbers 3, 4, and 5 were grown in Shandong province, China. This
region-to-region difference is shown in HPLC-PCA study (Figure 2.15) .There
are 9 technical replicates of each batch of Danshen, because the extraction
process was repeated 3 times, and each extract was injected 3 times into the
HPLC.
PCA scores plots consist of many principal components (PCs). Only the
first two main PCs were shown in this case. PC1 and PC2 counts for 83.7% of
the total variance, therefore it is a good indication of the differences between
samples. PC1 is the summary of HPLC retention times, at which makes the
biggest variance between all the HPLC datasets. PC2 is the summary of
HPLC retention times, at which makes the second biggest variance between
all the HPLC datasets. The retention times belong to PC1 and PC2 were
not related to each other, which mean that retention times contributing to
PC1 and PC2 should not belong to the same compound.
In figure 2.15, Danshen 1 and 2 were produced in Shaanxi province. These
samples are located on the left of the PCA plot with a negative value of PC1,
which means they have a negative contribution of PC1. PC1 is a summary
of many variables, in this case retention times. Therefore Danshen produced
in Shaanxi province had lower peaks at the retention times positively con-
tributed to PC1.
The points for Danshen produced in Shandong province were located on
the positive side of PC1. This means that Danshen produced in Shandong
have higher HPLC peaks at those retention times which contribute positively
to PC1. Higher HPLC peak at a certain retention time and the same ex-
perimental condition, means a higher concentration of a certain compound.
Therefore Danshen grown in Shandong has a higher concentration of the
compounds positively contributed to PC1 than Danshen grown in Shaanxi,
and Danshen grown in Shaanxi have a higher concentration of the compounds
negatively contributed to PC1. The retention times correlated to those com-
pounds could be found out by comparing the PCA scores plot to the PCA
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loadings plot.
PCA loadings plot also consists of many PCs. Loadings means the vari-
ables, in this case retention times. The loadings located in the positive side
of PC1 contribute positively to PC1, and the loadings located in the negative
side of PC1 contributed negatively to PC1. The same case is for PC2. The
loadings plots could be compared to the scores plot. If the variable in a load-
ings plot was found at the same location as a sample in the scores plot, that
sample has a high value at that variable, in this case mean the sample has a
high concentration of the compound with a retention time at that variable.
By comparing the loadings plot to the original chromatogram, it was
found that the peaks with retention times 33.7, 32.12, 31.13, 29.30, 25.63,
18.63, 18.07, 16.44 min contribute positively to PC1, and peaks at 21.83,
17.50, 12.83 and 10.70 min contribute negatively to PC1. Since Danshen
grown in Shandong located on the positive side of PC1, they have a higher
content of compounds with retention times on 33.7, 32.12, 31.13, 29.30,
25.63, 18.63, 18.07, 16.44 min. Conversely, Danshen grown in Shaanxi have
a higher content of compounds with retention times on 21.83, 17.50, 12.83
and 10.70 min.
Most of the peaks contributing to PC1 were identified using HPLC stan-
dard addition method. A small amount of Danshen standard reference was
used to spike the Danshen root extraction. The samples before and after
spiked extraction were subjected to HPLC analysis. The peak area differ-
ence of the standard reference was calculated. If the difference was equal to
the amount of spiking, then the identity of the peak was confirmed.
The peaks were identified as following: 10.70 min, salvianolic acid A;
12.83 min, protocatechuic aldehyde; 18.07 min, salvianolic acid B (SAB).
Therefore, Danshen grown in Shandong have a higher concentration of
SAB but Danshen gown in Shaanxi have a higher content of salvianolic acid
A and protocatechuic aldehyde. As a preliminary study to evaluate methods,
not all the peaks were identified.
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Figure 2.16: Scores plot PC1 versus PC2 obtained from ATR-IR spectro-
scopic dataset of Danshen from different regions. Danshen was in the form
of powder and measured with the solid sample method. Left hand side of zero
coordinate are Danshen grown in Shaanxi province: Red triangle: Danshen 1,
green dot: Danshen 2, Right hand side of zero coordinate are Danshen grown
in Shandong province: blue square: Danshen 3, orange diamond: Danshen
4, purple star: Danshen 5. Details of the samples were listed in Table 2.1.
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ATR-IR method
Difference between different geographical Danshen could also be detected by
ATR-IR -PCA. According to the PCA on the Danshen root powder (Fig-
ure 2.16), Danshen grown in Shaanxi and Shandong can be distinguished by
PC1. PCA on the Danshen extract using the evaporation method shows the
same differentiation as the analysis using Danshen powder with the solid sam-
ple method. This indicates that both powdered and extract forms provide
good differentiation of Danshen samples of different origins.
By analysing the corresponding loadings plot and observing the recon-
structed spectra after first derivatisation and normalisation, the differences
between Danshen grown in these two plantations were found to be as follows:
Danshen batch 1 and 2 grown in Shaanxi have higher responses at 2353,
2348, 2305, 2025, 2091, 2085, 2082, 2062, 2026, 2019, 1977, 1972, 1966, 1960,
1956, 1952, 1569, 1558, 1551, 1360, 1115, 1060 and 945 cm−1.
Danshen batch 3, 4 and 5 grown in Shandong have higher responses
at 1760-1720, 1630-1610 (1624, 1616), 1513, 1015, 1002, 979, 829, 788 and
675 cm−1.
It is difficult to assign the above bands to a standard compound due to
the many overlapping peaks. The spectra of standard reference compounds,
such as SAB, consist of mainly sharp peaks and the spectra of Danshen or
its extraction consist of mainly broad peaks. This is because Danshen/ its
extraction is a mixture of hundreds of compounds and many of their IR
absorptions overlap. Therefore the identification of a single biomarker from
the spectra of the plant is difficult. However, in regions where it happens
to have no overlapping, the identity of some biomarkers could be detected
from the spectra of Danshen plants. The derivatized and normalized IR band
between 1760-1720 cm−1 of salvianolic acid B and Danshen powder show the
same shape. This means that IR band (1760-1720 cm−1) in the spectrum of
Danshen roots is possibly directly due to absorption by salvianolic acid B.
Because 1760-1720 cm−1 is higher in Danshen grown in Shandong, it may
mean that those Danshen has a higher content of SAB. If true, this coincides
with the result shown by HPLC analysis.
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NMR spectroscopic method
Good resolution NMR spectra of 5 batches of Danshen products were ob-
tained. However, Danshen grown in Shandong and Shaanxi province could
not be distinguished by NMR-PCA method. All the spectra obtained looked
almost identical. This is because the concentration of the secondary metabo-
lite is very low, therefore a slight difference cannot be detected.
2.3.7 Differentiation of Sanqi samples with different
supply date
ATR-IR method
Sanqi plant roots supplied in different months from the plantation base of
Tasly can be differentiated by PCA (Figure 2.17). Sanqi 5 is located on the
left side of the PCA map, and has the latest supply date as March 2009.
Sanqi 4 (supplied in November 2008) is located in the middle of the map and
Sanqi 1 to 3 (supplied in October 2008) are located on the right of the map.
A few IR bands have been found to be responsible for the differences and
those bands are compared with Sanqi biomarkers ginsenoside Re and Rb1 in
table 2.4. Ginsenoside Re and Rb1 are two main secondary metabolites in
Sanqi.
Table 2.4 shows the derivatized wavelengths of the difference between
Sanqi plant roots are close to the derivatized wavelengths ginsenoside Re
and Rb1. The first derivative plots the value of the slope of each data in the
IR spectra. It is not directly related to the intensity. However, if one peak is
high in the original spectra, it has a higher slope and the lower peaks with the
same peak width. This becomes very complex when the testing material is
TCM, which contains many chemicals. However, the correlation of differences
between Sanqi to ginsenosides might indicate that, the content of ginsenoside
Re and Rb1 are likely to contribute to the date-to-date differences between
5 batches of Sanqi plants. There might be other biomarkers of Sanqi also
contributing to the date-to-date difference of Sanqi samples which are not
tested.
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Figure 2.17: Scores plot PC1 versus PC2 was obtained from ATR-IR spec-
troscopic dataset of Sanqi supplied in different dates. Sanqi 1,2 and 3 were
supplied in October 2008, Sanqi 4 was supplied in November 2008, and Sanqi
5 was supplied in March 2009. All of them were grown in the same planting
base in Yunnan. Red triangle: Sanqi 1 supplied on 28/10/2008, green dot:
Sanqi 2 supplied on 20/10/2008, blue box: Sanqi 3 supplied on 25/10/2008,
orange diamond: Sanqi 4 supplied on 15/11/2008, purple star: supplied on
03/03/2009. Details of the production dates are listed in Table 2.1.
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Table 2.3: Comparison of the derivatized spectra of Sanqi plant root, gin-
senoside Re and Rb1. Unit in cm
−1.














Figure 2.18 are 5 batches of Sanqi supplied in different dates from Tasly’s
planting base. No differences can be spotted by the naked eye.
Figure 2.19 is the PCA scores plot of 5 the NMR spectra of 5 batches of
Sanqi. From right to left, the supply dates arranged as Oct. 2008, Nov.2008,
Mar. 2009. This sequence is the same as the IR-PCA shown in figure 2.17
from left to right.
In PCA scores plot, the importance of the negative and positive side of
a principal component is equal. Using difference PCA software, the scores
plot obtained can be mirrored. Therefore, it does not matter if the sequence
of samples if from one side or the other, as long as the order is the same.
Therefore, Sanqi samples were arranged similarly in NMR and IR -PCA
scores plot. In NMR-PCA, Sanqi with different dates are more separated
from each other than in IR-PCA. This may mean NMR is better at finding
the differences from Sanqi metabolites.
According to the loadings plot, Sanqi supplied in Mar. 2009 have a higher
response at 5.29, 3.7 and 4.0 ppm than other batches. Sanqi supplied in Oct.
2008 have a higher response at 0.81, 1.52, 3.12, 3.29, 3.61 and 3.65 ppm. As a
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Figure 2.18: NMR spectra of 5 batches of Sanqi supplied in different dates.
Sanqi 1,2 and 3 were supplied in October 2008, Sanqi 4 was supplied in
November 2008, and Sanqi 5 was supplied in March 2009. All of them were
grown in the same planting base in Yunnan. 0–10 ppm. 1: Sanqi 1, 2: Sanqi
2, 3, Sanqi 3, 4: Sanqi 4 and 5: Sanqi 5
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Figure 2.19: Scores plot PC1 versus PC2 was obtained from NMR spec-
troscopic dataset of Sanqi supplied in different dates. Sanqi 1, 2 and 3 were
supplied in October 2008, Sanqi 4 was supplied in November 2008, and Sanqi
5 was supplied in March 2009. All of them were grown in the same planting
base in Yunnan. Red triangle: Sanqi 1 supplied on 28/10/2008, green dot:
Sanqi 2 supplied on 20/10/2008, blue box: Sanqi 3 supplied on 25/10/2008,
orange diamond: Sanqi 4 supplied on 15/11/2008, purple star: supplied on
03/03/2009. Details of the production dates in Table 2.1.
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brief study of different spectroscopic methods, these peaks are not identified.
However, Sanqi roots supplied in the earliest date(Oct. 2008) are located
on one side, those supplied in the latest date (Mar. 2009) are located on the
other side, and those supplied in the time between (Nov.2008) are located
in the middle in the PCA scores plot, indicates the composition of Sanqi
is changing with time. Sanqi is usually harvested after the third year since
it was planted. It usually flowers in August, and fruits in September, ma-
tures in October or November. The supply date is probably quickly after
the harvesting of Sanqi. The Sanqi supplied in Oct. and Nov. 2008 are
probably from the same year harvesting. The Sanqi supplied in Mar. 2009
might be a late harvested batch, or have been stored in the warehouse for
a while. If this is the case, the separation of the spectra of Sanqi supplied
at different times indicates a difference of metabolite composition of Sanqi
harvested in different times of the year or stored for different lengths of time.
Storage factors such as temperature and moisture affects the shelf-life of
herbal medicines[92]. However, the exact storage condition of Sanqi from he
company is unknown. In future work, the chemical shifts that contribute
to the difference can be assigned to Sanqi metabolites. In chapter 3, the
author demonstrated that 1H-NMR is an effective method to identify gin-
seng metabolites. This provides useful information of quality control of raw
material for TCM companies.
HPLC method
Sanqi is difficult to be analysed by PCA using HPLC fingerprint since the
main UV absorption of Sanqi extract is at 205 nm which is very close to
the detection limit of the DAD detector. The baseline of the HPLC chro-
matogram leans down with the increase of composition of acetonitrile in the
HPLC mobile phase. The baseline is related to the pressure of the system,
and the pressure of the system is related to the viscosity of mobile phase.
Acetonitrile has a low viscosity. Therefore, an increase of acetonitrile in mo-
bile phase results in a decreased system pressure, thus leading to a decreased
baseline. It is very difficult to use PCA to handle the tilted chromatogram,
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Figure 2.20: Scores plot PC1(t[1]) versus PC2(t[2]) obtained from HPLC
dataset of CDDP produced by Tasly with different batch numbers. Batch
number: CDDP 1: 090312, CDDP 2: 090310, CDDP 3: 090311, CDDP 4:
090313, CDDP 5: 090314. Details of the production dates in Table 2.2.
even if baseline subtraction was performed. Maybe it is possible to adjust the
baseline manually before PCA, but it is time consuming. ELSD was demon-
strated in previous research [93] that it is feasible to detect Sanqi metabolites
but it is not available in our lab. Therefore HPLC was not used to study
Sanqi.
2.3.8 Differentiation of different batches of CDDP
HPLC method
5 batches of CDDP were produced in one week by Tasly. Figure 2.21 is the
PCA scores plot. However, still differences in composition between these
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Figure 2.21: Scores plot PC1 versus PC2 obtained from ATR-IR spectro-
scopic dataset of CDDP produced in different years. Red triangle: CDDP
produced in 2009 including CDDP 1 – 5, green dot: CDDP produced in 2007
including CDDP 6 – 9. Details of the production dates in Table 2.2
batches are evident. PC1 is positively contributed by 18.65 min which is due
to SAB, negatively contributed by 19.48 min. PC1 is positively contributed
by 12.75 min which is due to protocatechuic aldehyde. Therefore, CDDP
batch 3 has a higher content of protocatechuic aldehyde than the rest of
bathes. Batch 4 and 5 have a higher content of SAB. Batch 1 and 2 have a
higher content of a compound with a retention time of 19.48 min.
IR spectroscopy
5 batches of CDDP produced in 2009 and 4 batches produced in 2007 can
be distinguished by IR-PCA method. Figure 2.21 is the PCA scores plot of
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9 batches of CDDP. PC2 is the main component in the PCA to distinguish
CDDP produced in different years. The CDDP produced in 2007 contributed
mainly positively to PC2 and the CDDP produced in 2009 contributed mainly
negatively to PC2. The following wave numbers were found to contribute the
main differences between CDDP that were produced in different years: 751,
1713, 1692, 1672, 1652, 1649, 1460, 1436, 1407, 1391, 1386, 1340 cm−1. These
wave numbers coincide with the wave numbers that distinguish Sanqi with
different supply dates. These could mean the difference of CDDPs produced
in 2007 and 2009 mainly due to the different of the Sanqi ingredient. It
is possibly because they have changed the production methods or sites of
the Sanqi product in the years between 2007 and 2009, although the exact
information was not provided by the company. This could be a potential
method to trace the quality from finished products to the raw plant.
A 2D IR might be performed in order to correlate these wave numbers to
compounds.
NMR spectroscopy
The NMR-PCA of 5 batches of CDDP produced in 2009 showed no difference
between them. This might be because 1H-NMR mainly detects primary
metabolites (more explanation in section 2.1.4) which are largely present in
the extract of herbal remedies, and the primary metabolites present in the
CDDPs are quite similar. This may be also because NMR is intrinsically less
sensitive than HPLC.
2.3.9 Comparison of analytical approaches for raw ma-
terial and finished products
The weight to weight concentrations of salvianolic acid A and protocatechuic
aldehyde is much higher in CDDP than in Danshen root. In this study 70%
aqueous methanol is used. In the industrial precess, water is used. Therefore
the polar compounds such as salvianolic acid A and protocatechuic aldehyde
are better extracted in industry than in this study.
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(a) PLS-DA scores plot of HPLC dataset of 5 Danshen A–E
(b) PLS-DA scores plot of HPLC dataset of 5 intermediate
products A–E
Figure 2.22: Correlated raw material-Danshen and intermediate material
intermediate products A–E made from Danshen A–E and Sanqi A-E respec-
tively.
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Figure 2.22 shows correlated Danshen and the intermediate product. In-
termediate product A (IM A) was made from Danshen A and Sanqi. In the
upper scores plot, Danshen batched A and C are overlapping, D and E are
next to each other, B is on its own. The same grouping trend is shown in the
corresponding intermediate product. The intermediate products were pre-
pared following the same method as in the industry. This indicates that the
difference between raw materials can possibly be carried to the intermediate
product, and likely to the final product. Therefore, the control of the raw
material is very important.
2.3.10 Overall Comparison of HPLC, NMR and IR
spectroscopy for Danshen and Sanqi product
Table 2.4: Ability of distinguishing minor difference of TCM samples.
Abbreviations: l/o: lyophilization/evaporation. Correlation: Correlation
from raw to intermediate products. * 4 hours is based on individual sample
lyophilising time in small quantities. In reality samples subjected to NMR
spectroscopic analysis were lyophilysed for 24 hours with many batches to-
gether.
Products HPLC NMR ATR-IR
Danshen Good Difficult Difficult
Sanqi Difficult Good Good
CDDP Good Good Good
Correlation to metabolites Good difficult N/A
Method Evaluation Discrete Non-discrete Non-discrete
Peak Assignment Easy Difficult Very difficult
Sample recycle l/o l/o direct use
Sample preparation time 50 min 4 hours* 10 min
Measuring time 60 min 5 min 2 min
Sensitivity Good Ok OK
HPLC and NMR, ATR-IR coupled with PCA have the ability to distin-
guish between minor differences of most Danshen and Sanqi products that
are studied in this chapter. HPLC could distinguish the differences between
region-to-region difference of Danshen, different batches of CDDP produced
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in the same year, and correlate from raw material to intermediate material.
However, Sanqi with different supply date could not be distinguished by
HPLC-DAD. Ginsenosides mainly absorb at 205 nm which makes the HPLC
analysis very difficult.[94] Other detectors such as Evaporative Light Scat-
tering Detector (ELSD) might be used to detect ginsenosides[94].
NMR spectroscopic analysis could distinguish differences between Sanqi
with different supply dates. Although good resolution spectra were obtained
for all the samples studied, Danshen region to region and CDDP batch-to-
batch differences are not able to be seen by NMR-PCA method.
ATR-IR spectroscopy is faster than HPLC and NMR spectroscopy. ATR-
IR does not require complex sample preprocessing procedures. Ground plant
powder could be measured directly. 12 minutes or less is usually enough for
one sample using ATR-IR spectroscopy, from product to spectrum. TCM
products need to be extracted in solvents before HPLC and NMR spectro-
scopic analysis. 50 minutes was needed to prepare the extraction. In practice,
6 or 9 samples were usually handled as one group. For the measurement time,
at least 45 minutes is required for a HPLC chromatogram of most TCM prod-
ucts, and 5 minutes is usually enough to obtain a NMR spectrum with good
resolution.
It is easy to correlate signals to compounds in HPLC because standard
compounds can be used to match the HPLC peaks. 1H-NMR spectroscopic is
non-selective in plant study since proton exists in most of plant metabolites.
Because the secondary metabolites are less abundant than the primary
metabolites in plants, and NMR spectroscopy is intrinsically insensitive, it
is not usually used to study the secondary metabolites, but the primary
metabolites.
2.4 Conclusion
In this chapter various TCM materials from raw to finished products have
been analysed using HPLC-DAD, ATR-IR and 1H-NMR spectroscopy with
PCA data analysis.
A sensitivity test was carried out on all the fingerprinting methods. Iden-
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tical protocatechuic aldehyde-spiked Danshen extractions were used for NMR
and HPLC-PCA study. HPLC was found to be more sensitive than NMR,
and can distinguish samples with a >5% protocatechuic aldehyde difference.
Sample preparation and measuring method for each technique were op-
timised. A comparison of solid sample method and extraction evaporation
method of ATR-IR was made. The solid sample method was chosen as the
more easy and reliable one. The ATR-IR evaporation method is not rec-
ommended because: 1. It is time consuming. 2. It does not give a better
resolution for the spectra than the solid sample method, 3. There is a risk
of minor component losses during extraction.
Danshen from different regions can be distinguished by HPLC, ATR-IR,
but not NMR spectroscopy. This is the first time that ATR-IR is reported
to discriminate geographical different plant to the author’s best knowledge.
Sanqi with different supply date but from the same region can be dis-
tinguished by ATR-IR and NMR spectroscopy, but not HPLC. CDDP with
different batch numbers can be distinguished by HPLC, but not ATR-IR and
NMR spectroscopy. CDDP produced in different years (2007 and 2009) can
be distinguished by ATR-IR spectroscopy. This was not tested using other
techniques. Different brands of compound Danshen products were success-
fully distinguished by PCA by both HPLC and NMR methods. This was not
tested using ATR-IR spectroscopy. Intermediate products were not tested
by ATR-IR due to their hard and sticky nature.
Differences between batches can be distinguished in raw plant material,
intermediate products and finished commercial products. Correlated batches
cluster similarly in Danshen raw and intermediate products. Geographical
different Danshen can be distinguished.
HPLC and NMR, ATR-IR spectroscopy can be used as complementary
methods depending on the nature of the compounds concerned. The ad-
vantages and disadvantages of each method has been discussed. HPLC was
found to be able to distinguish small differences between samples. As a
powerful separation technique, the identification of chemicals is relatively
easy. As a brief study, pure chemical standards were used to determine some
HPLC peaks. To verify the identification, HPLC is often coupled with MS
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and NMR. In the TCM industry, HPLC provides a quick and easy solution
for profiling TCM metabolites, allows the user to obtain a chromatogram
which is easy to interpret. However, as a discrete method, HPLC can not
detect all the metabolites. In the future world of quality control of TCM,
which emphasise the synergy effect of all the metabolites, HPLC might lose
its primary position.
1H-NMR was found to be a powerful non-discrete method, to reveal all the
protons present in a mixture of TCM extract. This fits the synergy concept
of TCM, and might be a potential method for quality control of TCM. The
assignments of NMR peaks is not straight forward, but are possible with
the assistance of 2D-NMR such as correlation spectroscopy (COSY), total
correlation spectroscopy (TOCSY) etc. 1H-NMR is fast and reliable and
can be used as a high-throughput methods for pharmacies and industries to
perform TCM quality check.
ATR-IR is not used as much as the above methods in the quality control
of TCM, because the spectra are almost impossible to interpret. However,
this study demonstrates its ability to discriminate very similar TCM sam-
ples. ATR-IR is small and portable, which is an advantage over HPLC and
1H-NMR. It is also solvent free that TCM powder can be measured directly.
With these benefits, ATR-IR can be carried to TCM planting field, to per-
form a fast and high-throughput checking.
PCA is proved to be a powerful multivariate statistical analysis, which
reveals differences between similar samples that otherwise difficult to be de-
termined. It was found especially useful when coupled with spectroscopic
methods. PCA also helps to visualise the differences of HPLC chromatograms
of very similar TCM samples[83].
Chapter 3





In this chapter, 1H-NMR metabolomics was used to catalogue variations in
the spectra of 45 batches of commercially available ginseng. Ginseng samples
used in this study were purchased from five different regions in China and
include 4 different species, and possibly some counterfeit products.
This chapter starts by introducing some background knowledge about
ginseng, including its history, use, morphology and chemical composition.
This is followed by an introduction of the existing quality control methods
of ginseng, and the method used in the current thesis.
3.1.1 Ginseng species
The term “ginseng” is usually used to indicate the root of Panax species. The
genus Panax consists of 12 species including Asian ginseng (Panax ginseng
C. A. Meyer), American ginseng ((Panax quinquefolius L.) and Sanqi (Panax
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notoginseng). Asian and American ginseng are the two Panax species mainly
used in TCM. Panax belongs to the family Araliaceae. The genus Panax is
a relic of the Tertiary Period dating back to 0.3 billion years ago. The root
is the part used in traditional medicine.
3.1.2 History of use
The use of Asian ginseng dates back 4,000 years. Its first use was probably
mystical, because the shape of ginseng looks human. It was first recorded in
“Shennong’s Chinese Materia Medica”(Shen Nong Ben Cao Jing), considered
the oldest book on traditional Chinese medicine, compiled approximately
during the Latter Han Dynasty (ca. 25-220 A.D.). [95] Asian ginseng was
recorded with other 119 herbs, as “the first treatise”, which were used for
their “stimulating properties”, and stated to be harmless to humans. The
function of Asian ginseng was recorded as “supplement for five main internal
organs” and “mental-tranquillization”[47].
Till the 16th century, Asian ginseng gained great popularity. In Ben
Cao Gang Mu (“Compendium of Materia Medica”; ca.1593), regarded as
the most complete and comprehensive medical book written in the history of
TCM, the use of Asian ginseng in treating 31 medical conditions including
sweats, weakness, and nausea, was described comprehensively in respect of
dose, combination with other TCM, and preparation methods[96]. Asian gin-
seng was almost seen as an omnipotent herb. Due to its popularity, although
strictly controlled by several Emperors, the wild Asian ginseng became al-
most extinct in China.
This passion for Asian ginseng from the Chinese influenced French mis-
sionaries in the 17th century. A similar looking ginseng was soon found by
them in north America, which was used by the native Americans as a healthy
food. This was later known as American ginseng. It was first documented
in “New compilation of Materia Medica” (Bencao Congxin) by Yiluo Wu
in 1757[97]. American ginseng was found to have a similar effect to Asian
ginseng. In fact, the chemical composition of American ginseng is similar to
Asian ginseng[98].
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American ginseng quickly gained popularity in China. In the late 19th
century, about 282 tons of wild American ginseng was imported to China[99].
As might have been expected, wild American ginseng decreased rapidly in
north America as well.
Due to the complex conditions for its successful cultivation, it was not un-
til 1885 that George Stanton, who is often called today “The father of Amer-
ican Ginseng”, successfully planted 150 acres of American ginseng. Since
then, American ginseng is successfully cultivated in the US, Canada, Aus-
tralia and China.
Ginseng has the effect of decreasing fatigue. Possible mechanisms of ac-
tion of ginseng is linked to antioxidant[100], anti-inflammatory, anti-tumour[101]
and immunostimulatory activities[17]. American ginseng stimulates insulin
production and has an anti-hyperglycaemic effect[17].
3.1.3 Morphology characters of ginseng samples
The shape of different ginseng samples is shown in figure 3.1. WAG32 is an
example of wild American ginseng with an age older than 15 years according
to the retailer. CAG 2 and CAG 5 are examples of cylindrical and conical
shaped cultivated American ginseng with an age of around 4-5 years. ASG
is an example of Asian ginseng. The shape of Asian ginseng is long and slim
with an untrimmed beard. American ginseng is usually trimmed. The shape
of the cylinder shaped American ginseng is very similar to Asian ginseng.
There are minor differences between wild and cultivated American ginseng
samples. The head of the wild American ginseng is smaller compared to
cultivated American ginseng. There are circles that develop from the head
and all the way down the body of the roots. The colour of wild American
ginseng is usually dark whereas the colour of cultivated American ginseng is
lighter and the skin is more smooth and with even scars.
Sample 20 (figure 3.1) was purchased from a less renowned small ginseng
store on the famous Chinese medicine retailing area called “Shanghuan”,
where it was claimed to be cultivated American ginseng grown in Wisconsin,
USA, and it was supplied with so claimed certificate of authenticity. The gin-
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Figure 3.1: Representative photos of 6 ginseng samples. The numbers in
the names indicate the experimental numbers used in the present study in
table 3.2. WAG: Wild American ginseng root. CAG2: an example of long
shaped cultivated American ginseng root. CAG5: an example of short shaped
cultivated American ginseng root. ASG: Asian ginseng root. Sample20: a
claimed cultivated American ginseng batch but with distinct morphological
characters. Photo taken by the author.
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seng roots were stored in large baskets and trimmed by staff in the store. The
claimed American ginseng roots are about 5 cm long and 3 cm in diameter.
As seen in figure 3.1, it is much bigger, less wrinkled, lighter in colour and
cheaper compared to American ginseng samples purchased from well reputed
stores. This sample was suspected to be a counterfeit product and this was
confirmed in this study (in section 3.3.6).
In the markets, there is a huge price variation among the different grades
of American ginseng. The price is generally in the trend as follows: wild
American ginseng > cultivated American ginseng > Asian ginseng > Sanqi.
In China, wild American ginseng can be as expensive as £20 per gram while
the cheaper cultivated American ginseng can be £1 per gram. Cheaper gin-
seng was sometimes used to adulterate or sold as a higher price ginseng,
especially when the samples were sliced, it is more difficult to identify its
morphological characters. The huge profit margin of wild American ginseng
drives shops to adulterate cultivated American ginseng using Asian ginseng
or other plants since their shapes appear very similar to inexperienced cus-
tomers. The look of Sanqi is very different from American and Asian ginseng,
however, the composition and medical use are quite similar[55]. Sanqi was
sometimes used to adulterate American and Asian ginseng.
3.1.4 Constituents of ginseng in general
The constituents of ginseng root include amino acids, fatty acids, carbo-
hydrates, alkaloids, triterpenoid saponins, polysaccharides, sesquiterpenes,
polyacetylene, peptidoglycans, minor elements, vitamins, and phenolic com-
pounds[102][11].
Most attention has been focused on a group of triterpenoid saponins, the
ginsenosides, which have been associated with significant pharmacological
effects, including antioxidant[87], anti-diabetic[88] and anti-tumor effects[89].
However, the exact therapeutic mechanisms were not clear.
More than 30 ginsenosides have been identified so far. The most common
ones are listed in figure 3.2 and table 3.1. Ginsenosides are divided into
2 groups according to their aglycone moieties: the protopanaxadiol group:
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Figure 3.2: A general structure of ginsenosides. Values for R1, R2 and R3
of major ginsenosides are listed in table 3.1
Rb1, Rb2, Rc, Rd, and the protopanaxatriol group: for example Re, Rf, Rg1,
Rg2)[103]. A general structure of ginsenoside is illustrates in figure 3.2. The
most abundant saponins in ginseng are Rb1, Rb2, Rc, Rd, Re and Rg1.
Other studies showed that ginseng polysaccharides have various impor-
tant biological activities [17] such as antioxidant [100], anti-tumor, anti-
adhesive, immunomodulating[101] and hypoglycemic activities.
3.1.5 Current regulation methods
Many ginseng products in the market are in the form of slices or powder
in capsules, which makes identification using morphological characters im-
possible. Even when the ginseng is not sliced or ground, the identification
might be difficult since some of the cheap products (lower age, cultivated,
fake) have a similar look to the expensive ones. The identification using mor-
phological characters requires considerable expertise in the field and it is not
always practical. Adulteration and faulty products could cause unexpected
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Table 3.1: Chemical structures of some major ginsenosides referring to fig-
ure 3.2. Glc = glucose, Ara(p) = alpha-L arabinopyranose, Ara(f) = alpha-L
arabinofuranose. Rha = rhamnose.






Rc -Glc2-Glc -H -Glc6-Ara(f)
Rd -Glc2-Glc -H -Glc
protopanaxatriols
Re -H -Glc2-Rha -Glc
Rf -H -Glc2-Glc -H
Rg1 -H -Glc -Glc
Rg2 -H -Glc
2-Rha -H
side effects. Therefore the need of developing an easy and effective quality
control method is urgent.
In order to regulate the market, the Chinese Pharmacopoeia defines the
morphological characters and a few simple tests including identification and
quantification of a few secondary metabolites using TLC and HPLC[45].
The total amount of ginsenoside Rg1, Re and Rb1 should not be less than
0.5% of the dried Asian ginseng (Rg1 and Re should be higher than 0.3%
in total, Rb1 should be higher than 0.2%). The analogous requirement is
2.0% for American ginseng. There is no quantification requirement for other
potentially effective metabolites.
The test methods by Chinese pharmacopoeia are not adequate to distin-
guish all the counterfeit products[104].
3.1.6 Advanced quality control methods
Because of the inadequacy of the Chinese Pharmacopoeia, some reports have
suggested using advanced quality assessment method on ginseng products
including HPLC, NMR and IR [103][16][11][105].
HPLC is the most widely used and popular method due to its simplicity,
sensitivity and accuracy. The resulting data is easy to be interpreted since
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one compounds present in the form of one peak. The detection power of
HPLC was made stronger with various detectors such as UV, DAD, and
ELSD[103].
HPLC with different detectors such as UV[106] and ELSD[103] have been
used in these methods to simultaneously quantify a dozen of ginsenosides. 19
ginsenosides were quantified in black ginseng developed from Asian ginseng
using HPLC-ELSD[107].
However, there are limitations of these methods. Firstly, HPLC methods
are selective. Saponins mostly absorb at 203 nm, which is close to the detec-
tion limit of DAD detectors. Many solvents and even oxygen also absorb at
this wavelength thus increase the baseline noise and lower the sensitivity of
detection. The baseline is poor at 203 nm especially when using a gradient
elution method. The baseline is related to the pressure of the system, and
the pressure of the system is related to the viscosity of mobile phase. Ace-
tonitrile has a low viscosity. Therefore, an increase of acetonitrile in mobile
phase results in a decreased system pressure, thus leading to a decreased
baseline.
Secondly, it is not sufficient to quantify only ginsenosides because they
are not the only active compounds existing in ginseng. However, despite the
limitations of HPLC, it is still the most used method in quality control of
TCM using selected biomarkers.
NMR spectroscopy became increasingly popular in quality assessment of
herbal medicines[15][16]. Most of the reports on quality assessment of TCM
by 1H NMR metabolite fingerprinting analysed the primary metabolites,
because primary metabolites are more abundant in plants than secondary
metabolites, and NMR spectroscopy intrinsically lacks high sensitivity.
PCA or PLS methods have often been used to analyse datasets of NMR
spectra. Because the NMR spectra of plant extracts are very complex with
many overlapping peaks. PCA is thus useful to summarise and find the dif-
ferences between groups. Therefore it is often used with NMR spectroscopy
on quality assessment of similar herbal medicines[15][16]..
There are several reports on the metabolite compositions of various gin-
seng types. Lee et al. analysed the primary metabolite composition of Asian
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ginseng samples aged 2 to 6 years using NMR-PCA method.[16]. However,
most of the reports were not representative since only a small number of
samples from each species were analysed[38][16].
3.1.7 Aim of study
The aim of study in this chapter is 1. to investigate the suitability of 1H-
NMR-PCA on distinguishing Asian ginseng, cultivated and wild American
ginseng. 2. to investigate the differences in primary and secondary metabo-
lites between Asian ginseng, cultivated and wild American ginseng. 3. to
study the differences in between wild American ginseng samples. 4. to dis-
tinguish a possibly fake CAG product sample 20.
3.2 Materials and methods
3.2.1 Panax samples studied
37 batches of crude commercial ginseng products were purchased from five
different sources in China including HongKong, Beijing, Taiyuan, Hangzhou
and Tangshan. These products include 15 batches of cultivated American
ginseng, 11 batches of wild American ginseng, 5 batches of Asian ginseng (all
cultivated), 5 batchs of sanqi and 1 batch claimed to be cultivated American
ginseng, with a clear morphological difference from other cultivated American
ginseng samples. A typical commercial ginseng product from each group is
shown in figure 3.1. Except for the wild American ginseng, all the other
samples were cultivated. A detailed sample list is specified in table 3.2.
The grading criteria of ginseng is objective depending on different com-
panies. Usually the older ginseng, the better. However, exact criteria in
companies is unknown.
As 90% of wild American ginseng samples from the US was exported to
HongKong, and the samples used in this research were purchased from the
most prestige TCM companies in HongKong, together with the knowledge of
the author on identified the appearance of wild American ginseng, it is very
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likely that the wild American ginseng samples used in this study are genuine
as stated.
Among them, sample 18 was purchased from a less noted ginseng store,
the average size of this batch was around 2-3 cm, the morphology features
mostly matched the features of the wild American ginseng, although some
of them look like cultivated American ginseng. Sample 20 was purchased
from a store in “Shanghuan” in Hong Kong, the morphological features is
distinctively different from all the other ginseng purchased (figure 3.1).
3.2.2 Chemicals used
Ginsenoside Re, Rg1, Rb1, Rg2, Rc, Rd were purchased from Carbosynth
(Berkshire, UK).
All the sugar samples including sucrose, glucose, lactose, fructose and
deuterium oxide (D2O, 661643, %99.99 atom % D, contains 1% DSS-d6) were
purchased from Sigma (Sigma Co., St Louis, MO, USA). Other deuterated
solvents and 5 mm NMR tubes (Wilmad 507-PP) were purchased from Goss
Scientific (Goss Scientific Instruments, Great Baddow, Essex, UK).
3.2.3 Ginseng roots extraction method
Ginseng dried root material was ground using a coffee grinder and filtered
through a 350µm sieve. Large pieces which did not go through were re-
ground, passed though the same sieve and mixed with the rest of the powder.
2 g of the powder was extracted with 100 ml 70% methanol in a volumetric
flask, using a bath sonicator for 15 minutes at 30◦C followed by shaking man-
ually and sonicating for a further 15 min. After cooling to room temperature,
evaporated solvent was replaced with 70% methanol and the volume of the
solvent was made up to 100 ml. The supernatant was filtered with a 0.2µm
syringe filter.
The filtered solvent was evaporated under reduced pressure for 30 minutes
to remove most of the methanol. The residual solution was frozen in dry ice
then lyophilized for 24 hours.
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Table 3.2: Details of 37 batches of ginseng studied in this chapter. P.F.:
purchased from. COP:country of production. CAG: cultivated American gin-
seng. ASG: Asian ginseng. WAG: wild American ginseng. TFH: Tung Fong
Hung Ltd, HongKong. EYS: Eu Yan Sang, HongKong. BJ: Beijing. TRT:
Tong Ren Tang Group Co., Ltd. Anhui WS: Anhui Wan Sheng pharma-
ceutics. FHCT: Fang Hui Chun Tang, Hangzhou £/37.8 g: Price per 37.8 g
(Chinese weight unit “Liang”) in British Pounds. Cy.: cylindrical shaped.
Co.: conical shaped. P. no.: production number. Blank area means informa-
tion not available.
No Type P.F. COP Grade £/37.8 g P. no.
1 CAG TRT,BJ Ca. Co.,5 9.1 20090547
2 CAG TRT,BJ Ca. Cy., 1 7.5 20090448
4 CAG TRT,BJ Ca. Co. 8.7 20100101
5 CAG TRT,BJ BJ Sliced 8.7 100107
6 CAG TRT,BJ BJ Co. 11.2 706069
8 CAG TFH US 20 142418
9 CAG TFH US 16 141617
10 CAG TFH US 12 140414
11 CAG TFH US 9 142714
12 CAG TFH US 6 142614
13 CAG TFH US 2.5 140718
28 CAG TRT,LD US
15 CAG NPH US 16 40603
16 CAG NPH US 4.8 41101
21 CAG FHCT
19 ASG TRT,BJ China 1.9
22 ASG TRT,SX China 9.3 101201
23 ASG TRT,JL China 2.1 263274
24 ASG Anhui WS China
25 ASG Shanxi PS
7 WAG TFH US 159
14 WAG NPH US 130 40101
17 WAG EYS US 120 11115
18 WAG TakTai US
29 WAG TFH US 4 132 149924
30 WAG TFH US 3 199 138910
31 WAG TFH US 1 373 139824
32 WAG TFH US 1 398
33 WAG EYS US Cy. 95 11115
34 WAG EYS US 4 252 11050
35 WAG EYS US 1 410 11155
20 unknown HongKong
41-45 Sanqi Yunnan province 08/2009
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Table 3.3: Extra information for ginseng sample 1-6. TRT: Tong Ren Tang
Group Co., Ltd. JL: Jilin Ginseng Co., Ltd. GS: Ginseng Co., Ltd. BXLB:
Benxi Longbao group gingseng Co., Ltd. BJTH: Huairou, Beijing Tianhui
ginseng industrial Co., Ltd. BJCG: Beijing Chongguang medical Co., Ltd.
No Type Production Company Manufacture date Expiry date
1 CAG TRT, JL 20090511 20120510
2 CAG TRT, GS 20090415 20120414
4 CAG BXLB 20100102 20120101
5 CAG BJTH 20100112 201212
6 CAG BJCG 20080817 20130817
3.2.4 NMR measurement
D2O, [D4]-MeOD, and DMSO were attempted to reconstitute the lyophilised
samples, and D2O was found the best solvent. Concentrations of 5, 10, 15,
and 30 mg/ml were tested and the best spectra were found to be produced
at a concentration of 10 mg/ml. The spectra of 15, and 30 mg/ml contain
broad peaks, which were probably due to undissolved particles. The spectra
of 5 mg/ml were not as clear as those of 10 mg/ml.
One dimensional 1H NMR spectra were measured at a temperature of
300K on a Bruker DRX 400 MHz Spectrometer (Bruker, Coventry, UK)
equipped with a 5 mm triple resonance inverse detection (TXI) probe. Spec-
tra were the result of the summation of 16 free induction decays (FIDs), with
data collected into 65k data points and a sweep width of 20 ppm. Acquisition
parameters were 0.126 Hz/point, pulse width was 17.857 kHz 90 and relax-
ation delay was 1.0 s. Prior to Fourier transformation, an exponential line
broadening equivalent to 0.3 Hz was applied to the FIDs. The signal inten-
sities for all samples were referenced to DSS (4,4-dimethyl-4-silapentane-1-
sulfonic acid) at 0.00 ppm.
3.2.5 Data analysis
Data pretreatment
The NMR spectra of all the ginseng samples were bucketed in 0.002 ppm,
instead of 0.04 ppm which was used in most of the previous reports using
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NMR-PCA method to do quality assessment of herbal medicine[16]. The
small bucket size allows details to be revealed and provides more information
of small peaks. Bucketing of spectra was performed using MestReNova R©
(MNova) software version 5.2.3. The NMR spectra were aligned using LineUp
software (Infometrix), and treated with vector length normalization (refer to
section 2.2.7) using Pirouette R© software (Infometrix).
The water peak at 5.07-4.6 ppm, DSS peak at 0-0.07 ppm and methanol
peaks at 3.3-3.4 ppm were excluded before normalisation (section 2.2.7),
pareto scaling(section 2.2.7), and PCA.
PCA
PCA is a multivariate data analysis method to summarise massive variables
in a dataset into a few correlated variables. In this study each bucketed
ppm value is considered to be one variable. There are 2,270 variables in each
spectrum. In the results and discussion section, some selected spectroscopic
regions were deleted during the analysis as the study progressed and became
more focused.
PCA, normalization and pareto scaling were performed using Pirouette R©
software version 4.5. The terms “PC 1” and “factor 1” are used interchange-
ably.
3.3 Results and discussion
3.3.1 NMR spectra of 4 ginseng samples
Typical NMR spectra for ginseng samples including Sanqi root, cultivated
American ginseng root, Asian ginseng root and wild American ginseng root
at 0.5-6.5 ppm are shown in figure 3.3.
There are a few differences that can be observed by eye without statistical
analysis. Apart from the water and methanol peaks which were excluded
during analysis, the most noticeable responses in these chemical shifts are
due to sugar, the peaks of which occur in the regions of 3.5-4.5 ppm and
5.0-5.5 ppm. Among these, sucrose largely dominates in this 70% aqueous
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Figure 3.3: Representative NMR spectra of extractions of 4 ginseng types.
0.5-6.0 ppm parts were shown as where the most metabolites presents. CAG:
cultivated American ginseng batch 4 . ASG: Asian ginseng batch 24. WAG:
wild American ginseng batch 35. Peaks marked in boxes in CAG belong to
sucrose. Detailed assignment of sucrose is given in table 3.4.
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Figure 3.4: Structures of sucrose, glucose and xylose. The 1H-NMR as-
signments are listed in table 3.4.
methanol extract of ginseng samples. The sucrose regions were marked using
boxes in figure 3.3. Sucrose is the most abundant metabolite in the extract of
all the ginseng samples studied in this chapter, except wild American ginseng
sample 32 and 29, and Asian ginseng 24, where glucose is the most abundant
metabolite. This is further discussed in the following subsection. Apart from
the sugar regions, there are less abundant peaks from 1.0 to 3.5 ppm and
from 4.0-8.5 ppm. These were mainly due to primary metabolites and these
are assigned in the next section.
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Figure 3.5: Structures of assigned amino acids in the 1H-NMR spectra
of ginseng extract. The 1H-NMR assignments are listed in table 3.5. The
protons were numbered according to the Human Metabolome Database http:
// www. hmdb. ca/ .
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Figure 3.6: Structures of assigned organic acids in the 1H-NMR spectra
of ginseng extract. The 1H-NMR assignments are listed in table 3.5. The
protons were numbered according to the Human Metabolome Database http:
// www. hmdb. ca/ .
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Figure 3.7: Assignment of primary metabolites in the 1H-NMR spectrum of
Asian ginseng sample no.19, from 0.9 to 3.3 ppm. The sample was extracted
using 70% aqueous methanol and dissolved in D2O. Detailed assignments of
primary metabolites in this region are listed in table 3.4.
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Figure 3.8: Assignment of primary metabolites in the 1H-NMR spectrum of
Asian ginseng sample no.19, from 4.2 to 8.5 ppm. The sample was extracted
using 70% aqueous methanol and dissolved in D2O. The water peak (4.7 to
5.1 ppm) was deleted from the spectrum. Detailed assignments of primary
metabolites in this region are listed in table 3.5.
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Table 3.4: Assignment of sucrose, glucose and xylose- on 1H-NMR spectrum
of a representative Asian ginseng sample (No. 19), extracted using 70%
aqueous methanol and dissolved in D2O. s: singlet. d: doublet. dd: double
doublets. t: triplet. J: J-coupling constants. Assignment of H see figure 3.4.
Metabolite 1H Assignment
Sucrose 3.47(t,J =9.6) H-10








3.56(dd,J =9.9, 3.8) H-3
3.72-3.91(m) H-11,6
5.22(d,J =3.8) H-2
Xylose 3.38(t), J =9.4) H-4
3.534(d, J =8.1) H-2
5.18(m), J =3.9) H-2
3.3.2 Assignment of peaks
The assignments were performed by comparison to reference spectra obtained
using standard compounds, assignments in previous publications[11][108][109],
Human Metabolome Database (HMDB,http://www.hmdb.ca/), and the Bi-
ological Magnetic Resonance Data Bank (http://www.bmrb.wisc.edu/meta\
bolomics/). J coupling constants were matches with references during as-
signment.
The assignments are listed in table 3.4 and 3.5, and illustrated in fig-
ure 3.7 and figure 3.8. Peaks in 1.0-3.5 ppm and 4.5-8.5 ppm were assigned to
20 primary metabolites, including 2 sugars (structures shown in figure 3.4),10
amino acids (structures shown in figure 3.5), and 7 organic acids and 1 vita-
min (structures shown in figure 3.6).
A first impression of an American ginseng spectrum is that it was domi-
nated by sucrose signals. This was confirmed by adding 3 mg of sucrose into
10 mg of Asian ginseng extract.
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Table 3.5: Assignment of 18 primary metabolites on 1H-NMR spectrum of
a representative Asian ginseng sample (No. 19), extracted using 70% aqueous
methanol and dissolved in D2O. The assignment of protons are marked on
the molecules in figure 3.5 and figure 3.6. The chemical shift values of some
metabolites were not assigned to a specific proton. s: singlet. d: doublet. dd:
double doublets. t: triplet. J: J-coupling constants (Hz).
No Metabolite δ 1H (p.p.m.) Assignment
Amino acids
Valine 0.98(d,J =7.0) H-8
1.02(d,J =7.0) H-7
Threonine 1.34(d,J =6.5) H-8



















Glutarate 2.27(t, J =7.46) H-4,6
Pyruvate 2.38(s) H-6
Malate 2.40(dd,J =15.5, 9.9) H-5
2.74(dd,J =15.5, 3.1) H-5
4.31(dd,J =9.9, 3.1) H-2
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3.3.3 Differentiation of ginseng types based on their
sugar contents
Figure 3.9 is the PCA scores plot of 1H-NMR spectra of 4 ginseng samples,
including wild and cultivated American ginseng root, Asian ginseng, sanqi
ginseng and sample 20, which is a different looking root but claimed to be
cultivated American ginseng. The differentiation of sample 20 is further
discussed in the end of this chapter, in section 3.3.6. This PCA scores plot
is formed by factor 1 and factor 2, which count for 52.5% and 16.0% of the
total variance respectively. The third principal component factor 3 counts for
5.3% of the total variance. Each factor is perpendicular to all other factors.
These 3 factors explain in total of 73.5% of the total variance of the samples.
The cultivated American ginseng samples are located on the top left,
Asian ginseng samples are located mainly on the left side below cultivated
American ginseng samples, except sample 24 are located on the right side,
sanqi samples are located on the top right, and wild American ginseng sam-
ples are located mainly in between Asian and cultivated American ginseng
samples, except sample 29 and 32 which are located on the bottom right of
the scores plot(figure 3.9) .
Cultivated American ginseng, Asian ginseng and sanqi are well separated
in the PCA scores plot, but wild American ginseng samples overlap with
all the other samples. In order to further analyse the difference of those
samples, the corresponding PCA loadings plots is analysed. Figure 3.10 is
the loadings plot correlated to the PCA scores plot(figure 3.9). On the top
left of the PCA loadings plot, the loadings are assigned to sucrose chemical
shifts. On the bottom right of the PCA loadings plot, the loadings are
assigned to glucose chemical shifts. The loadings directions of sucrose and
glucose are opposite each other in the loadings plot. This means that if
more sucrose is present in ginseng, then less glucose is present. It may be
because that sucrose broke down into glucose in plant’s metabolism[110].
Previous report by Lee et al. also found that cultivated American ginseng
has a higher content of sucrose than ASG, but Asian ginseng has a higher
content of glucose than CAG[16], based on three ginseng samples. Yang et
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Figure 3.9: PCA scores plot of 1H-NMR spectra of 4 ginseng types includ-
ing wild and cultivated American ginseng, Asian ginseng, sanqi ginseng and
sample 20. Each colour represents a different group of samples. Abbrevia-
tions: ASG: Asian ginseng root (green spot). WAG: wild American ginseng
root (red spot). CAG: cultivated American ginseng root (brown spot). Sanqi
root(Purple spot). Sample 20: claimed to be CAG (Blue spot).
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Figure 3.10: PCA loadings plot of 1H-NMR spectra of 4 ginseng samples.
This correlates to the PCA scores plot of figure 3.9. Colours of the loadings
are irrelevant to the analysis. On the top left side, the loadings were assigned
to the main sucrose 1H-NMR chemical shifts. On the bottom right side, the
loadings were assigned to glucose 1H-NMR chemical shifts. The details of the
assignment are listed in table 3.4.
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al. reported the metabolite differences between cultivated American ginseng
with different ages, sucrose was found in a higher level in age 4, 5 and 6 year
old than 2, 3 year old ginseng. The levels of glucose are lower in age 1, 4, 5
and 6 year old than the 3 year old ones [11].
In ginsenosides, there are glucose attached to it (see table 3.1). How-
ever, the glucose signal was not contributed by the the sugar substituents in
ginsenosides[30]. This was confirmed by Kang et al. using diffusion-ordered
spectroscopy analysis[30]. The current study also shed a light on this, that
many Asian ginseng samples are high in glucose, but have a similar level of
ginsenosides comparing to CAG samples.
Along the direction of sucrose, which is to the top left of the PCA scores
plot, the furthest top left group is cultivated American ginseng and wild
American ginseng sample 34 and 35. This means these samples contain the
highest percentage of sucrose, and lowest percentage of glucose among all the
samples studied. The NMR spectra of ginseng samples suggest that only a
small amount of glucose is present in cultivated American ginseng samples
and wild American ginseng sample 34 and 35, some glucose is present in
Asian ginseng samples. Conversely, more glucose but less sucrose are present
in sample 24 (ASG), 29 and 32 (WAG).
Apart from the variables contributed by sucrose and glucose, most of
the other variables are located close to the centre of the PCA loadings plot.
This means that sucrose and glucose contents represent the largest differ-
ence among the four types of ginseng samples. The relative sucrose content
among cultivated American ginseng samples is very similar, since the shape
of its group stretched out almost perpendicular to the direction of sucrose
loadings, as do the sanqi samples. The relative sucrose/glucose content of
Asian ginseng and wild American ginseng varies from almost none to a high
content within the group. This may be related to the growth condition of in-
dividual batch of samples. This is especially true for wild American ginseng,
because their growth conditions are almost isolated. The growth conditions
of cultivated American ginseng are controlled to meet the desired way, there-
fore it is understandable that it forms a tighter group in the PCA scores plot
showing good similarity between the samples.
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Details of the assignment of sucrose peaks are listed in table 3.4. 3.81,
3.818, 3.824 ppm peaks were assigned to H-17,19 of sucrose. These are the
larger peaks of sucrose, therefore are weighted more in PCA, and were lo-
cated further more from the centre in the PCA loadings plot. 5.408 ppm and
5.418 ppm peaks are assigned to H-7 of sucrose. These are smaller peaks
in sucrose, therefore they were counted of less importance in PCA, so these
loadings are located closer to the centre of the loadings plot. The rest of
the sucrose peaks are located in the top right area between the centre and
3.818 ppm in the PCA loadings plot. This is because pareto scaling was
used in this PCA: not all the variables were not given the same importance,
therefore higher peaks counted more in the analysis. This is discussed in the
method section.
The sucrose/glucose content may be used as a rough indicator to differ-
entiate cultivated American ginseng and Asian ginseng. The sucrose/glucose
content within 15 batches of cultivated American ginseng is very similar to
each other , but not very similar within the 5 batches of Asian ginseng stud-
ied. However, the sucrose/glucose content in the 5 batches of Asian ginseng
studied are all lower than that of the cultivated American ginseng. 8 out of
10 of the wild American ginseng studied in this chapter also have a high con-
tent of sucrose and a low content of glucose, but the other 2 wild American
ginseng have shown a similar content of sucrose/glucose with the cultivated
American ginseng. Therefore sucrose/glucose content can not be used to dis-
tinguish cultivated and wild American ginseng, or Asian and wild American
ginseng.
Xylose is more abundant in Sanqi and wild American ginseng batch 14
and 30. However, levels of detected xylose are very low compared to other
metabolites in ginseng samples; therefore it is not a main difference in PCA.
The sugar region shows the most intense signal in the NMR spectra of
Panax species, and often hides signals caused by other compounds in the
same region. Therefore, in some research on the quality assessment of Dan-
gshen, the sugar was removed by water elution using a C-18 cartridge[23].
However, research indicates that polysaccharides in Panax species have var-
ious activities including anti-fatigue[111][17], and immunomodulating[101].
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Therefore in the present study, sugar was not removed during preparation of
samples for NMR spectroscopic study. It is also because this work is aiming
to find an easy solution in quality control of ginseng samples with minimal
preparation and modification steps. Although sugar was included during ex-
traction process, its NMR spectroscopic region could be carefully excluded
electronically to serve the purpose to highlight the differences caused by other
compounds. In order to further study the differences between the Panax
groups, the sucrose and glucose regions were excluded in future analysis.
3.3.4 Differentiation of Panax species following exci-
sion of the sugar region
For the analysis below, sugar regions from 3.33-4.94 ppm, 5.20-5.26 ppm, and
5.35-5.51 ppm were excluded before PCA.
In the PCA scores plot shown in figure 3.11, cultivated American ginseng,
Asian ginseng, and Sanqi were well separated from each other and formed a
tight plot within each group. Asian ginseng products represented by green
spots are located in the top left, wild American ginseng samples (red spots)
are located in the middle, cultivated American ginseng (brown spots) are lo-
cated in the bottom left, and Sanqi samples (dark purple spots) are located
in the bottom right of the PCA scores plot. The NMR spectra of wild Amer-
ican ginseng are spread out over a large region in the scores plot, indicating
they are different from each other. This is possibly because the purchased
wild American ginseng roots have different ages, growth conditions, gene
type etc. The size of wild American ginseng is usually an indicator of the
age, the price is often proportional with the size.
Even if the sugar region was deleted, the separation between 4 kinds of
ginseng remains good. This means that sugars are not the only metabolites
distinguishing ginseng samples.
Because Sanqi is distinctly different from Asian and American ginseng and
highly influence the analysis, it was excluded in the next part of study and
the differences of the remaining three ginseng types were further explored.
PCA scores plot in figure 3.12 is composed of PC1 and PC2 which count
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Figure 3.11: PCA scores plot of 4 ginseng samples and sample 20. Each
colour represents a different group of samples. The number written behind
the coloured spots represents different batches of samples, which is correlated
to table 3.2. “a”, “b” or “c” after the batch numbers are repeated extracts
of the same batch of sample. Dark purple spot: Sanqi root. Brown spot:
Cultivated American ginseng root. Green spot: Asian ginseng root. Red spot:
Wild American ginseng root. Blue spot: Sample 20.
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Figure 3.12: PCA scores plot of 3 Panax species. Each colour represents
a different group of samples. The number written behind the coloured spots
represents different batches of samples, which is correlated to table 3.2. Pur-
ple spot: Sanqi root. Brown spot: Cultivated American ginseng root. Green
spot: Asian ginseng root. Red spot: Wild American ginseng root. Blue spot:
Sample 20.
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for 31.1% and 16.3% of the total variance. American ginseng were mainly
located on the left side of the PCA scores plot, except wild American ginseng
sample 32. Cultivated American ginseng samples are all located on the left
side of PC1 axis. Asian ginseng is located on the right side. This means that
cultivated American ginseng and Asian ginseng were clearly separated by
PC1 alone. Wild American ginseng samples 18 and 14 are grouped closely to
the cultivated American ginseng samples. However, in the three dimensional
view shown in figure 3.11, samples 14 and 18 are separated from CAG. This
means that WAG samples 18 and 14 are different from the CAG samples.
As mentioned before, sample 18 was purchased from a less noted store
and some of the ginseng roots in this sample looks like cultivated American
ginseng. This may suggest wild American ginseng sample 18 was adulterated
by cultivated American ginseng. This could also because the size of the root
of sample 18 is relatively small comparing with other wild ginseng samples.
This indicates a younger age. Therefore it might have a different composition
of metabolites according to its different location in the scores plot.
Figure 3.13 is the corresponding PCA loadings plot of the PCA scores plot
shown in figure 3.12. The variables in the loadings plot is packed therefore
they were shown in coloured spots for easier visualisation. Areas marked L1
(figure 3.14), L2 (figure 3.16) and L3 (figure 3.17) are in the same location in
the PCA loadings plot as ASG, WAG and CAG in the PCA scores plot. This
means ASG has a higher relative content of the metabolite correspond to the
variables indicated in L1. Variables with a high value on a principal com-
ponent contribute more to that principal component. For example, variable
3.244 ppm is located on the most right side of the loadings plot, therefore it
has the highest value on PC1. Also PC1 is the major difference among all
the PCs, thus the variable 3.244 ppm contributes the most to the PCA scores
separation. Therefore the metabolite with a chemical shift at 3.244 ppm is
most responsible for the separation along PC1, in this case, the difference
between Asian ginseng and American ginseng.
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Figure 3.13: PCA loadings plot of 3 Panax species correlating to the PCA
scores plot in figure 3.12. Each spot represents a different variable, in this
case, ppm value. The zoomed in figure of L1, L2 and L3 are shown in fig-
ure 3.14, figure 3.16 and figure 3.17.
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Figure 3.14: Enlarged L1 of PCA loadings plot of 3 Panax species fo-
cusing on the positive side of PC1. The colour of the loadings are irrele-
vant to the analysis. The loadings that are highly contributing to PC1 are
highlighted in boxes and assigned to metabolites. 3.228, 3.244, 3.262 ppm:
arginine H-8; 1.898, 1.90, 1.902 ppm: arginine H-6; 1.90 ppm: acetate H-
4;3.2 ppm: choline H-5,6,7; 3.01 ppm: 2-oxoglutarate; 2.396, 2.398, 2.4,
2.402, 2.742 ppm: malate H-5; 2.124, 2.126, 2.144 ppm: glutamate H-6;
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Differentiation of Asian ginseng and American ginseng
In order to closely study the difference between all the ginseng samples, the
loadings areas L1, L2 and L3 were enlarged in figure 3.14, figure 3.16 and
figure 3.17 and the variables are assigned to ginseng root metabolites.
The relative intensities of the NMR spectral peaks on the selected vari-
ables were calculated and plotted in figure 3.15. In order to eliminate the
potential influence from sample concentration and quantity, normalization
was performed on the whole dataset before obtaining the intensity values on
the interested chemical shifts. Standard errors were used to plot the error
bars. t-test with 95% confidence level was used to compare samples. The
average value for cultivated American ginseng samples was calculated base
on 15 batches. The values for Wild American ginseng and Asian ginseng
samples were based on 11 and 5 batches respectively.
By inspecting the original spectra, it was found that fumarate, tyrosine,
phenylalanine, and tryptophan are clearly visible in all the Asian ginseng
samples, but not in American ginseng samples. The responses of these peaks
are very low, around a few times higher than the baseline noise. Therefore
these peaks were not picked up by PCA loadings. However these peaks can
be checked manually to assist the separation of Asian and American ginseng.
In the loadings figure 3.14, apart from the highlighted variables, there are
other variables next to them but with some 0.002-0.006 ppm difference. These
usually belong to the same peak. Because the bucket size used in this study
is 0.002 ppm, it is normal that one NMR spectroscopic peak covers several
variables. 3.228, 3.244, 3.262 ppm were assigned to arginine H-8. 1.898, 1.90
and 1.902 ppm were assigned to arginine H-6. The fact that levels of arginine
are around 2-fold in ASG than in CAG or WAG at all the chemical shift
related to arginine indicates a real difference (figure 3.15).
The level of arginine is also higher in WAG than in CAG at most of
the assigned chemical shifts, including 3.26, 3.244, 3.768 ppm. However, at
3.288 and 1.898 ppm the difference is not significance. For 3.288 ppm, it may
be because interference of small peaks presented at 3.218 ppm. Nonetheless,
the ratio of arginine abundance between CAG, WAG and ASG are well sug-
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Figure 3.15: Relative levels of selected metabolite (from figure 3.14) that
differentiate between cultivated American ginseng (CAG), wild American gin-
seng (WAG) and Asian ginseng (ASG). The Y axis is the relative intensity
of the NMR spectra on selected chemical shifts. The X axis are the metabo-
lite names assigned to the chemical shift values in buckets with ppm as unit.
Error bars represent standard errors based on average values. A t-test with
p<0.05 was used to indicate a real difference between samples. Within the
same chemical shift group (3 samples), if a short “-” is seen on top of a sam-
ple, it means that this sample is not significantly different from others which
also have a “-” on them, but a sample with a “-” is significantly different
from a sample without a“-” within the same group.
CHAPTER 3. METABOLOMIC QUALITY CONTROL 127
gested by the H-8 and H-6 peak present at 3.26, 3.244 and 3.768 ppm, as no
overlapping and interfering peaks were found in this regions.
1.90 ppm assigned to single peak caused by acetate H-4, which overlaps
with arginine H-6, but the fact that the difference between ASG and WAG
or CAG thoughout the chemical shifts of arginine is the same, indicate that
the levels of acetate is the same in all the ginseng. Therefore arginine is the
metabolite that contributes the most difference between the Asian ginseng
and the American ginseng apart from the sugars.
Apart from arginine, there are other variables also contribute to the sep-
aration of the Asian ginseng from the American ginseng. These are 3.2 ppm
assigned to choline H-5,6,7, and 3.01 ppm assigned to 2-oxoglutarate. These
metabolites contribute the most to PC1. Since Asian ginseng samples are
located on the positive side of PC1, it indicates a higher content of argi-
nine, choline and 2-oxoglutarate in Asian ginseng samples. The bar plot in
figure 3.15 confirmed this.
There are other peaks contribute moderately to factor 1, these are 2.40
and 2.74 ppm which were assigned to malate H-5, 2.124, 2.126 and 2.144 ppm
assigned to glutamate H-6. These chemical shift values are located slightly
to the right of PC2 axis. By examining the original spectra, it is confirmed
that glutamate is higher in ASG and WAG than in CAG. The levels of
malate is higher in Asian than American ginseng samples, as the assignment
to 2.742 shows. However, at 2.4 ppm the error bar for ASG is very high.
By inspecting the original spectra, it was found that many small peaks are
overlapping around 2.4 ppm, this might explain the large variance.
To summarise, the metabolite composition of Asian ginseng is distinc-
tively different from American ginseng samples. Arginine, and choline are
much higher, 2-oxoglutarate and malate are moderately higher in Asian gin-
seng samples than American ginseng samples. Levels of glutamate and argi-
nine are higher in WAG than in CAG.
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Table 3.6: Summary of previous report[108][109] on the 1H-NMR assign-
ments of major ginsenosides including ginsenoside Rb1, Rg1, Re, Rd and
notoginsenoside R1. The underlined ginsenosides are assigned in figure 3.16.
Hydrogen Rb1 Rg1 Re Rg2 Rb2 Rc Rd R1
H-9 1.33 1.49 1.51 1.53 1.35 1.33 1.95 1.45
H-16β 1.82 1.26 1.24 1.29 1.36 1.33 1.35 1.26
H-16α 2.18 1.72 1.74 1.77 1.82 1.81 1.76 1.73
H-26 1.59 1.59 1.60 1.67 1.65 1.59 1.60 1.59
H-27 1.64 1.59 1.57 1.63 1.62 1.64 1.60 1.59
H-28 1.25 2.03 2.07 2.10 1.26 1.25 1.27 2.04
H-29 1.08 1.57 1.34 1.35 1.07 1.07 1.09 1.44
H-30 0.94 0.79 0.94 0.95 0.94 0.92 0.95 0.78
Differentiation of wild and cultivated American ginseng
Loadings area L2 is enlarged in figure 3.16. The variables were assigned
to methyl groups in ginsenosides which are secondary metabolite instead of
primary metabolite. A typical structure of ginsenoside is shown in figure 3.2.
The 1H-NMR assignments are shown in table 3.6.
Ginsenosides are assigned to the variables in the loadings figure 3.16 ac-
cording to previous reports[108][109] and 1H-NMR spectra of ginsenoside Re,
Rg1 and Rb1. It was found that the NMR spectra of various ginsenosides are
very similar to each other, especially the chemical shifts of methyl groups.
The chemical shifts shown in figure 3.16 can be assigned to the underlined
ginsenosides shown in table 3.6. Because L2 locates in the same area in the
loadings plot (figure 3.12) as WAG in the scores plot (figure 3.13), it indicates
WAG has a higher intensity of methyl peaks, and means a probably higher
content of ginsenosides in wild than cultivated American ginseng. However,
previous reports were not able to show a difference of total ginsenosides con-
tent between wild and cultivated American ginseng[112][113].
Figure 3.17 is the enlarged left bottom side of the PCA loadings plot.
1.486 and 1.468 ppm were assigned to alanine H-6. 1.334 and 1.318 ppm were
assigned to threonine H-8.
A quantitative analysis of the levels of metabolite that assigned to the
left side of the PCA loadings plot (figure 3.13) including area L2 (figure 3.16)
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Figure 3.16: Enlarged L2 area of PCA loadings plot of 3 Panax species
focusing on the positive side of PC2. The colour of the loadings are irrel-
evant to the analysis. The loadings that are highly contributed to PC2 are
highlighted in boxes and assigned to the general structure of ginsenosides,
referring to table 3.6.
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Figure 3.17: Enlarged L3 area of PCA loadings plot of 3 Panax species
focusing on the negative side of PC1 and PC2. The colour of the loadings are
irrelevant to the analysis. The loadings that are contributing to the negative
side of PC1 and PC2 are highlighted in boxes and assigned to metabolites
as follows: 1.486, 1.468 ppm alanine H-6; 1.334, 1.318 ppm threonine H-8.
Peaks at 1.296 and 1.298 ppm are probably due to ginsenosides H-16.
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Figure 3.18: Relative levels of selected metabolites (from figure 3.16 and
figure 3.17) in cultivated American ginseng (CAG), wild American ginseng
(WAG) and Asian ginseng (ASG). GSS: General ginsenoside structure re-
ferring to figure 3.2. The Y axis is the relative intensity of the NMR spectra
on selected chemical shifts. The X axis are the metabolites names assigned to
the chemical shift values in buckets with ppm as unit. Error bars represent
standard errors. A t-test with p<0.05 was used to indicate a real difference
between samples. Within the same chemical shift group (3 samples), if a short
“-” is seen on top of a sample, it means that this sample is not significantly
different from others which also have a “-” on them, but a sample with a “-”
is significantly different from a sample without a“-” within the same group.
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and L3 (figure 3.17) were plotted in figure 3.18.
The chemical shifts of the proton on the same location in the general
structure are sometimes the same, but sometimes different between different
types of ginsenosides. Take H-16β for example, in Rg1, Re, and R1, its
chemical shift is around 1.25 ppm, but in Rb2, Rc and Rd, its chemical shift
is around 1.35 ppm. This difference may be due to the different aglycone
moieties. Rg1 and Re are the protopanaxadiols, but Rb2, Rc and Rd are the
protopanaxiatriols. However, the aglycone moiety is not solely responsible for
the difference. Rb1 also belongs to the protopanaxiatriol group, but its H-16β
chemical shift is 1.82 ppm, which is very different from the other ginsenosides
in this group, which have chemical shifts around 1.35 ppm.
Apart from this, peaks at the same chemical shift may be caused by
protons located on different place in the GSS. For example, 1.25 ppm can be
caused by H-28 in Rb1, Rb2, Rc and Rd, or by H-16β in Rg1, Re, and R1.
For many reasons discussed above, it is difficult to attribute the selected
chemical shifts to particular ginsenosides, but to the ginsenoside general
structure. It was found that for almost all the selected chemical shifts anal-
ysed in figure 3.18, their intensities in WAG is almost twice as high as in CAG
and ASG, except at 1.29 ppm, where CAG is at the same level as WAG. This
may be because 1.29 ppm is only contributed by Rg2 (GSS-16β).
The suggested chemical shifts may be used as important markers to iden-
tify the wild American ginseng from the cultivated ones.
At 5.29 ppm there is almost no peaks in Asian ginseng samples, but there
is a single peak in all the cultivated American ginseng samples and most
of the wild American ginseng samples. At 1.29 ppm, the peak intensities in
WAG and CAG are almost twice as high as in ASG. However these peaks
remain unidentified.
3.3.5 Difference among wild American ginseng sam-
ples
Wild American ginseng sample 18, 29 and 32 are distinct from both wild and
cultivated American and Asian ginseng samples, and from each other. Peaks
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at (3.936, 3.962, 3.988)t, 3.646(s), 3.622(s), and (3.584, 3.594)d are high in
WAG 18, 29 and 32. However, these peaks are unidentified, but are likely
due to polysaccharides.
There are four peaks between 1.27-1.34 ppm present obviously in Ameri-
can ginseng, moderately in Asian ginseng, not detected from sample 32. The
intensities of these peaks in other WAG including 18 and 29 vary.
Sucrose peaks in sample 32 and 29 are higher than other WAG, but for
glucose peaks, it is the other way round. In almost all cases, either glucose or
sucrose responses are high, but not both. It might be that sucrose degraded
in to glucose in the metabolism [110].
Several reports suggested there are two chemotypes of wild American gin-
seng: the “low Rg1/high Re” type and the “high Rg1/low Re” type[114][115].
This can potentially be one of the reason that the wild American ginseng
studied in this chapter are so different from each other. However, this was
not confirmed in this study because the 1H-NMR spectra of these two gin-
senosides are very similar.
It is difficult to correlate the age and growth condition of wild Ameri-
can ginseng to their compositions of metabolites, because suppliers of wild
American ginseng do not wish to reveal the location of it. A common way
of detecting the age of ginseng is usually by counting the number of the bud
scars on the neck of the root. However, it is often trimmed when seen in the
market. Research of wild American ginseng is very limited due to the limited
availability.
3.3.6 Difference of a suspected counterfeit cultivated
American ginseng sample number 20
In the PCA of 4 different kinds of root samples, as shown in figure 3.11,
sample 20 was outside the group of cultivated American ginseng, this con-
firms the suspicion that this sample is probably not from a batch of genuine
cultivated American ginseng. However, sample 20 seems to be close to most
of the wild American ginseng samples. Since the variations between wild
American ginseng themselves were quite large, it is not adequate to say that
CHAPTER 3. METABOLOMIC QUALITY CONTROL 134
sample 20 is wild American ginseng, and clearly, it is not, because there is no
appearance features of sample 20 that fits those of wild American ginseng.
After exclusion of the sugar region, in the PCA (see scores plot figure 3.12)
of 31 batches of cultivated American ginseng, wild American ginseng and
Asian ginseng, the scores of sample 20 appeared close to the cultivated Amer-
ican ginseng in the PCA scores plot, but further away from wild American
ginseng.
By closely investigating the overlapping spectra of 4 kinds of ginseng
samples, it is found that at 3.213 ppm, there is a doublet peak in sample 20,
which does not occur in any of the cultivated American ginseng samples.
At 2.40, 2.74 and 4.31 ppm, doublet-doublet peaks were present in almost
all the ginseng samples, except for sample 20. These peaks were confirmed
to be malate.
At 4.65 ppm a a double-doublet peak was present in all the wild Ameri-
can ginseng samples and sample 20, but not in cultivated American ginseng
samples. All these evidences show sample 20 is neither wild nor cultivated
American ginseng, nor Asian ginseng.
Although PCA did not pick up sample 20 in the first stage, excluding the
sugar revealed that sample 20 is suspect. Based on 1H-NMR spectra, it is
almost certain that sample 20 is a different species other than those ginseng
studied in this chapter. Malate and 3.21, 4.65 ppm can be used to distinguish
sample 20 from commercially valuable ginseng, and potentially be usefully
at identifying fake ginseng with non-commercial value.
3.4 Conclusion
For the first time robust and distinctive difference of Asian ginseng from
American ginseng were found and the key metabolites responsible were iden-
tified as sucrose, glucose, arginine, and choline, based on the data of 15
batches of CAG, 11 batches of WAG and 5 batches of ASG from Chinese
medicine stores all over China. A previous report quantifying the metabolite
content did not report any difference of arginine and choline between culti-
vated American and Asian ginseng[16]. In that report only 2 geographically
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Table 3.7: Summary of difference in metabolites between CAG, WAG and
ASG. The underlined metabolites present a higher content in the underlined
ginseng type in each comparison.
Comparison metabolites that are different
CAG and ASG sucrose, glucose, arginine, choline, 2-oxoglutarate,
malate (2.742 ppm), glutamate, GSS-16, 28 (1.35, 1.29 ppm)
WAG and ASG arginine, choline, 2-oxoglutarate,
malate (2.742 ppm), glutamate, GSS-30, 29, 28, 26, 16
CAG and WAG (sucrose and glucose: for some of the WAG)
glutamate, GSS-30, 29, 28, 26, 16
different Asian ginseng batches and 1 American ginseng batch was studied.
Although 5 biological replicates were used, the fact that they were grown
in the same field and the same year results in the metabolite compositions
being very similar. Therefore the result might not be a good representative.
To the author’s best knowledge, it is the first time that 1H-NMR-PCA
method is used to analyse primary metabolites of wild American ginseng
samples, although there are several reports on major ginsenosides contents
of wild and cultivated American ginseng using HPLC[113][116][112].
This study used a large sample size of commercially available ginseng
samples collected from 15 pharmacy stores over 5 provinces in China. It
is a good representation of the metabolite composition of wild, cultivated
American ginseng and Asian ginseng. The relative content of metabolites
were quantified and compared, and summarised in table 3.7.
It was found that there is a large variance within the WAG and ASG
samples themselves. The variance between CAG samples is much smaller
comparing to those. Differences between wild American ginseng were dis-
cussed and analysed. A suspected fake American ginseng sample (Sample
20) was successfully distinguished from the genuine samples.
Novelty in the present study used a multi-step region-excision PCA on
analysing the metabolite composition of ginseng extract. This model excises
the most abundant metabolites of ginseng extract from the NMR spectra
before PCA, and correlated the differences between ginseng types to the less
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abundant metabolites.
Chapter 4
Proteomic quality control of
American ginseng on MIN6
pancreatic β cells using DIGE
4.1 Introduction
In the previous chapters, the quality of traditional Chinese medicines was
assessed using chromatography and spectroscopy of complex herbal extracts
by principal component analysis. Clear separations between very similar
TCM were achieved, including separation of Asian and American ginseng
(Chapter 3), and separation of Danshen grown in different locations (Chapter
2). This was carried out using principal component analysis on a holistic
profile of chemical constituents, obtained by either NMR, HPLC or IR. This
chemical based quality control method is usually applied using a number of
TCM samples from trusted sources and excluding the outliers using statistical
analysis on the profiles of chemical constituents, then comparing unknown
plant samples with the known ones.
However, there are always some undetectable compounds present due to
the limitations of detection methods (discussed in section 3.1.6), and those
compounds might also contribute to the effects of TCM. If the effects of TCM
can be measured and controlled directly, the control of chemical composition
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might be skipped. This is the purpose of the study in this chapter.
In order to control the complex effects of the multiple ingredient TCM,
a high-throughput, information-rich biological assay is needed. In the next
section, Various high-throughput, information-rich “Omics” techniques are
compared and discussed, based on their potential application on quality con-
trol of TCM. Among those, proteomics was chosen as a potential method.
Various concentrations of wild and cultivated American ginseng were
tested on pancreatic MIN6 cells. The highest concentrations without caus-
ing >5% cell death were selected, and used to treat MIN6 cells over a period
of 24, 48 and 66 hours. The cellular proteins were analysed using the dif-
ference in gel electrophoresis (DIGE), and the up/down regulated proteins
before and after treatment were selected and compared between wild and
cultivated American ginseng treatment.
4.1.1 Various “Omics” techniques used in TCM study
In recent years, information rich, high through put “Omics” methods are be-
coming increasingly popular, including metabolomics, genomics, transcrip-
nomics, and proteomics. The “Omics” techniques are favourable for TCM
studies is because their holistic nature coincides with TCM’s “synergy” prin-
ciple[117].
Those “omics” methods can be used to describe the TCM’s own biological
features; or used as a systems biology approach to evaluate the biological
features of the in vitro/in vivo samples treated by the TCM.
Many of the previous published reports using “omics” focus on biological
features such as the metabolites[15], DNA sequence [118–120], proteomic
profile [121] of the TCM itself, instead of linking it to its effects on another
biological system, such as cells or animals. Only a fraction of the reports
using the “omics” methods are using the systems biology approach[117].
4.1.2 Metabolomics and metabonomics
Metabolomics and metabonomics are often used interchangeably, however,
strictly speaking there are some subtle differences in terms of their differ-
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ent usages. Metabolomics is usually about the analytical description of the
metabolite profile of a biological system, but metabonomics focuses more on
the effects of stimuli on global dynamic metabolites [122]. In terms of their
usage on TCM, metabolomics can be used to focus on the metabolites of a
TCM, as discussed in chapter 2 and 3; metabonomics may be used to relate
the quality of TCM to its biological effect. Usually, metabonomics studies on
TCM are done by collecting urine or blood samples of human or animal test
subjects treated by a TCM, thereby linking the changes in their metabolite
profiles to its effects [123].
A urinary metabonomic method based on ultra-performance liquid chro-
matography coupled with mass spectrometry (UPLC/MS) was used to study
the therapeutic effects of Rhizoma Drynariae on the “Kidney-Yang Deficiency
syndrome” [123]. Some significantly changed metabolites were found to be
related to the disturbance in energy metabolism, amino acid metabolism and
gut microflora, which were related to the syndrome. However, this research
is only focusing on the effect of the TCM, but not discussing the quality
which might lead to different effect.
To the author’s best knowledge, there is no report using metabonomics on
evaluating the quality of TCM by linking the TCM quality to the metabolite
changes in the treated and control animal/cell model. Animal metabolites are
usually primary metabolites, the numbers are less than the rich and distinc-
tive secondary metabolites existing in plants. There might be some animal
metabolites that specifically response to the TCM treatment, and make the
quality control process possible. Since some research has successfully shown
that the metabolite profiles of animal models change distinctly before and
after TCM treatment [123], it might also be possible to see some difference
of the profiles of the metabolite treated by different qualities of TCM.
4.1.3 Genomics
DNA sequencing
Various DNA methods including direct DNA sequencing, Random Amplifi-
cation of Polymorphic DNA (RAPD) [118], DNA bar coding [119] and DNA
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microchip electrophoresis were used to distinguish similar species of TCM
including Asian and American ginseng samples [120].
Asian and American ginseng were successfully distinguished by direct
DNA sequencing [118]. Within the Asian ginseng species, there are differ-
ent processing methods used, including steaming and drying. However, the
DNA methods can not distinguish these differences. Since these two types of
ginseng have some distinctly different chemicals due to different processing
methods, it is important to be able to see the difference. The 1H-NMR-PCA
method has been used successfully on this [16].
RAPD had also been used in this research, but only parts of the samples
gave good quality fingerprints [118]. The RAPD method is criticised by its
potential to amplify the DNA of contaminations such as bacteria and fungus.
Besides, RAPD only works well with reasonably preserved DNA, so it is not
feasible for many commercially available dried or ground herbal medicines
with highly degraded DNAs [118].
However, the composition of DNA is not affected by the growth environ-
ment, the age and different parts of the plant, but the chemical compositions
are affected [11][124]. Because the biological effects of the plant in the human
body are mainly related to the chemical composition of the plants, it is not
adequate to only authenticate the DNA.
To summarise the above discussions, DNA methods are good to distin-
guish genetically different plants, for example, different species, which are
used as adulterants of the authentic ones, but not be able to detect the var-
ious acquired features which are also very important for the chemical con-
stituents, which might lead to different effects. Therefore the DNA method
is not a true indication of the quality of TCM.
Transcriptomics
Transcriptomics is the study of the entire collection of RNAs (transcriptome)
encoded by the genome of a specific cell or organism at a specific time or
under a specific set of conditions. Since the genome is almost identical in
every cell within human or other animals, it is interesting to know which gene
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is turned on (transcribed into RNA molecules) or off in the cells or tissues in
an organism.
Some researchers used transcriptomics on the study of the activities of
TCM. A well established TCM formula “Huang Qin Tang” consists of four
herbs which were found to reduce chemotherapy(CPT-11)-induced gastroin-
testinal toxicity in a phase I/II clinical trial [125]. The expression levels
of four important marker genes related to cell recovery were monitored in
the control and treated experiments, and “Huang Qin Tang” was found to
be able to recover the gene expression levels of Lgr5 and Olfm4, which was
decreased by CPT-11 [125].
This demonstrates a potential possibility of using gene expression mi-
croarray analysis for activity-based quality control of TCM. Although it is
not “high-throughput”, in that they have used only four marker genes sug-
gested by previous research to investigate the activity of TCM, it is partially
“systematic” by using a herbal mixture instead of isolated compounds. The
ideal systems biology quality control method for TCM should be “system” to
“system”, that is, from the “system” of complex herbal compounds mixture,
to the “system” of the TCM treated biological sample, focusing on either
RNA, small molecule metabolite or proteins in cell, animal, or human. It
will be even better to unite all of the information mentioned together, which
is impossible with the current ability.
4.1.4 Proteomics
The original definition of “PROTEOME” analysis means “The analysis of the
entire PROTEin complement expressed by a genOME, or by a cell or tissue
type.” [126] The idea of studying the complete complement of proteins in
a cell was made possible by two dimensional gel electrophoresis (2D-GE),
which had already been used in the 1970s to separate proteins [127]. 2D-
GE offers a high resolution of protein separation, that up to thousands of
proteins can be separated in one gel.
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Various proteomic methods
2D-GE separates proteins according to their isoelectric points in the first
dimension and molecular sizes in the second dimension, which are indepen-
dent of each other. These two parameters can separate several thousands of
proteins in a gel. The separated proteins can be preserved in the gel matrix
until further identification using MS.
Apart from 2D-GE techniques, gel-free methods including iTRAQ (iso-
baric tag for relative and absolute quantitation) and iCATs (isotope-coded
affinity tags) also became popular [128][129][130]. These methods use iso-
tope tags to label proteins, then separate them using multiple liquid chro-
matography, followed by MS identification. The gel-free proteomic methods
eliminate the complex 2D-GE experimental process, but are not be able to
visualise a large part of proteome and analyse complex protein lysates as
easily. Currently no report was found using gel-free proteomic methods on
quality control of TCM.
Conventional two dimensional electrophoresis gel and its applica-
tion on plant proteomic analysis
Only a few preliminary reports have discussed the feasibility of using pro-
teomics on quality control of TCM. Most of the reports use proteomics to
study the proteome of TCM, but not TCM-treated calls or animals. For
example, silver staining 2D-GE was used to distinguish Asian and American
ginseng by profiling the proteome of their cultured cells.
The proteome profile of four parts of Asian ginseng including the main
roots, lateral roots, rhizome head and ginseng skin were analysed and 9
common protein spots were found throughout the gels. Although hundreds
of proteins were shown in the gels obtained, cross-gel matching is poor and
the the clarity of the image is not good enough to draw any firm conclusion
on the difference of the proteome of different parts of the plant [131].
Coomassie Brilliant Blue staining has been applied to the proteomic anal-
ysis of rice seedling infection [132]. The changes in the proteomics profile of
rice plants before and after Sinorhizobium meliloti 1021 infection was stud-
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ied. It was found that photosynthesis related proteins were up-regulated only
in leaf sheath and leaf, while the up-regulated proteins in roots were solely
defense related [132].
Two-fold changes of protein abundance are regarded as significant using
Coomassie Brilliant Blue. However, this ratio of changes can be reduced to
1.2 with the use of the modern DIGE method, since difference of protein
changes less than 10% can be detected with over 95% confidence [133].
Difference in gel electrophoresis(DIGE)
Comparing to the conventional 1-sample-per-gel 2D-GE techniques including
silver staining or Coomassie Brilliant Blue methods, the 3-sample-per gel
DIGE method is a great improvement allowing internal standard, control
and treated samples to be loaded on the same gel, therefore reducing the
number of technical replicates needed.
One of the drawbacks of using silver staining 2D-GE technique is that
not only biological replicates, but also technical replicates should be used for
each sample. “Biological replicates” means different batches of the prepared
protein samples, in order to eliminate the protein preparation/sample vari-
ance; “technical replicates” means to run a few (at least 3) gels for each batch
of proteins, in order to eliminate the many possibilities causing variance dur-
ing gel preparing/running/staining practice. It is a great amount of work to
run enough gels to meet the statistical significance requirement. Therefore
many papers published using conventional staining methods including silver
or Coomassie Brilliant Blue, have difficulties to quantify the proteins and to
tell the differences between gels.
As indicated in figure 4.1, 1/3 of control and 1/3 of treated samples
were taken and combined to make the internal standard sample, which was
labelled with Cy2. Test samples (Control and treated) are labelled with Cy3
and Cy5. The three labelled samples are then mixed together and loaded
on an immobilised pH gradient (IPG) strip, which is the first dimensional
separation according to the isoelectric points of the proteins. Then the IPG
strip (1D) is placed on top of an SDS gel for the second dimension separation
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Figure 4.1: Simplified schematic representation showing the creation of a
pooled standard in DIGE. The sample proteins are labelled with Cy3 and Cy5,
the internal standard with Cy2. Details of the dyes see section 4.2.8. Adapted
from “Proteomics in Practice” by Westermeieret al. (2008) [133].
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according to the molecular weight of the proteins.
After the second dimension is finished, the gel is then scanned at different
wavelengths to obtain three separate images representing the protein profiles
of the three samples. Because the three protein samples are run in the same
gel, they have the same experimental conditions, and therefore a largely
improved reproducibility and accuracy of 2D-GE technique. The excitation
range of Cy3, Cy5 and Cy2 are not overlapping with each other, therefore
there is no risk of interfering during scanning.
Comparing to the medium sensitive Coomassie Brilliant Blue staining
method, with a sensitivity of 20 ng of BSA, DIGE fluorescent labelling has a
high sensitivity of 25 pg. Although this sensitivity is similar to silver staining
which is around 1-60 ng, the dynamic range of DIGE fluorescent labelling
(< 105) is much higher that that of the silver staining(< 102) method (Ettan
DIGE System, User Manual, GE Healthcare). Therefore in terms of precise,
quantitative, and sensitive analysis, DIGE is much preferable over Coomassie
brilliant Blue and silver staining. The invention of DIGE greatly advanced
the ability of 2D-GE and remains unrivalled among the various proteomic
techniques [134].
Limitations
Although DIGE is already a great improvement than the traditional one
protein per gel staining method, it still has some shortcomings:
1. The following proteins cannot be analysed: proteins with PI lower
than 3 or higher than 11; similarly, proteins having a molecular weight lower
than 8 kDa or higher than 250 kDa.
2. The experimental time is long. It usually takes 4 days from labelling
the protein to obtain a DIGE image. This excludes the time spent on cell
culturing, protein extraction and purification, and MS identification, which
could easily be a few weeks.
3. Hundred of experimental steps were included in the protocol. There-
fore technical skill and experience is required. Attention should be paid to
every detail. For example, the sides of DIGE image can be blank if excessive
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water was present in the paper pads on the side of the IEF gel during 1D.
This can sometimes be seen even in published results.
4. There is a limitation of the sample numbers that can be analysed in
one batch. The capacities of both 1D IEF and 2D electrophoresis equipments
only allow 12 samples to be loaded.
Cross lab comparison has always been a difficulty in a 2D-GE. During the
experiment, about 20 self-mixed solvents are used and some solvents could
be stored in the fridge or at room temperature for a few weeks to a few
months. Various storage times across labs might result in slight difference in
the results. The self-made polyacrylamide gel might also be a main source of
variance. Different labs usually have different optimised recipes for making
the gels. The slight difference in gel composition might also affect the results.
Besides, among the many steps involved in preparing the DIGE experiment,
for many of them there are several ways of doing it. Usually, different labs
have their own preferences depends on the protein samples they are analysing.
Some internet-based program might assist the comparison between the
gels obtained and similar ones existed in online databases[135], including
SIB (Swiss Institute of Bioinformatics), by warping and matching the 2D
gel images automatically and manually . However, even if the same cell type
was used, due to the many factors that might affect the result - including cell
treatment, protein extraction method and pH range selected, the comparison
might become very difficult. In the current study, only one paper showing
a DIGE image of MIN6 cell was found, however this paper was using pH
4-7 as opposed to the current thesis using pH 3-10[136]. This image is not
included in the SIB. The most similar cell listed in SIB to the current study
is a mouse pancreatic islet cell 2D page map. Although MIN6 cell count for
65-80% of the cells in mouse pancreatic islet, it is still difficult to correlate
without much information of MS identified proteins. However if the DIGE
parameters are standardised, cross lab comparison should be possible.
The accuracy and reproducibility of the method is important. In a previ-
ous report, a preliminary comparison of results across 5 labs and 10 practi-
tioners were carried out, using 2 similar test samples, with each participant
using the same protocol and need to report the 200 most different proteins
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between these two samples (Voshol, H., Oral presentation, Reproducibility of
2D gel-based proteomics experiments Workshop for Proteomics Validation,
HUPO 2008, 7th Annual World Conference., 2008). The results showed that
the cross lab reproducibility is good (>84 similarity) and the results of with-
lab but different operator is excellent(>90 similarity). Most of the variation
is believed to come from the sample preparation procedure.
Application of DIGE on plant proteomic analysis
DIGE has been used to distinguish very similar plants. Strawberries grown
in different conditions were distinguished by DIGE according to their differ-
ent proteomes [121]. Grape berries during post harvest withering were also
analysed using DIGE [137]. 90 proteins were found to express differently
during berry ripening/withering and 72 were identified using MS/MS. These
papers demonstrate the possibilities of using DIGE to distinguish different
TCM. However, this method still focus on studying plant proteins, but not
link the quality to its activity on cells.
DIGE has been used to study the activities herbal medicine on cells. Con-
ventional and herbal antidepressant treatments were tested on H22 neuronal
cells, and similar changes in protein expression levels were found [138]. This
demonstrates the possibility of analysing the proteome of cells treated by
TCM.
Although the purposes of none of the papers mentioned were to use DIGE
to profile the proteome of the cells treated by different TCM, therefore to
control the quality of TCM, it indicate the possibility of doing it.
Proteins participate in the most essential life activities, and also reflect
the effect of a medicine. It will be highly beneficial if the quality of TCM
could be linked to its effect in a cell.
In this chapter, DIGE is used to study the feasibility of activity-based QC
of TCM using 2D-GE. Because ginseng products were thoroughly studied in
Chapter 3, they was selected as the ideal TCM to study their biological effects
on cells. Besides, there some known effect of ginseng on diabetes, which is
further explained in section 4.1.6. Therefore came the idea using one stable
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cell line related to diabetes (pancreatic β cell line MIN6, which is further
explained in the next section 4.1.5) as the biological system. The changes of
proteome in the cell before and after treatments by American ginseng was
studied, to explore the feasibility of quality control of TCM using proteomics.
4.1.5 Diabetes and MIN6 cells
There are three main types of diabetes: Type 1, Type 2, and gestational
diabetes. Type 1 diabetes, sometimes called insulin-dependent diabetes, is
considered to be an autoimmune disease. In this type of diabetes, pancreatic
β cells lost the function of producing insulin. Type 2 diabetes, sometimes
called non-insulin dependent diabetes, is the most common type which ac-
counts for at least 90% diabetic patients. Type 2 diabetes is related to insulin
resistance or relative insulin deficiency, usually together with pancreatic β
cell failure.
Pancreatic β cells are closely related to diabetes, due to their function
of storing and releasing insulin. They make up of 65-80% of the pancreatic
islet.
MIN6 cells are insulinoma pancreatic β cells derived from transgenic
mouse developed by Miyazaki[139]. The MIN6 cell line retains the abil-
ity to respond to glucose and other secretagogues comparable with cultured
normal mouse islet cells and has been used extensively for insulin secretion
studies [140].
In order to apply proteomics on quality control of TCM, a stable protein
composition is preferred. The reason that MIN6 cells are used instead of
pancreatic islet tissue is because, the latter is made up of at least 5 types of
cells, resulting a complex and unstable mixture of proteins that is difficult
to quantify.
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4.1.6 Herbal medicine including American ginseng used
in treatment of diabetes
Traditional Chinese medicine has been used to treat diabetes mellitus for a
long history. Li et al. have summarised 86 traditional Chinese medicines
which have demonstrated experimental or clinical effectiveness, including
Asian and American ginseng, Radix Astragali seu Hedysari, Rhizoma Ane-
marrhenae[7].
Besides TCM, there are other natural products also reported to have
anti-diabetic effects. The Indian herbal medicine Gemnema sylvestre was
reported to stimulate insulin secretion and increase intake of glucose in both
in-vivo (Wistar rats) and in-vitro (β cells in Langerhans islets) studies[141].
The effect is considered to be contributed by a group of triterpenoid saponins,
known as Gemnema acids [142].
Among those medicines, American ginseng has been found to increase
ATP and insulin production/secretion, and reduce apoptosis [143]. American
ginseng down regulates uncoupling protein-2, which is a critical protein in the
process of insulin secretion and cell survival [143]. More research is needed
to fully understand the mechanisms of the effects of American ginseng on
pancreatic β cells.
Wild (WAG) and cultivated American ginseng (CAG) studied in the pre-
vious chapter were used to treat MIN6 cells. The changes of the protein
profiles of the cells were compared and analysed between treated and un-
treated cells, and between different treatment conditions (CAG and WAG
over 24, 48, and 66 hours), thereby attempting to link the activity of Amer-
ican ginseng to its quality.
4.2 Methods
4.2.1 Preparation of ginseng extract
Wild American ginseng batch 17 and cultivated American ginseng batch 8
studied in chapter 3 were used in this study following the same extraction
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method. These two batches are available in a larger quantity and reflect a
representative character of wild and cultivated American ginseng. Ginseng
dried root material was ground using a coffee grinder and filtered through a
350µm sieve. 2.00 g of the samples was extracted with 100 ml 70% methanol
in a volumetric flask, by sonicating for 15 minutes at 30◦C followed by shak-
ing manually and sonicating for a further 15 min. After cooling to room
temperature, evaporated solvent was replaced with 70% methanol and the
volume of the solvent was made up to 100 ml. The supernatant was filtered
with a 0.2µm syringe filter.
The filtered solvent was under rotary evaporation for 30 minutes to evap-
orate methanol. The remaining of the solvent was frozen using dry ice then
lyophilized for 24 hours.
4.2.2 Cell culture
Maintenance of MIN6 cells
MIN6 cell lines were kindly provided by Professor Shanta Persaud and Profes-
sor Peter Jones (Diabetes & Nutritional Sciences Division, School of Medicine,
King’s College London).
MIN6 cells were grown in cell culture medium DMEM (D5796, Sigma)
containing 10% fetal bovine serum FBS, 1% glutamine and 2% penicillin-
streptomycin at 30◦C in an atmosphere of 95% air/5% CO2. The cell culture
flask is negatively charged for cells to attach. Cell culture medium was
changed every 3 or 4 days. When changing medium for cells in a T75 flask,
6 ml room temperature sterile phosphate buffered saline (PBS) was used to
wash the cells briefly followed by adding 10 ml 37◦C cell culture medium.
Passages 27 to 37 of MIN6 cells were used in this chapter.
Subculturing
MIN6 cells were subcultured at around 70% confluence. The cells were briefly
washed with 6 ml PBS, then trypsinized using 3 ml trypsin/EDTA solution in
a 37◦C cell culture incubator. When cells start to detach from the bottom,
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which usually takes 2-3 minutes, the flask was knocked firmly against the
palm of the hand to detach the cells completely. 7 ml of cell culture medium
was added to the flask. An autopipette was used to pipette the medium
up and down until the cells were separated into singlet or doublet. This is
important because if the cells are aggregated, they will grow in groups in new
flasks. This will result in uneven growth rate, which means that cells within
the aggregation group will grow faster and start to die while other parts of
the flask are still empty. The combined 10 ml medium was centrifuged at
1,000 rpm (200g) for 3 min. The supernatant was discarded by aspiration.
The cells were then suspended by 1 ml cell culture medium and seeded in 4
flasks.
American ginseng-treated MIN6 cells
The seeded cells grow into 70% confluence in about 7 days. Various con-
centrations of American ginseng were used to treat MIN6 cells for different
time lengths in cell viability test. When speaking of “treated” and the corre-
sponding “control” cells, it means that the same passage of MIN6 cells were
used in these two groups cultured in the same incubator.
In order to obtain a sufficient amount of protein for DIGE experiment,
American ginseng extracts were added to the cell flasks in different time
points to make sure the cells will be at 70% confluency when harvest. For
example, in order to treat the cells for 24 hours, the American ginseng ex-
tract were added in day 6, to make sure at the 7th day (when the cells are
harvested), the cell confluency is at 70%. By the same logic, in order to
obtain 48 hours treated cell, ginseng extract need to be added on the 5th day,
and for the 66 hours treated cells on the 4th day.
0.125 mg/ml wild American ginseng and 0.25 mg/ml cultivated American
ginseng were prepared by dissolving the American ginseng extract in cell cul-
ture medium directly. These ginseng concentrations were selected using cell
viability test, which are further explained in section 4.2.4 and section 4.3.1.
The solution was filtered through a sterile 0.2µm syringe filter to exclude
bacteria and particles.
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Figure 4.2: A simplified illustration of a haemocytometer grid and glass
slides. Cells that are within or touch the left or top boundary of each primary
squares are counted (shown in green), and the cells that are outside or touch
the right or bottom are not counted (shown in red).
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4.2.3 Estimation of cell number
For some experiments such as the viability test in section 4.2.4, a defined
number of cells are required. A Neubauer haemocytometer (figure 4.2) was
used to accurately determine the numbers of cells in a sample. It consists of
a heavy glass slide and a cover slip, together creating a 0.1 mm depth space.
A 10µl pipette was used to transfer cell solution into this narrow space due
to capillary action.
Under the microscope, it can be observed that the haemocytometer grid
on the thick glass slide consists of 9 main squares. Each square is 1 mm wide.
The volume of the space under the four main squares can thus be calculated:
1 mm2 × 0.1 mm × 4 = 0.4 mm3.
The cells in the 4 main squares on the four corners were used in cell
counting. To further define what means “in” the square, an illustration of
cell counting is shown in figure 4.2. Cells that are within or touching the left
or top boundary of the primary squares are counted(shown in green), and the
cells that are outside or touching the right or bottom of the primary squares
are not counted (shown in red). Using the information of the cell number
and the volume (0.4 mm3), the cell concentration of a tested sample can be
calculated. Therefore if a certain number of cells are required, the required
volume of the sample can be calculated.
4.2.4 CellTiter-Glo R© Luminescent Cell Viability As-
say
In order to select the highest possible concentration of American ginseng to
treat MIN6 cells without causing >% cell death, a cell viability test was per-
formed. CellTiter-Glo R© Luminescent Cell Viability Assay (G7570, Promega,
Madison, WI, USA) was selected due to its simplicity and precision.
Approximately 10,000 cells were seeded in each well on a 8×12 well
plate, except the 26 wells on the edge of the plates, because the medium
in the wells on the edge might evaporate more than those in the middle.
Therefore only 6×10 wells in the centre of the plate were used. After 24
hours, A series concentration of WAG and CAG were added to each well.
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Each sample was prepared with 6 technical replicates and 3 biological repli-
cates. After another 24 hours, the CellTiter-Glo R© Luminescent Cell Via-
bility Assay was added to each well. The plate was scanned by a lumi-
nescent scanner. The reagent causes cell lysis and by reacting with ATP,
it generates a luminescent signal. This signal is directly proportional to
the quantity of ATP, thus proportional to metabolically active cell num-
bers. By calculating the ratio between absorption values of treated and
control MIN6 cells, the cell viability percentage was obtained. The pro-
cedure of this experiment was following a standard protocol provided by




4.2.5 Protein extraction and purification
Treated and control MIN6 cells were trypsinized from the T75 flasks and
washed with PBS solution. This suspension was centrifuged at 13,000 rpm,
0◦C for 10 min. The supernatant was discarded and the cell pellet was lysed
in a lysis buffer containing 30 mM Tris, 7 M urea, 2 M thiourea, 4% (w/v)
CHAPS, 5µM EDTA and 10µl/ml Protease Arrest
TM
(G-Biosciences, St
Louis, MO. USA). Protease Arrest
TM
is suitable to protect protein by in-
hibiting protease activities.
This cell mixture was subjected to two quick freeze-thaw cycles with liquid
nitrogen and subsequent thawing at room temperature. The protein mixture
was centrifuged at 13,000 rpm, 0◦C for 20 min. The supernatant was col-
lected and subjected to protein purification using Perfect-FOCUS
TM
(82021-
274, G-Biosciences, St. Louis, MO. USA). This step is to get rid of agents
including ionic detergents, salts, lipids, charged polysaccharides, peptides,
nucleic acids, enzyme substrates, etc.) These agents might change the net
protein charge, therefore interfere with the later iso-electric focusing (IEF)
experiment(Technical Bulletin, Perfect-FOCUS
TM
, G-Biosciences). The pu-
rification process also has the function to concentrate protein samples, since
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there will be a minimal concentration requirement (1-5 mg/ml) in the later
fluorescence labelling process. The purification procedure involves 11 steps
and was performed according to the manufacturer’s instruction. Purified
protein was dissolved in 30-50µl lysis buffer for further experiment.
4.2.6 Protein quantification
Protein quantification was performed using Bradford Reagent (B6916, Sigma).
Bradford Reagent contains Brilliant Blue G in phosphoric acid and methanol.
Protein bonded with Brilliant Blue G shifts its absorption from 465 nm to
595 nm. The quantity of absorption is directly proportional to the quantity
of protein present in the linear range from 0.1-1.4 mg/ml.
The “96 Well Plate Assay Protocol” indicated in the technical bulletin
of Bradford Reagent was used in this study. A series of protein standards
(blank, 0.1, 0.2, 0.4, 0.8, 1.0, 1.2, 1.4 mg/ml) were prepared in a 1/3 diluted
lysis buffer (30 mM Tris, 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 5µM
EDTA and 10µl/ml Protease Arrest) using bovine serum albumin (BSA).
5µl of BSA standards and test samples were added in triplicate to separate
wells. Bradford reagent stored in the fridge was gently shaken and brought
to room temperature before use. 250µl of Bradford reagent was added to
each well that contains protein sample or standard. The 96-well plate was
gently shaken for 30 seconds and left at room temperature. After 20 minutes,
absorbance was measured using a plate reader (EL 311SX, BIOTEX, UK).
A standard curve was obtained based on the series of standard BSA protein
concentration and used to calculate the protein concentration of test samples.
4.2.7 Experimental design
70% aqueous methanol extract of wild and cultivated American ginseng were
used to treat MIN6 cells for 24, 48 and 66 hours respectively. The con-
trol and treated cells were harvested and lyophilized, and their proteins
were extracted, purified and quantified according to method described in
section 4.2.5. The proteins obtained were labelled according to table 4.1.
Details of the dyes are described in section 4.2.8 . Cy2 was used to label
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Table 4.1: Experimental design of CyDye labelling. 22 gels including 44
samples were ran in two batches. Cy3 and Cy5 were used to label test samples,
and Cy2 is used to label the internal standard. Pooled sample is made by
taking 1/3 of each test sample and mixed together in each experimental batch.
Gel 1-12 include 13 batches of cultivated American ginseng-treated cells: 24
hours × 3, 48 hours × 5, and 66 hours × 4. Gel 13-22 include 12 batches
of wild American ginseng- treated samples: 24 hours × 5, 48 hours × 3, and
66 hours × 4. Abbreviation: AG, American ginseng
Gel no. Cy2 Cy3 Cy5
Internal standard Test samples Test samples
1 Pool Cultivated AG 24h Control
2 Pool Cultivated AG 24h Cultivated AG 66h
3 Pool Cultivated AG 48h Control
4 Pool Cultivated AG 48h Cultivated AG 24h
5 Pool Cultivated AG 66h Control
6 Pool Cultivated AG 66h Control
7 Pool Cultivated AG 66h Control
8 Pool Control Cultivated AG 48h
9 Pool Control Wild AG 24h
10 Pool Control Cultivated AG 48h
11 Pool Control Cultivated AG 66h
12 Pool Control Cultivated AG 48h
13 Pool Wild AG 24h Control
14 Pool Wild AG 48h Control
15 Pool Wild AG 48h Wild AG 66h
16 Pool Wild AG 66h Control
17 Pool Wild AG 66h Wild AG 24h
18 Pool Wild AG 24h Control
19 Pool Control Wild AG 24h
20 Pool Control Wild AG 48h
21 Pool Control Wild AG 66h
22 Pool Control Wild AG 24h
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the pooled protein samples, which was used as an internal standard across
gels for normalisation. Pooled protein was made by taking 25µg from each
test sample and mixed together, and 50µg was taken from the mixture as an
internal standard used in each gel.
The protein samples were labelled with either Cy3 and Cy5. Protein
replicates were avoided to be labelled all by the same dye, in order to avoid
bias. For example, there are four biological replicates for “Wild AG 66h” in
table 4.1, two of them were labelled with Cy3 in gel 16 and 17, the other two
were labelled with Cy5 in gel 15 and 21.
4.2.8 CyDye labelling
CyDye DIGE Fluro minimal dyes are cyanine dyes including Cy3, Cy5 and
Cy2, with an NHS ester group which can bond with lysine residues in pro-
teins. This does not significantly alter the pI of the protein because a dye
carries a “+1” charge to replace a “+1” charge in the lysine residue. CyDye
DIGE Fluor saturation dyes are available for cysteine labelling, but lysine
labelling is preferable due to the simpler procedure, and the fact that lysine
is one of the most frequent present amino acids in proteins. It is rare that a
protein does not have a lysine residue.
The ratio that 50µg protein was labelled by 400 pmol CyDye is to ensure
that only 3-5% of protein will receive a tag, and the rest of the proteins will
remain unlabelled. Using this ratio, most of the labelled proteins have only
one (or two sometimes) lysine residue labelled.
50µg protein solution was adjusted to pH 8.5 by adding approximately
0.1µl diluted sodium hydroxide (100 mM). 50µg protein was labelled with
400 pmol CyDye Fluors. The labelling reaction was performed in an ice
bucket in the dark for 30 minutes. Excessive dye was quenched with 1µl
10 mM lysine in the dark on ice for 10 min. A detailed protocol of the labelling
reaction is available on the product booklet and GE Healthcare website
(http://www.gelifesciences.com/webapp/wcs/stores/servlet/product\
ById/zh/GELifeSciences-fr/25800861).
Some important details need to be noted during the experiment. 1µl of
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the CyDye working solution which contains 400 pmol CyDye DIGE Fluor was
used to label 50µg of protein. Extra attention should be paid on measuring
the volume of 1µl. An 2µl air displacement auto-pipette (Gilson Pipetman
P2 Classic Pipettes, 0.2 to 2UL) and polypropylene pipette tips were used
in this experiment. Normally water is used to calibrate the auto pipette,
using the weight and the density to calculate the corresponding volume.
However, in this case it was found not appropriate to use water to calibrate
1µl, because more than 1µl, actually around 1.2µl CyDye working solution
was taken using this water calibrated to 1µl pipette. 12µl CyDye working
solution was finished after withdrawal 10 times. In order to obtain the correct
volume of CyDye working solution, the pipette was adjusted to be able to
separate 12µl CyDye working solution into 12 parts. In this experiment,
the pipette volume mark was found to be 0.85µl to measure 1µl working
solution. The reason might be the density of DMF which was used to dissolve
the Cydyes is 944 kg/m3, lower than that of water which is 1,000 kg/m3. For
air displacement pipettes, a larger dose of liquid is aspirated for lower density
solutions. This is caused by the flexible dead air volume along with the earth
gravity (Good Laboratory Pipetting Guide, Thermo Scientific Finnpipette
Finntip, hermo Scientific). The purpose of noticing this is to make sure the
expensive CyDye DIGE Fluor is not over used than necessary. Although
400 pmol CyDye is suggested to label 50µg of protein, it has been reported
that 200 pmol CyDye should be enough [144].
4.2.9 Two dimensional electrophoresis
1D-isoelectric focusing (IEF)
Immobiline DryStrip was used in 1D-IEF. This drystrip comes with different
pH ranges. When rehydrated, it reswells and absorbs proteins. During the
IEF, proteins migrate into positions according to their isoelectric points.
pH3-10NL(NL: non linear) was chosen for this experiment, because pH3-
10 covers a reasonably large amount of proteins yet gives relatively good
separation. Non-linear means the pH range of the 1D strip is not linearly
distributed. Instead, the part where most proteins were concentrated which
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is between pH5-7 is enlarged comparing to the pH3-5 and 7-10 parts. This
allows a better separation.
50µg pooled internal standard protein, 50µg test sample labelled with
Cy3, and 50µg test sample labelled with Cy5 (according to table 4.2) were
combined and topped up to 450µl using rehydration buffer(30 mM Tris, 7M
urea, 2M Thiourea, 4% (w/v) CHAPS, 0.5% IPG buffer, 18 mM DTT and
0.002% bromophenol blue). This buffer was placed in a reswelling tray to-
gether with the Immobilized dryStrips pH3-10NL (24 cm) over night (>10
hours), for the proteins to diffuse into the gels in the strips.
The Immobiline DryStrip was rinsed briefly by spraying water using a 1 ml
auto-pipette tip and wiped dry. IEF was performed using an Ettan IPGphor
II (GE Healthcare) following a standard protocol: 500 V (1 h, step-n-hold),
1000 V (8 h, gradient), 8000 V (3 h, gradient), 8000 V (3.45 h, step-n-hold),
10,000 V (3 h, gradient) and 10,000 V (2.45 h, step-n-hold).
After the IEF, 1D strips were equilibrated using equilibration buffer con-
taining 50 mM TrisHCl (pH 8.8), 6 M urea, 30% (v/v) glycerol, 2% (w/v)
SDS, and 0.002% (w/v) bromophenol blue. The equilibration process involves
two steps. In the first step, 1D strips were incubated using the equilibration
buffer with 1% DTT for 12 minutes. In the second step, 1D strips were
incubated using the equilibration buffer with 4% iodoacetamide for another
12 min.
2D-GE
1D strips were rinsed by cathode buffer containing 0.25 M Tris, 1.92 M gly-
sine and 1% (w/v) SDS using an auto-pipette, then carefully sealed into a
18x24 cm 12.5% ployacrylamide gel (28-9374-51, GE Healthcare) with agarose
solution (gel buffer with 0.5% agarose and 0.002% bromophenol blue). The
second dimension of electrophoresis was carried out as follows: Step A,
1W/gel for 1 hour; Step B, 1.5 W/gel for 15-16 hours until the bromephenol
blue lines ran to the bottom of the gels (2-D Electrophoresis: Principles and
Methods, Handbook, GE Heathcare).
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4.2.10 DIGE gel scanning
DIGE gels sealed in low fluorescent glass plates were wiped clean using
Aldrich-Crew R© lint free wipers (Z236810, Sigma). This was used to avoid
dust showing up in the scanned images. An Ettan DIGE scanner (GE Health-
care, Chalfont St Giles, England) was used to scan the gels. The scanner is
equipped with using three lasers with wavelength at 532 nm, 633 nm, and
488 nm. The image scanning process was performed according to the manu-
facturer’s instruction. (Ettan
TM
DIGE Imager, User Manual, GE Healthcare)
Exposure and emission settings of each dye were set according to the pro-
tocol. The pixel size was set to 100µm which is required for the subsequent
analysis using DeCyder
TM
software. A test scan was carried out on a small
area of a random gel in order to optimise the exposure settings. The area
between pH 5-7 is usually where the most abundant proteins are present,
thus a good indication of the whole gel. If this area is not saturated, then it
is likely that no other experimental areas (excluding the edges) is saturated.
The exposure time should be as long as necessary yet short enough to avoid
any saturation. The maximum pixel value of the scanned image is ideally
between 30,000 and 55,000, and must be below 65,000. The same settings
should be used across all the gels belong to the same experiment. Following
these criteria, exposure settings used through out the current study were:
CY2 at 0.6 exposure, CY3 at 0.12 exposure, CY5 at 0.2 exposure.
The edges of the images were excluded during the analysis because they
were usually saturated with large amount of proteins outside the detecting
range.
4.2.11 Protein statistics
The scanned and cropped gel images were imported into DeCyder
TM
2D V.
7.0 software(GE Healthcare, Chalfont St Giles, England), which was designed
for the analysis of DIGE . It can normalise the gels according to the internal
standards and align the protein spots across images to an automatically
selected “master” image.
CHAPTER 4. PROTEOMIC QUALITY CONTROL 161
4.2.12 Protein identification
After statistical analysis of DIGE gels, interesting proteins are often selected
for further understandings of pathways and mechanisms. This is done by
running a separate preparative 2D gel which contains around 300-450µg pro-
teins for identification purposes. The preparative gel is then subjected to
silver staining and matched to the analytical gels. The selected proteins are
cut out and subjected to MS/MS analysis. In this thesis, only a few proteins
were identified as a preliminary test. Protein identification was carried out
by the proteomic service in University of Cambridge.
Silver staining
Preparative 2D gels were prepared for protein identification. CyDye labelling
was used for analytical gels and silver staining was used for preparative gels.
450µg protein was dissolved in 450µl rehydration buffer and loaded on a 1D
Immobiline DryStrip. The experimental conditions of the IEF and 2D-GE
remain the same as descried in section 4.2.9. After the second dimension,
the gel was removed carefully from the glass plates, and fixed in 45%(v/v)
methanol with 1%(v/v) acetic acid overnight. The gel was then washed
with Milli-Q water to regain shape overnight. The fixed gel was sensitised
with 0.02% (w/v) sodium thiosulfate for 1 minutes, then rinsed with Milli-Q
water for 3 times, each time 20 seconds. The gel was stained using 0.2%
silver nitrate and 0.02% formaldehyde for 20 minutes, then rinsed with Milli-
Q water for 2 times, each time 20 seconds. The stained gel was developed
using 3% sodium carbonate, 0.0005% (w/v) sodium thiosulfate and 0.05%
formaldehyde for approximately 3 minutes until the desired colour level of
the spots was shown, then termination solution which is 5% acetic acid was
poured in the gel tank from a corner. The gel was then scanned by an Epson
Expression 10000 XL scanner, and a tiff file was obtained. This image was
matched with analytical gels, and selected proteins during analysis were cut
out and subjected to in-gel digestion and further MS identification.
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In gel digestion
Desired spots were cut off using a 10 ml pipette tip in a laminar hood, and
placed into a 96-well plate. Briefly, the gel bands were destained, reduced
using DTT and alkylated using iodoacetamide and subjected to enzymatic
digestion with trypsin overnight at 37◦C. After digestion, 10µl of supernatant
was pipetted into a sample vial and loaded onto an auto sampler for auto-
mated LC-MS/MS analysis.
Orbitrap LC MS/MS
All LC-MS/MS experiments were performed using an Eksigent NanoLC-1D
Plus (Eksigent Technologies, Dublin, CA) HPLC system and an LTQ Orbi-
trap Velos mass spectrometer (ThermoFisher, Waltham, MA). Separation of
peptides was performed by reverse-phase chromatography with a flow rate of
300 nL/min and an LC-Packings (Dionex, Sunnyvale, CA) PepMap 100 col-
umn (C18, 75µM i.d. x 150 mm, 3µM particle size). Peptides were loaded
onto a precolumn (Dionex Acclaim PepMap 100 C18, 5µM particle size,
100 A, 300µM i.d x 5 mm) from the autosampler with 0.1% formic acid for 5
minutes at a flow rate of 10µL/min. After this period, the valve was switched
to allow elution of peptides from the precolumn onto the analytical column.
Solvent A was water + 0.1% formic acid and solvent B was acetonitrile +
0.1% formic acid. The gradient employed was 5-50% B in 45 minutes.
The LC eluent was sprayed into the mass spectrometer by means of a
New Objective nanospray source. All m/z (mass number/charge number)
values of eluting ions were measured in an Orbitrap Velos mass analyser, set
at a resolution to 30,000. Data dependent scans (Top 20) were employed to
automatically isolate and generate fragment ions by collision-induced disso-
ciation in the linear ion trap, resulting in the generation of MS/MS spectra.
Ions with charge states of 2+ and above were selected for fragmentation.
CHAPTER 4. PROTEOMIC QUALITY CONTROL 163
4.2.13 Data processing and database searching
Post-run, the data was processed using Protein Discoverer (version 1.2, Ther-
moFisher). Briefly, all MS/MS data were converted to mgf (text) files. These
files were then submitted to the Mascot search algorithm (Matrix Science,
London UK) and searched against Uniprot mouse database, using a fixed
modification of carbamidomethyl and variable modifications of oxidation.
4.3 Results and discussion
4.3.1 Viability test
Figure 4.3 shows the result of the cell titre viability test (section 4.2.4) of
MIN6 cells treated by a series of concentrations of 1, 0.5, 0.25, 0.125 and
0.063 mg/ml of wild American ginseng (WAG), and 0.5, 0.25, 0.125 and
0.063 mg/ml cultivated American ginseng (CAG) during 24, 48 and 66 hours.
These values of all the treated cells were normalised to the corresponding con-
trol cells. Figure 4.3 shows that a high American ginseng concentration and
a long treatment time are the two key factors causing cell death.
For MIN6 cells treated with 1 mg/ml WAG, at 24 hours 19% of the cells
were dead comparing to the controls. At 48 hours, 93% of the cells were dead
and in 66 hours, 97%. This death rate is much higher than the 0.5 mg/ml
WAG treated cells. It could be that the high concentration of WAG promoted
necrosis of the MIN6 cells. Typical morphological changes for necrosis was
visible under microscope: cells appeared swollen up like a balloon, with the
cell nucleus clearly visible [145].
For cells treated with 0.5 mg/ml wild American ginseng extract, 124% of
cells at 24 hours were alive, this means the cell number was increased by
24% compared to the untreated controls. However, after 48 hours the cell
viability level dropped to 48%, and after 66 hours it dropped to 25%. This
means that 0.5 mg/ml wild American ginseng extract promoted cell growth
in the first 24 hours, then promoted cell death.
The same case happened in 0.5 mg/ml cultivated American ginseng-treated
cells, higher than 60% cell deaths occurred in 48 and 66 hours treatment. The
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Figure 4.3: Cell titre viability test of MIN6 cells treated by a serial con-
centration of 1, 0.5, 0.25, 0.125 and 0.063 mg/ml of wild American ginseng
(WAG), and 0.5, 0.25, 0.125 and 0.063 mg/ml cultivated American ginseng
(CAG) during 24, 48, 66 hours. Control cells are untreated MIN6 cells. The
y-axis is the viability level where “1” means 100% alive. Error bars are the
standard deviations based on 6 replicates of each sample.
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cell death caused by high concentration wild/cultivated American ginseng
may be related to the ginsenosides. Rb1 and Rg1 are two of the main gin-
senosides in American ginseng extract [146], and have been found to enhance
MIN6 cell viability throughout a four hours treatment compared to control.
This might explain the increased cell growth that occurred in this experi-
ment. On the other hand, ginsenoside Rb1 and Rg1 are saponins, which
may be detrimental to membrane integrity and cell viability because of their
detergent properties [140]. This might explain cell death under treatment
with high concentrations.
The viability of MIN6 cells treated with 0.25 mg/ml WAG maintained
the same as the control after a 24 hours treatment, but was only around
80% after 48 and 66 hours treatment time. Therefore, about 20% cell dead
between 24 hours and 66 hours treated by 0.25 mg/ml wild American ginseng.
Comparing to WAG, In the case of 0.25 mg/ml, the viability level of CAG
treated MIN6 cells were 110%, 100% and 98% respectively, higher than the
WAG treated cells which were 102%, 86%(p < 0.05), and 80% (p < 0.05).
When treated by lower than 0.25 mg/ml CAG, MIN6 cells have a viability
value higher than 95% after 24, 48, and 66 hours respectively. However for
wild American ginseng, the higher than 95 % viability level only occurred
when using a concentration below 0.125 mg/ml after 24, 48, and 66 hours
respectively. Therefore wild American ginseng is “stronger” than cultivated
American ginseng when using the concentration between 0.125-0.25 mg/ml
on MIN6 cells. This finding coincide with the metabolic research in chapter
3 of this thesis. Wild American ginseng batch 17 and cultivated American
ginseng batch 8 from chapter 3 were used in this viability study. Wild Ameri-
can ginseng was shown to have more glucose but less sucrose than cultivated
American ginseng as shown by 1H-NMR, refer to section 3.3.3, and possi-
bly more ginsenosides as well, refer to section 3.3.4. MIN6 cells response
to glucose by secreting insulin. However, considering the very small quan-
tity of WAG added, the glucose content is unlikely to make a difference to
MIN6 cells[136]. The exact interaction between ginsenosides and MIN6 is
unknown. There are also many primary metabolites present in ginseng ex-
tract, and they may stimulate cell growth or induce cell death in a different
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composition. More research is needed to explain the exact mechanism.
The highest possible concentrations that caused less than 10% cell death
were chosen for further experiments. Therefore, 0.125 mg/ml for wild Ameri-
can ginseng and 0.25 mg/ml for cultivated American ginseng were chosen for
treatment concentrations.
4.3.2 A brief analysis of the DIGE images
Figure 4.4 is a typical image of a DIGE gel of MIN6 cells, treated by culti-
vated American ginseng. Each spot represents one protein. Horizontally the
proteins are between pH 3-10 NL (non-linear, with a smaller slope between
pH 5-7). Vertically the molecular weights are logarithmically arranged from
12 to 120 kDa. This image was set to black and white and the contrast
and brightness levels were manually adjusted to provide the best possible
visualisation. When a higher contrast and a higher brightness settings were
used, the smaller protein spots tend to be invisible, and with the opposite
settings the bigger protein spots tend to join with the adjacent spots and
form a back smear. This only changes the visualisation and does not affect
the stored image because the data of protein spots are stored as volume num-
bers, which are the absorption value of each spot. It is not possible to analyse
the complex DIGE images by visualisation. The function of the visualisable
image is to manually check if the alignment has been done correctly by the
software and spots were correctly selected. Sometimes when two spots are
almost overlapping each other, the software might consider them as the same
spot. This only happens in rare cases, that it can only be confirmed to be
one or two peaks by comparing it with the same spot in contain replicates
of that protein sample. In this case, adjacent proteins can be manually split
or merged as needed.
The scanned images of DIGE protein profile (a sample is shown in fig-
ure 4.4) were subjected to the batch analysis using DeCyder
TM
2-D Differen-
tial Analysis Software v7.0. The edges of the DIGE image were cropped be-
fore analysis, because they are highly saturated with proteins that do not be-
long to the analytical range (pH 3-10, molecular weight between 12-120 kDa),
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Figure 4.4: Representative 2D-DIGE image of proteins extracted from
MIN6 cells treated by American ginseng. This specific image is MIN6 treated
with cultivated American ginseng for 66 hours labelled with Cy5. Horizontally
the proteins are between pH 3-10 (non-linear, with a smaller slop between pH
5-7, referencing to the pH slope graph offered by GE). Vertically the molec-
ular weights are logarithmically arranged from 12-120 kDa referencing to a
molecular weight marker. This image was set to black and white and the con-
trast and brightness level were manually adjusted to provide the best possible
visualisation.
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thus will affect the normalisation process during the calculation.
Each of the gels were aligned to the master gel, which was automatically
selected by the software. The same proteins might not show up in exactly the
same place in different images, because of the unavoidable distortion, curving
of the gels. This can happen if there is a bubble trapped in between the 1D
IPG strip and the 2D gel, after the 2D gel is developed, the whole vertical
line under that bubble will be shifted up a little, therefore cause a curve
horizontally. It is difficult to avoid this kind of curve during 2D protein
development, because the top of the 2D gel is not usually perfectly flat,
therefore is not perfectly contacted with the 1D strip. Thus it is important to
perform alignment. The same protein across gels were automatically aligned
according to their relative positions. The protein spots labelled by Cy3 and
Cy5 were normalised to the corresponding internal standard protein labelled
by Cy2, within the same gel, in order to eliminate gel-to-gel variance.
Table 4.2: A summary of number of proteins in DIGE gel of CAG and
WAG treated and control MIN6 cells using DeCyder software. total: total
number of protein detected. up-reg: number of up regulated protein.
Treatment time total up-reg. down-reg.
CAG 24h 3563 1705 1579
48h 3563 1382 1553
66h 3563 1600 1574
WAG 48h 3504 1559 1539
66h 3504 1519 1432
As indicated in table 4.2, there are 3,563 proteins detected in the culti-
vated American ginseng-treated and control MIN6 cells, and 3,504 proteins
in the WAG treated and control MIN6 cells.
The data for treatment with WAG for 24 hours was not available, because
less than 75µg protein was collected after the cell lysis process, which is not
enough to perform DIGE (minimum 75µg).
The average of protein abundance of one treated protein among replicate
gels is divided by the average of protein abundance of that protein in control
gels. Thus a ratio of treated to control was obtained. As a brief calculation,
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without using t-test, and any ratio above 1.01 is considered up-regulated
and any below -1.01 were considered down-regulated, there are 1,705 protein
up-regulated, and 1,579 proteins down-regulated out of 3,563 proteins in
24 hours treatment with CAG. This table allows an overview of the data
obtained. However, in order to understand the changes of protein expression
levels before and after treatment, the data were analysed using student t-
test. The ratios of the abundance of the proteins in the treated MIN6 to
the controlled MIN6 cells were calculated. The t-test P value < 0.05 and a
ratio > 1.2-fold and <-1.2-fold were used as a selection criteria. Besides, the
protein need to appear in more than 90% of all the gels.
When analysing thousands of data points (protein expression levels),
p=0.05 means for every 1000 proteins there are 50 “statistically significant”
proteins can not be ruled out by the null hypothesis, which means that the
expression changes of these 50 proteins happened by randomness. One way
to solve this problem is to correct false discovery rate (FDR) on p values.
Correction methods include the Benjamini-Hochberg and the Bonferroni cor-
rections[147]. The basic theory to apply these corrections is to multiply the
p values by 3,000 (the number of protein analysed. However, this method is
often found too stringent in DIGE analysis. When applied, often few proteins
were found significant, because of the inherent variations in 2D-GE method,
and usually not many replicates are available due to the expenses. Therefore
few publications reported the FDR corrected p values.
To reduce the effect of false discovery, all the proteins that meet the initial
selection criteria were manually checked for validity, in order to exclude spots
due to dust (appeared as a very sharp peak), very tiny or overlapped proteins,
which are difficult to calculate and be distinguished from the neighbouring
proteins.
When a wide pH range (3-10) was used, the proteins are very crowded
in the top part of the gels and in the anode area, resulting the edge of the
proteins difficult to define. Sometimes it is difficult to know if the proteins
adjacent to each other are different proteins or the post-translational mod-
ifications (PTMs) of the same protein (further discussed in section 4.3.3).
When proteins are too crowded, it is also difficult to perform alignment on
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them, because their relative position are difficult to define. Proteins present
in small amount are especially affected because they can easily hide in the
shoulder of a large protein spot.
A narrow pH range such as 4-7, or even one unit pH range such as 4-5, 5-
6, can be used to achieve a high resolution, but less proteins can be included.
Therefore this is a trade-off.
However, as this chapter is only an initial study on American ginseng-
treated MIN6, a wider range of proteins were desired to be included. As
a matter of fact, some proteins have been found to be responsive to the
treatment, such as protein 2659 (figure 4.7), with a theoretical pI=8.15 which
would otherwise not show up in the narrow range pH 4-7 gel.
4.3.3 Issue with protein post-translational modifica-
tions
The effect of single or multiple post-translational modifications (PTMs) can
cause one protein to exhibit slightly different isoelectric points and molecular
weights on a 2D gel[148]. Therefore, multiple adjacent spots maybe the
same protein with different PTMs. This may be confirmed with protein
identification using mass spectrometry in future studies.
If the adjacent spots are all increasing (or decreasing), this means that
either several proteins are up (or down)-regulated, or PTMs of the same
protein are increasing(or decreasing), thus only one protein is up(or down)-
regulated. However, if the adjacent proteins show different regulation trends,
for example one increases but the one next to it decreases, it might be differ-
ent proteins with different regulation trends, or PTMs of the same protein
shift into each other. In the later case, the expression level of the protein
might not change. Figure 4.5 and figure 4.6 are two examples.
Adjacent spots show different regulation trends
Figure 4.5 shows an examples that one spot was up-regulated while its neigh-
bouring spot was down regulated before and after treatment. If these spots
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Figure 4.5: Representative 2D and 3D DIGE images of three adjacent
spots 2611, 2601 and 2604 shift into each other after treated with American
ginseng. This specific image is protein extracted from MIN6 control and
treated with cultivated American ginseng for 48 hours.
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were measured as a group, their expression levels remain the same. These
spots are likely due to PTMs.
If this was not considered during the analysis, it is likely to appear as a
false discovery. For example, spot 2611 was decreased by 60% in 48 hours
after treatment, with a t-test p value 0.017. It seems to be a significant
change. However, its neighbouring spot 2604 increased by 44% (p=0.23).
With a close inspection, it was found that even in replicate gels, spot 2611
and its neighbouring spots move into each other. After adding up all three
spots, it was found that the group expression decreased by only 12% before
and after treatment. The three spots are likely to be different PTMs of one
single protein. If that is the case, the addition of American ginseng extract
only promoted the post-translational modification of that protein. Again this
is something that can be confirmed by MS.
Adjacent spots did not change
As indicated in figure 4.6, spot M1990 is down regulated by 46% with a very
small p value of 0.00033. However the amount of this spot is very low and
it is located in between two proteins with high intensity. These two proteins
did not change after treatment (with a T/C ratio=1.01). It is likely that
M1990 is not an individual protein, but a PTM form of the neighbouring
proteins. This is why manual inspection was performed for all the proteins
that passed the initial selection criteria.
4.3.4 Expression change of protein M2659 as an exam-
ple
In figure 4.7, protein M2659 was selected as an example showing protein
expression changes with wild and cultivated American ginseng treatment
for 48 hours. Protein M2659 has a master number 2642 in wild American
ginseng-treated MIN6 cells, and master number 2659 in cultivated American
ginseng. Master number is generated by the DeCyder software according
to the location for each spot detected, started from number 1. Because
proteins extracted from WAG and CAG treated cells were analysed in two
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Figure 4.6: Representative 2D and 3D DIGE images of protein M1990
before and after treatment. This specific image is protein extracted from
MIN6 control and treated with cultivated American ginseng for 48 hours.
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Figure 4.7: Expression change of protein M2659 treated by cultivated
(CAG:left) and wild (WAG: right) American ginseng for 48 hours. Top:
View of protein spots in 2D gel. Protein M2659 were circled in purple lines.
5 replicates of MIN6 treated with cultivated American ginseng and 3 repli-
cates with wild American ginseng were shown. Middle: The average standard
abundance of replicates with standard error bars. t-test p<0.05. Bottom: 3D
view of protein M2659, arrow pointed.
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batches, the master numbers for the same protein are different in each batch.
However a manual correlation can be made according to the relative positions
of the proteins. That is the reason in this study each protein has two master
numbers when mentioning the WAG and CAG comparison.
5 replicates of protein profiles of control and treated MIN6 cells with
cultivated American ginseng were available, and 3 replicates for wild Amer-
ican ginseng were available. Highlighted spots represent protein M2659 in
replicate DIGE gels. An up-regulated 1.96-fold (t-test p=0.00028) change
was observed for cultivated American ginseng and an up-regulated 1.73-fold
(t-test p=0.0027) change was observed for wild American ginseng in 48 hours.
This result means that M2659 responded to both cultivated and wild
American ginseng treatment, but more strongly (error bars of the ratios do
not overlap) to 1 mg/ml cultivated than 0.5 mg/ml wild American ginseng
treatment.
In order to further understand how does protein M2659 respond to culti-
vated American ginseng ginseng treatment over time, a plot consisting of the
standard abundance of M2659 at 24, 48, and 66 hours is shown in figure 4.8.
Figure 4.8 consists of 3 sets of data, each representing the standard abun-
dance of protein M2659 in control and treated MIN6 cells in 24, 48 and 66
hours respectively. 1.77, 1.96 and 1.46 fold increased protein expression were
found at 24, 48 and 66 hours. Among those, the 2D views of 48 hours control
and treated proteins were shown on the left hand side of figure 4.7.
The ratios of treated to control proteins are plotted in the later discussions
in the form of three columns, instead of plotting each of the replicate proteins.
If only the ratio is plotted, the error bar of the ratios must also be plotted,
based on the error bar of the control and treated protein abundance. The
next section explains this.
Calculation of protein expression changes
The ratio of protein standard abundance of treated cells to the corresponding
control cells were calculated and unpaired t test was used, because each sam-
ple come from a different flask. The standard error of the ratio is calculated
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Figure 4.8: Plot of standard abundance of protein M2659 between CAG
treated and control MIN6 in a period 24 hours (3 replicates for both control
and treated MIN6 cells), 48 (5 replicates for both control and treated ) and
66 hours (3 replicates for control, 4 for treated) treatment.
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The abbreviations are: st.err.: standard error. Ratio: Ratio of protein
standard abundance of treated to control cells. Aver.: Average. T: pro-
tein standard abundance of treated cells. C: protein standard abundance of
control cells.
4.3.5 Effect of cultivated American ginseng on protein
expression of MIN6 cells
In order to study the protein expression changes of MIN6 cells caused by
the extract of American ginseng, some proteins were selected based on the
criteria that on one or more treatment times, the expression of the protein
was up- or down-regulated after treatment more than 1.2-fold, with a t-test
p value less than 0.05, and the protein must appear in more than 33 of the
36 gels. After the initial selection, 250 proteins out of 3563 meet the criteria.
The selected protein were then manually checked, and any fault detections
such as half proteins on the edge of the gel, dusts and PTMs were excluded.
So 73 out of the 250 proteins were finally selected and analysed. Among those,
48 proteins were significantly up-regulated, and 35 proteins were significantly
down regulated.
Based on the trend of expression changes with time, the selected proteins
were shown in 6 graphs in figure 4.9, 4.10 and 4.11. The changed ratio of
standard abundance of selected proteins extracted from control and treated
MIN6 cells were plotted.
A box drawn around some proteins using dotted lines means the included
proteins are adjacent and showed similar trend of regulation after treatment,
and they are potential PTMs of the same protein.
In the top graph of figure 4.9, proteins are up-regulated in all three time
points. Some proteins were up-regulated significantly over 50% in 48 or/and
66 hours, including 2344, 2659, 2642, 2652, 2110. This significant large
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Figure 4.9: The changed ratio of standard abundance of selected proteins
extracted from control and treated MIN6 cells. MIN6 cells were treated with
CAG in a period 24, 48, 66 hours. Top figure: An up-regulating trend is
shown in all 24, 48 and 66 hours. Bottom figure: Where the ratio goes up
above 1.2 in 48 and 66 hours treatment, but not showing a strong tendency of
increasing in 24 hours. The figures shown here are with a general trend of up
regulating and reaching its peak at 66 hours. The X-axis indicates the master
number of the proteins. The Y-axis is ratio of standard abundance of protein
between treated and control samples. Error bars are calculated according to
equation 4.1 based on 3 control and 3 treated samples for 24 hours, 5 control
and 5 treated samples for 48 hours, 4 control and 3 treated samples for 66
hours. * sign on top of the bar means that the p value from the t-test for
that data is less than 0.05, and the ratio between control and treated is <-1.2
and >1.2. A box drawn around some proteins using dotted lines means the
included proteins are adjacent and showed similar trend of regulation after
treatment, and they are potential PTMs of the same protein.
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amount of changes indicate some proteins are especially affected by CAG
treatment. Identification of those proteins might assist further understanding
of the mechanism of how American ginseng affects pancreatic β cells.
For protein 2435, in 24 hours the expression increased more than 120%
(p=0.0037), and in 48 and 66 hours it increased only 28% (p=0.28) and
35% (p=0.16). This could be that the protein responded immediately when
contacted the American ginseng, then it slowed down as time passes.
For protein 2110, it increased 76% (p=0.0024) in 66 hours, 42% (p=0.0076)
and 19% (p=0.067) in 24 and 48 hours respectively. The irregular changes
of this protein is unclear but may be related to the cell growth cycle.
There are some proteins very close to each other and form a tight group.
For example 2741, 2666, 2659, 2660, 2642, and 2652, these 6 proteins are
grouped together in the same area with a theoretical molecular weight of
22,600 kDa and pH 7.4-8.3.
A group of up regulated proteins are shown in the bottom of figure 4.9.
The general regulation trend for this group of proteins after treatment is
increasing from 24 hours and reached their highest levels in 66 hours. Proteins
2885, 2929, and 2962 are adjacent spots and the same regulation trends were
observed between them.
In the top graph in figure 4.10, the expression levels of proteins treated
for 24 and 48 hours were increased significantly, but in 66 hours there is
no significant change between control and treated proteins. Proteins 805,
798, 791, 877, 863, and 853 are adjacent and a similar regulation trend was
observed between them.
In the bottom graph in figure 4.10, only proteins treated for 48 hours
were significantly up regulated, but proteins treated for 24 and 66 hours were
not changed significantly after treatment. Among them, proteins 1779, 1785,
1799 and 1811 are adjacent. They were all increased over 30% after treatment
in 48 hours. For these proteins, at 66 hours treatment their expression levels
were decreased. The error bars for these proteins are large, this could mean
that the protein expression level started to drop down around 66 hours.
In the top graph in figure 4.11, down-regulated proteins are listed. Protein
2862 and 3172 were significantly decreased by 96% and 111% after 33 hours
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Figure 4.10: The changed ratio of standard abundance of selected proteins
extracted from control and treated MIN6 cells. MIN6 cells were treated with
CAG in a period 24, 48, 66 hours. Top figure: where the protein up-regulated
in 48 and 66 hours treatment. However did not change in 66 hours. Bottom
figure: protein up-regulated only after 66 hours treatment, but not after 24
or 66 hours. The X-axis indicates the master number of the proteins. *
Specifications are the same as for figure 4.9.
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Figure 4.11: The changed ratio of standard abundance of selected proteins
extracted from control and treated MIN6 cells. MIN6 cells were treated with
CAG in a period 24, 48, 66 hours. Top figure: Proteins were down regulated
in one or more time points of 24, 48 and 66 hours. Bottom figure: Proteins
showed different regulation trend in 24, 48 and 66 hours. The X-axis indicates
the master number of the proteins. The Y-axis is ratio of standard abundance
of protein between treated and control samples. Error bars are calculated
according to equation 4.1 based on 3 control and 3 treated samples for 24
hours, 5 control and 5 treated samples for 48 hours, 4 control and 3 treated
samples for 66 hours. * sign on top of the bar means that the p value from
the t-test for that data is less than 0.05, and the ratio between control and
treated is <-1.2 and >1.2. A box drawn around some proteins using dotted
lines means the included proteins are adjacent and showed similar trend of
regulation after treatment, and they are potential PTMs of the same protein.
.
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treatment. Proteins 446, 453 belong to one group, 1235, 1246 1263 and 1257
belong to one group, 816 and 883 belong to one group. 2771 2811 and 2862
belong to one group.
In the bottom graph in figure 4.11, most of the proteins significantly de-
creased in one time point, either 24, 48 or 66 hours. For example, protein
3164 decreased significantly by 75% (p=0.049) in 24 hours and protein 3394
decreased significantly by 62% (p=0.0086) in 48 hours. However, the proteins
in this group also have one or more time points down regulated, for example,
protein 2552 is significantly up-regulated in 24 hours treatment, but signif-
icantly decreased in 48 hours. Not all of the up-regulation trends shown
in this graph are with great significance, but it shows that those proteins
responded to the stimuli differently over time.
4.3.6 Effect of wild American ginseng on protein ex-
pression of MIN6 cells
The data in this section for wild American ginseng underwent identical anal-
ysis as for cultivated American ginseng. Selected proteins are presented in
figure 4.12 and figure 4.13. The first figure shows up-regulated proteins after
treatment, and the second figure shows the down-regulated proteins.
On the left of figure 4.12, proteins 2389, 808, 456, 461, 752, 2046 and 1732,
have a higher ratio of treated to control protein expression level in 66 hours
than in 48 hours. However, on the right part of the figure, an opposite trend
is shown in protein 250, 2321, and 235, that the changed protein expression
ratio of treated to control is higher in 48 hours than in 66 hours. This may
indicate that for the proteins on the left part of the figure, a longer treatment
time induces a larger increase of protein level.
Protein 461 and 752 increased more than 70% after treatment for 66
hours; protein 2589 and 2642 increased more than 70% after treatment for
48 hours.
In figure 4.13, some down-regulated proteins are summarised. Protein
3439 was down-regulated by 200% after 48 hours treatment, and after 66
hours, it only went down by 20%. Therefore the most changes occurred
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Figure 4.12: The changed ratio of standard abundance of selected proteins
extracted from control and treated MIN6 cells. MIN6 cells were treated with
wild American ginseng in a period of 48 and 66 hours. The proteins in
this group are up-regulated after treatment. The X-axis indicates the master
number of the proteins. The Y-axis is ratio of standard abundance of protein
between treated and control samples. Error bars are calculated according to
equation 4.1 based on 5 control and 3 treated samples for 48 hours, 4 control
and 4 treated samples for 66 hours.* sign on top of the bar means that the
p value from the t-test for that data is less than 0.05, and the ratio between
control and treated is <-1.2 and >1.2.
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Figure 4.13: The changed ratio of standard abundance of selected pro-
teins extracted from control and treated MIN6 cells. MIN6 cells were treated
with wild American ginseng in a period of 48 and 66 hours. The X-axis in-
dicates the master number of the proteins. The proteins in this group are
down-regulated after treatment. The Y-axis is ratio of standard abundance
of protein between treated and control samples. Error bars are calculated ac-
cording to equation 4.1 based on 5 control and 3 treated samples for 48 hours,
4 control and 4 treated samples for 66 hours. * sign on top of the bar means
that the p value from the t-test for that data is less than 0.05, and the ratio
between control and treated is <-1.2 and >1.2.
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around 48 hours. However, the same protein did not change after treatment
with cultivated American ginseng in any of the treated time length. Proteins
like this might be used to distinguish treatment with wild and cultivated
American ginseng.
The mechanisms of the protein changes are not clear unless further iden-
tification is carried out.
4.3.7 Change of protein expression between treatments
by wild and cultivated American ginseng
Two batches of DIGE gels with proteins extracted from MIN6 treated by wild
and cultivated American ginseng were analysed separately, and the selected
proteins were matched and compared in table 4.3, and plotted in figure 4.14
(re-arranged).
Most of the proteins showed similar regulation trend treated with both
cultivated and wild American ginseng. However, the amount of changes of
expression levels is sometimes different.
Some proteins shows a similar regulation trend between wild and culti-
vated American ginseng-treated MIN6 cells, including protein 2659 in cul-
tivated American ginseng, up-regulated by 1.96 in 48 hours, with a t-test
p value = 0.00028. When treated by wild American ginseng (master num-
ber 2642), upregulated by 1.73 in 48 hours, with a p value 0.0027. Protein
2652 in cultivated American ginseng, up-regulated by 1.95 (p=0.00078) in
48 hours, when treated by in wild American ginseng (protein master number
2589), up-regulated by 1.73 (p=0.0035) in 48 hours. In both cases proteins
in MIN6 cells treated with 1mg/ml cultivated American ginseng were up-
regulated more than those treated with 0.5mg/ml wild American ginseng.
This could mean that cultivated American ginseng has a stronger effect with
the maximum concentration that does not cause cell death on these proteins.
Although a higher concentration (0.25 mg/ml) of CAG was used than WAG
(0.125 mg/ml), these concentrations are the highest concentrations that does
not cause more than 5% cell death. The consistent changes of levels of pro-
teins in MIN6 indicated, that there are similar responses of MIN6 cells toward
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Figure 4.14: Comparison of proteins treated by wild and cultivated Amer-
ican ginseng. This bar plot presents the same data in table 4.3. Error bars
are calculated. Data bars without error bars ploted are not significant.
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Table 4.3: Comparison of proteins treated by wild and cultivated American
ginseng. 1 Protein master number, outside the bracket is the master number
for cultivated American ginseng MIN6, inside the bracket is for wild Amer-
ican ginseng. 2 Theoretical molecular weight and protein isoelectric point. 3
Treatment time.4 Ratio/t-test p value for CAG treated. 5 Ratio/t-test p value
for WAG treated.
Protein1 Th. MW/PI2 time 3 r/p CAG4 r/p WAG5
2659(2642) 22738/8.15 48h 0.00028/1.96 0.0027 /1.73
66h 0.0017/1.52 0.32/1.44
2652(2589) 22290/7.62 48h 0.00078/1.95 0.0035 /1.73
66h 0.026/1.47 0.31/1.56
2890(2889) 18323/5.28 48h 0.026 /-1.32 0.04/ -1.43
3462(3439) 10366/8.37 48h 0.038/-1.51 0.038/-3.05
2885(2848) 18453/6.13 48h 0.011/1.46 0.86 / 1.01
2503(2491) 25802/5.10 66h 0.012/1.28 0.05 /1.33
2862(2865) 18824/4.78 48h 0.0016/-1.37 0.057 / -1.3
3377(3334) 11305/7.16 48h 0.005/1.40 0.083/1.01
2929(2893) 17810/6.13 48h 0.0011/1.64 0.18/1.18
798(667) 70232/4.72 48h 0.063/1.43 0.1/1.38
805(666) 69834/4.80 48h 0.041/1.28 0.054/1.39
853(752) 68459/4.62 48h 0.07/1.35 0.017/1.77
1836(1748) 41822/4.46 48h 0.53/-1.07 0.044/-1.45
66h 0.041/-1.41 0.086/ -1.29
2323(2229) 30037/7.51 48h 0.069 /-1.34 0.027 / -1.61
66h 0.044/ -1.85 0.31/-1.52
different concentration/types of American ginseng treatment.
There are also proteins that respond differently to these different treat-
ments. For protein 2929(2893), treatment with CAG for 48 hours caused an
increase of 1.64-fold (p=0.0011), whereas treated with WAG the expression
level did not change.
Protein 798, 805, and 853 are adjacent proteins, and all showed an up-
regulating trend. Although the p value for 798 is larger than 0.05, there is
still confidence that the up regulation trend is real.
Protein 1836(1748) were down-regulated by -1.45-fold with WAG, but did
not change with CAG in 48 hours. However, in 66 hours this protein down
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regulated -1.41-fold in CAG, but only -1.29-fold in WAG. This means that
this protein started to decrease earlier in WAG treated MIN6. This same
case is shown in protein 2323(2229).
Because the data for 24h WAG treated MIN6 are not available, and less
replicates samples were used for WAG (3 replicates) than CAG (5 replicates),
standard error of protein data in CAG study is smaller than in WAG study.
Therefore more proteins in CAG study were selected as statistically signifi-
cant. Some proteins in WAG study may be ruled out with a larger p value,
purely because of technical reasons, for example, they are located on a per-
turbation area of the 2D-Gel. However, despite of the fact that less replicates
were used, there are still these proteins listed in table 4.3 that showed similar
protein changes in MIN6 cells between CAG and WAG study.
Because the DIGE experiment were performed in different batches for
WAG and CAG treated cells, the results indicate that some protein responses
of treatment with American ginseng are reproducible. This means DIGE can
be a potential tool to assess the protein profiles of MIN6 cells before and after
treated with American ginseng. If the difference of protein profiles treated
by different TCM can be standardised, DIGE can be used as a reliable tool
to perform quality control of TCM.
4.3.8 Protein identification
Table 4.4: MIN6 cell proteins identified by 2D gel electrophoresis and
ELSD-MS. PAN: primary (citable) accession number. M.W.: molecular
weight. Oat: Ornithine aminotransferase, mitochondrial
Protein name PAN M.W. location
Oat P04182 48723 mitochondrion matrix
In order to demonstrate the feasibility of orbitrap LC MS/MS for protein
identification of 2D-GE, one protein listed in table 4.4 was identified. Or-
nithine aminotransferase, mitochondrial (Oat) (p1446) was down-regulated
by 24% (p=0.0089) at 48 hours treated by CAG. It is not possible to dis-
cuss the mechanisms of American ginseng on MIN6 cells with few proteins
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identified.
In the future studies, it is suggested that all the selected proteins in sec-
tion 4.3.5, section 4.3.6 and section 4.3.7 should be identified, and their path-
ways will be analysed. It is possible that proteins shows similar regulation
trend after treatment belongs to the same pathway.
Although most of the selected proteins are not identified, their theoretical
pIs and molecular weights are known because the pH scale of the 1D IPG
strip and the range of the molecular weights of the second dimension are
known.
4.4 Conclusion and future studies
This chapter explored the possibility of connecting ginseng quality to the
proteomic profile of the MIN6 cells treated by ginsengs. A MIN6 cell viabil-
ity test was carried out before the proteomic study. When ginseng extracts
were higher than 0.5 mg/ml in cell culturing medium, both cultivated and
wild ginseng caused more than 50% MIN6 cell death after 48 hours. Wild
American ginseng was found to cause more cell death than cultivated Amer-
ican ginseng at 0.25 and 0.125 mg/ml, in 48 and 66 hours treatment. This
might indicate a more toxic effect of wild than cultivated American ginseng.
0.25 mg/ml for cultivated American ginseng and 0.125 mg/ml wild American
ginseng were selected to treat MIN6 because those concentrations caused less
than 5% cell death.
In the case that several proteins are next to each other, there may be
chance of a false discovery of protein change. Some potential PTMs of pro-
teins and a protein shoulder were illustrated. This information can contribute
and be analysed together with the future MS identifications.
Wild and cultivated American ginseng were used to treat MIN6 cells for
24, 48 and 66 hours, and DIGE analysis was performed on MIN6 cells before
and after treatment.
This method demonstrated changes more than 20% in certain proteins
in one or more of the selected time points. The protein expression level
increase or decrease in response to the treatment. Some proteins were up- or
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down-regulated in all of the three treatment times, in various degrees. Some
proteins increased or decreased more in one time point than the other time
points.
Interesting proteins were selected based on the criteria that a ratio of >
1.2 or <-1.2 of proteins abundance between control and treated was shown,
besides the t-test p value should be lower than 0.05, and the protein spots
should show up in more than 90% of all the gels analysed. 48 proteins
out of 3563 detected spots have demonstrated significant up-regulation, and
35 proteins have demonstrated significant down-regulation in at least one
treatment times in cultivated American ginseng. For wild American ginseng,
the numbers are 21 for up-regulation and 12 for down-regulation out of 3504.
The number of proteins which meet the selection criteria may increase if more
replicates were available, because the p values will be smaller accordingly.
It is possible that the regulation trends of proteins are related to protein
pathways, but it is not possible to understand the meaning and the rela-
tionship between changes of proteins and their correlations to the chemical
composition of TCM used without further study.
Apart from this, the biological samples can also be variable from each
other, because they are unique biological individuals. Even for the most
stable cell lines, different passages might have slight different compositions.
Previous research showed the difference of protein profiles between high and
low passage proteins (passage 19 and 40) in MIN6 cells[136]. In the current
study, cell passages close to each other (33, 35, and 37) were used in order to
make sure the result was not affected by the passage differences. The same
passage of cells was used for each control and the correspondent treated
experiment.
The effect of American ginseng has long been known as gentle, these
might leading to a mild effect toward the protein changes of MIN6 cells. If a
TCM with proven strong effect are selected to treat a cell line, it might be
easier to see bigger difference before and after treatment.
It is also recommended that for a preliminary experiment, less treatment
conditions including different time points, should be used but increase the
biological replicates, in order to obtain a good statistical result. For other
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techniques such as 1H-NMR, HPLC, it is possible to use many technical
and biological replicates, where using a large sample size is cheap and easy.
However this is not possible for the current DIGE analysis, due to the high
price and many experimental steps involved. It is recommended that 24
samples are loaded on 12 gels as one experiment, this could include 4 groups,
for example 2 control and 2 treated groups, with 6 replicates each. This will
allow a good statistic result to be obtained. In this study, 5 batches of MIN6
cells treated by cultivated American ginseng for 48 hours were available for
analysis, and a very good reproducibility and a small error bar was obtained.
This is a preliminary study innovatively using DIGE technique on the
systematic quality control of herbal medicines, attempting to connect the
activity of TCM, in this case the whole protein profile to the whole plant ex-
tract. In this study the protein expression level of MIN6 changed by treating
with CAG and WAG, besides there are some similar and different changes
caused by CAG and WAG. Statistical analysis shows that these changes are
significant and stable, therefore it is possible to correlate these changes to
the quality of the American ginseng.
MS identifications of all the selected proteins in this chapter will help
to understand the relationship of changes of protein expression level to the
different types or concentrations of American ginseng. Some pathways might
be found to be related to disease control. If this can be linked successfully,
the quality of TCM can be linked to the protein changes directly, thus using
the “effect” to control the quality, and skip the complex intermediate steps
which might or might not relevant to the eventual purpose of TCM.
Chapter 5
General conclusion
This thesis explored the feasibility of chemical- and acitivity-based quality
control methods on TCMs including Danshen and Sanqi roots, with their
compound products, and three ginseng species.
Chemical-based methods including chromatography using HPLC-DAD
and spectroscopy including 1H-NMR and ATR-IR were used with PCA anal-
ysis. The advantages and disadvantages of each method was discussed. Each
method was found to be able to distinguish between some very similar TCMs,
depending on the type. Among them, ATR-IR spectrum is fast and easy
to do a quick screening, but was found difficult to be correlated to TCM
metabolites.
In the second chapter, various Danshen industrial and commercial prod-
ucts were screened using different methods. Danshen grown in different re-
gions, Sanqi supplied at different dates, and compound Danshen dripping pill
(CDDP) produced in different years were found to be different using HPLC-
DAD, 1H-NMR and ATR-IR hyphenated with PCA. As an initial study some
metabolites were identified.
This study shows TCM grown in different regions, and supplied at dif-
ferent times (possibly different harvesting times) have different metabolite
compositions. Therefore, it is necessary to set quality standards in planting
farms and perform routine checks. On-site labs may be set up to minimise
the quality change during harvesting, drying and transporting.
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In the third chapter, a large sample of 4 types of commercial ginseng
was studied using 1H-NMR-PCA. The differences were identified to be pri-
mary and secondary metabolites. American ginseng and Asian ginseng were
successfully distinguished from each other. Primary metabolites including
arginine and choline were found for the first time to be potential candidates
to distinguish the two species. This has provided a potential usage of these
metabolites to identify adulterant from American ginseng. Wild American
ginseng samples with different prices and suppliers were found to be very
different from each other, and some were found similar to the cultivated ones
potentially due to adulteration or low age. However, the majority of wild
American ginseng showed potentially a higher content of ginsenosides.
Chapters 2 and 3 show chemical-based TCM standardisation methods are
fast, quantitative, and comprehensive. However, it is not known if it is effec-
tive. Chemical-based methods focus on the chemical composition of TCM,
it can tell how different and what the differences are in terms of chemical
metabolites. However, what does those complex chemical mixtures mean
to human diseases, is unknown. Therefore, it is very difficult to say which
chemical composition is “good” and which is “bad”. Unless the composition
of TCM is correlated to its efficacy, it is not possible to judge whether the
quality is good.
Some studies have been carried out using TCM on specific diseases[2][3][4].
However, the effect of TCM might not only be related to one disease category
according to the western medicine. In the concept of TCM practice, different
diseases in western medicine can belong to one Zheng, which means the un-
derlying principles of diseases according to the TCM philosophy. Therefore
it is not adequate to test TCM on only one type of disease. A non-discrete
method that can reveal the holistic activity of TCM is needed. The “-omics”
techniques profiles a whole biological system from different points of view,
whether it is transcriptome or proteome. Using such a method, a holistic
view can be achieved, and details of this view may be explored if needed.
Therefore, a proteomic approach was chosen to evaluate the quality of
TCM. In the fourth chapter, concentrations of 0.25 mg/ml cultivated Ameri-
can ginseng and 0.125 mg/ml wild American ginseng extract were selected as
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the highest concentrations without causing more than 5% MIN6 cell death.
The fact that the selected concentrations were different suggested that wild
and cultivated American ginseng are different. As it was discussed, the differ-
ence might be due to the higher content of total ginsenosides in wild American
ginseng. A cell viability test may be used to test the potential toxicity of
TCM before it is used.
After the appropriate concentrations of ginseng extracts were selected,
they were used to treat MIN6 cells, and the proteins in MIN6 cells were
extracted, purified and subjected to DIGE analysis. The advantages of DIGE
are that it is quantitative, precise, and reproducible, than conventional 2D-
gel staining methods such as silver or Coomassie blue. The use of three
Cy-Dyes with no interaction to each other allows three proteins samples to
loaded on the same gel, with one sample being the internal standard. The
introduction of internal standard allows the comparison between multiple
gels, which was not possible before the invention of DIGE.
The results of the proteomic chapter showed DIGE is sensitive enough
to identify protein changes before and after ginseng treatment, and between
wild and cultivated ginseng treatment. The protein changes after treatment
were plotted at 24, 48, and 66 hours, thus a trend can be observed. After
automatic and manual selection, 48 and 35 protein spots out of 3563 were
significantly up or down-regulated by more than 20% after treated with cul-
tivated American ginseng. Among them, 20 proteins were changed by more
than 50%. The cells treated with wild American ginseng were analysed by
the same way. 33 protein spots of of 3504 were found to be significantly in-
creased or decreased by more than 20%. 10 proteins among the selected ones
were found to be up/down-regulated similarly between wild and cultivated
American ginseng, but the rest of the selected proteins either changed with
wild, or with cultivated ginseng extract.
The differences of protein changes of MIN6 cells caused by cultivated and
wild American ginseng extracts can possibly be used to distinguish ginseng
types and control the quality. Although currently it is too expensive and
time consuming to use DIGE as a routine quality control method, it shows
the possibility, and the price, and efficiency may be improved in the future
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with the advancement of techniques.
This is the first time that DIGE was used as a holistic activity-based
method to assess the quality of TCM. The significant protein changes af-
ter treatment and between treatments indicated that protein changes are
related to the addition of American ginseng, and to the types of ginseng
extracts added. These changes were also found to be reliable. For future
studies, it is suggested that the changed proteins be identified, thus a bet-
ter understanding of the relationship between protein pathways and ginseng
metabolites can be achieved.
The DIGE activity-based method used in this study can be used to study
other TCMs, preferably with a cell line which it has some known effects on.
With the invention and improvement of modern techniques, it is possible
that DIGE will work faster, cheaper and more precise.
This thesis evaluated many different techniques, and showed DIGE to
be possible as an potential TCM quality control method. This is a small
step achieving the ultimate goal of controlling the quality of a very complex
mixture of nature products. It is to be hoped that this work may contribute
to the eventual licensing of TCM preparation as traditional medicines.
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